PANTHER GO-Slim Biological Process	background_genes.par_all.raisd.txt - REFLIST (10833)	(146)	(expected)	(over/under)	(fold Enrichment)	P-value
centriole elongation (GO:0061511)	1	1	.01	+	74.20	1.35E-02
kinetochore assembly (GO:0051382)	6	2	.08	+	24.73	2.61E-03
vesicle targeting, to, from or within Golgi (GO:0048199)	3	1	.04	+	24.73	3.99E-02
calcineurin-mediated signaling (GO:0097720)	7	2	.09	+	21.20	3.62E-03
response to UV (GO:0009411)	7	2	.09	+	21.20	3.62E-03
endoderm development (GO:0007492)	7	2	.09	+	21.20	3.62E-03
positive regulation of apoptotic signaling pathway (GO:2001235)	7	2	.09	+	21.20	3.62E-03
endoderm formation (GO:0001706)	7	2	.09	+	21.20	3.62E-03
protein K63-linked ubiquitination (GO:0070534)	4	1	.05	+	18.55	5.28E-02
kinetochore organization (GO:0051383)	8	2	.11	+	18.55	4.79E-03
cytokine production (GO:0001816)	5	1	.07	+	14.84	6.56E-02
mRNA splice site recognition (GO:0006376)	10	2	.13	+	14.84	7.56E-03
regulation of cell adhesion mediated by integrin (GO:0033628)	5	1	.07	+	14.84	6.56E-02
DNA demethylation (GO:0080111)	5	1	.07	+	14.84	6.56E-02
centrosome duplication (GO:0051298)	10	2	.13	+	14.84	7.56E-03
positive regulation of protein serine/threonine kinase activity (GO:0071902)	11	2	.15	+	13.49	9.16E-03
regulation of response to wounding (GO:1903034)	6	1	.08	+	12.37	7.82E-02
platelet activation (GO:0030168)	6	1	.08	+	12.37	7.82E-02
negative regulation of MAPK cascade (GO:0043409)	24	4	.32	+	12.37	2.73E-04
regulation of telomere maintenance (GO:0032204)	6	1	.08	+	12.37	7.82E-02
heart morphogenesis (GO:0003007)	12	2	.16	+	12.37	1.09E-02
regulation of wound healing (GO:0061041)	6	1	.08	+	12.37	7.82E-02
zymogen activation (GO:0031638)	6	1	.08	+	12.37	7.82E-02
gastrulation (GO:0007369)	13	2	.18	+	11.42	1.28E-02
formation of primary germ layer (GO:0001704)	13	2	.18	+	11.42	1.28E-02
peptide catabolic process (GO:0043171)	7	1	.09	+	10.60	9.06E-02
positive regulation of actin filament bundle assembly (GO:0032233)	7	1	.09	+	10.60	9.06E-02
regulation of coagulation (GO:0050818)	7	1	.09	+	10.60	9.06E-02
SRP-dependent cotranslational protein targeting to membrane (GO:0006614)	7	1	.09	+	10.60	9.06E-02
cotranslational protein targeting to membrane (GO:0006613)	7	1	.09	+	10.60	9.06E-02
vesicle targeting (GO:0006903)	7	1	.09	+	10.60	9.06E-02
cardiac muscle tissue development (GO:0048738)	14	2	.19	+	10.60	1.48E-02
striated muscle tissue development (GO:0014706)	14	2	.19	+	10.60	1.48E-02
sarcomere organization (GO:0045214)	15	2	.20	+	9.89	1.69E-02
polysaccharide biosynthetic process (GO:0000271)	8	1	.11	+	9.27	1.03E-01
spliceosomal complex assembly (GO:0000245)	16	2	.22	+	9.27	1.91E-02
purine nucleobase metabolic process (GO:0006144)	8	1	.11	+	9.27	1.03E-01
ribosomal subunit export from nucleus (GO:0000054)	8	1	.11	+	9.27	1.03E-01
negative regulation of inflammatory response (GO:0050728)	8	1	.11	+	9.27	1.03E-01
regulation of alternative mRNA splicing, via spliceosome (GO:0000381)	17	2	.23	+	8.73	2.15E-02
centrosome cycle (GO:0007098)	17	2	.23	+	8.73	2.15E-02
centriole assembly (GO:0098534)	9	1	.12	+	8.24	1.15E-01
hemostasis (GO:0007599)	9	1	.12	+	8.24	1.15E-01
blood coagulation (GO:0007596)	9	1	.12	+	8.24	1.15E-01
glutamate receptor signaling pathway (GO:0007215)	9	1	.12	+	8.24	1.15E-01
regulation of neuron differentiation (GO:0045664)	9	1	.12	+	8.24	1.15E-01
myeloid cell differentiation (GO:0030099)	9	1	.12	+	8.24	1.15E-01
DNA modification (GO:0006304)	9	1	.12	+	8.24	1.15E-01
coagulation (GO:0050817)	9	1	.12	+	8.24	1.15E-01
centriole replication (GO:0007099)	9	1	.12	+	8.24	1.15E-01
COPII-coated vesicle budding (GO:0090114)	9	1	.12	+	8.24	1.15E-01
regulation of inflammatory response (GO:0050727)	9	1	.12	+	8.24	1.15E-01
muscle organ development (GO:0007517)	19	2	.26	+	7.81	2.66E-02
regulation of MAP kinase activity (GO:0043405)	19	2	.26	+	7.81	2.66E-02
positive regulation of synaptic transmission (GO:0050806)	19	2	.26	+	7.81	2.66E-02
tissue morphogenesis (GO:0048729)	20	2	.27	+	7.42	2.92E-02
regulation of actin filament bundle assembly (GO:0032231)	10	1	.13	+	7.42	1.27E-01
NLS-bearing protein import into nucleus (GO:0006607)	10	1	.13	+	7.42	1.27E-01
vesicle budding from membrane (GO:0006900)	20	2	.27	+	7.42	2.92E-02
response to oxidative stress (GO:0006979)	21	2	.28	+	7.07	3.20E-02
microtubule organizing center organization (GO:0031023)	21	2	.28	+	7.07	3.20E-02
negative regulation of intracellular signal transduction (GO:1902532)	54	5	.73	+	6.87	7.72E-04
activation of GTPase activity (GO:0090630)	33	3	.44	+	6.75	9.73E-03
response to light stimulus (GO:0009416)	22	2	.30	+	6.75	3.49E-02
protein targeting to ER (GO:0045047)	11	1	.15	+	6.75	1.39E-01
mitophagy (GO:0000423)	11	1	.15	+	6.75	1.39E-01
establishment of protein localization to endoplasmic reticulum (GO:0072599)	11	1	.15	+	6.75	1.39E-01
regulation of apoptotic signaling pathway (GO:2001233)	22	2	.30	+	6.75	3.49E-02
negative regulation of defense response (GO:0031348)	11	1	.15	+	6.75	1.39E-01
positive regulation of protein kinase activity (GO:0045860)	23	2	.31	+	6.45	3.79E-02
cellular component assembly involved in morphogenesis (GO:0010927)	24	2	.32	+	6.18	4.10E-02
polysaccharide metabolic process (GO:0005976)	12	1	.16	+	6.18	1.50E-01
striated muscle cell development (GO:0055002)	24	2	.32	+	6.18	4.10E-02
regulation of axonogenesis (GO:0050770)	12	1	.16	+	6.18	1.50E-01
myofibril assembly (GO:0030239)	24	2	.32	+	6.18	4.10E-02
regulation of mRNA splicing, via spliceosome (GO:0048024)	25	2	.34	+	5.94	4.42E-02
glutathione metabolic process (GO:0006749)	13	1	.18	+	5.71	1.62E-01
regulation of synaptic transmission, glutamatergic (GO:0051966)	13	1	.18	+	5.71	1.62E-01
regulation of body fluid levels (GO:0050878)	13	1	.18	+	5.71	1.62E-01
nucleus organization (GO:0006997)	13	1	.18	+	5.71	1.62E-01
calcium-ion regulated exocytosis (GO:0017156)	13	1	.18	+	5.71	1.62E-01
maturation of SSU-rRNA (GO:0030490)	27	2	.36	+	5.50	5.08E-02
translational initiation (GO:0006413)	27	2	.36	+	5.50	5.08E-02
response to radiation (GO:0009314)	27	2	.36	+	5.50	5.08E-02
calcium-mediated signaling (GO:0019722)	28	2	.38	+	5.30	5.43E-02
lytic vacuole organization (GO:0080171)	14	1	.19	+	5.30	1.73E-01
late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511)	14	1	.19	+	5.30	1.73E-01
lysosome organization (GO:0007040)	14	1	.19	+	5.30	1.73E-01
muscle tissue development (GO:0060537)	29	2	.39	+	5.12	5.78E-02
protein-DNA complex assembly (GO:0065004)	29	2	.39	+	5.12	5.78E-02
positive regulation of GTPase activity (GO:0043547)	45	3	.61	+	4.95	2.25E-02
hippo signaling (GO:0035329)	15	1	.20	+	4.95	1.84E-01
regulation of mRNA processing (GO:0050684)	30	2	.40	+	4.95	6.14E-02
positive regulation of apoptotic process (GO:0043065)	30	2	.40	+	4.95	6.14E-02
negative regulation of response to external stimulus (GO:0032102)	15	1	.20	+	4.95	1.84E-01
regulation of protein serine/threonine kinase activity (GO:0071900)	46	3	.62	+	4.84	2.39E-02
heart development (GO:0007507)	46	3	.62	+	4.84	2.39E-02
positive regulation of programmed cell death (GO:0043068)	31	2	.42	+	4.79	6.51E-02
striated muscle cell differentiation (GO:0051146)	32	2	.43	+	4.64	6.88E-02
nucleobase metabolic process (GO:0009112)	16	1	.22	+	4.64	1.95E-01
microautophagy (GO:0016237)	16	1	.22	+	4.64	1.95E-01
piecemeal microautophagy of the nucleus (GO:0034727)	16	1	.22	+	4.64	1.95E-01
embryonic morphogenesis (GO:0048598)	32	2	.43	+	4.64	6.88E-02
muscle cell development (GO:0055001)	32	2	.43	+	4.64	6.88E-02
regulation of RNA splicing (GO:0043484)	50	3	.67	+	4.45	2.96E-02
wound healing (GO:0042060)	17	1	.23	+	4.36	2.06E-01
synaptic transmission, glutamatergic (GO:0035249)	17	1	.23	+	4.36	2.06E-01
maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)	17	1	.23	+	4.36	2.06E-01
snRNA 3'-end processing (GO:0034472)	17	1	.23	+	4.36	2.06E-01
synaptic vesicle exocytosis (GO:0016079)	17	1	.23	+	4.36	2.06E-01
carbohydrate biosynthetic process (GO:0016051)	17	1	.23	+	4.36	2.06E-01
non-membrane-bounded organelle assembly (GO:0140694)	85	5	1.15	+	4.36	5.74E-03
regulation of endocytosis (GO:0030100)	18	1	.24	+	4.12	2.17E-01
microtubule polymerization (GO:0046785)	18	1	.24	+	4.12	2.17E-01
regulation of MAPK cascade (GO:0043408)	110	6	1.48	+	4.05	3.67E-03
muscle structure development (GO:0061061)	55	3	.74	+	4.05	3.78E-02
multivesicular body sorting pathway (GO:0071985)	19	1	.26	+	3.91	2.27E-01
snRNA processing (GO:0016180)	19	1	.26	+	3.91	2.27E-01
muscle cell differentiation (GO:0042692)	38	2	.51	+	3.91	9.26E-02
regulation of trans-synaptic signaling (GO:0099177)	76	4	1.02	+	3.91	1.92E-02
endosome transport via multivesicular body sorting pathway (GO:0032509)	19	1	.26	+	3.91	2.27E-01
modulation of chemical synaptic transmission (GO:0050804)	76	4	1.02	+	3.91	1.92E-02
positive regulation of organelle organization (GO:0010638)	39	2	.53	+	3.81	9.68E-02
positive regulation of canonical Wnt signaling pathway (GO:0090263)	20	1	.27	+	3.71	2.38E-01
plasma membrane organization (GO:0007009)	20	1	.27	+	3.71	2.38E-01
anatomical structure formation involved in morphogenesis (GO:0048646)	81	4	1.09	+	3.66	2.37E-02
positive regulation of protein phosphorylation (GO:0001934)	62	3	.84	+	3.59	5.10E-02
regulation of intracellular pH (GO:0051453)	21	1	.28	+	3.53	2.48E-01
Notch signaling pathway (GO:0007219)	21	1	.28	+	3.53	2.48E-01
regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079)	21	1	.28	+	3.53	2.48E-01
ribosomal small subunit biogenesis (GO:0042274)	42	2	.57	+	3.53	1.10E-01
positive regulation of hydrolase activity (GO:0051345)	63	3	.85	+	3.53	5.30E-02
regulation of GTPase activity (GO:0043087)	63	3	.85	+	3.53	5.30E-02
circulatory system development (GO:0072359)	85	4	1.15	+	3.49	2.77E-02
sulfur compound metabolic process (GO:0006790)	65	3	.88	+	3.42	5.72E-02
late endosome to vacuole transport (GO:0045324)	22	1	.30	+	3.37	2.58E-01
hemopoiesis (GO:0030097)	22	1	.30	+	3.37	2.58E-01
regulation of cellular pH (GO:0030641)	22	1	.30	+	3.37	2.58E-01
protein localization to endoplasmic reticulum (GO:0070972)	22	1	.30	+	3.37	2.58E-01
regulation of pH (GO:0006885)	22	1	.30	+	3.37	2.58E-01
positive regulation of protein modification process (GO:0031401)	67	3	.90	+	3.32	6.15E-02
actomyosin structure organization (GO:0031032)	45	2	.61	+	3.30	1.23E-01
positive regulation of Wnt signaling pathway (GO:0030177)	23	1	.31	+	3.23	2.68E-01
proteoglycan biosynthetic process (GO:0030166)	23	1	.31	+	3.23	2.68E-01
response to wounding (GO:0009611)	23	1	.31	+	3.23	2.68E-01
cell activation (GO:0001775)	23	1	.31	+	3.23	2.68E-01
regulation of response to external stimulus (GO:0032101)	46	2	.62	+	3.23	1.27E-01
negative regulation of response to stimulus (GO:0048585)	166	7	2.24	+	3.13	7.16E-03
phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200)	24	1	.32	+	3.09	2.78E-01
protein dephosphorylation (GO:0006470)	48	2	.65	+	3.09	1.36E-01
regulated exocytosis (GO:0045055)	24	1	.32	+	3.09	2.78E-01
snRNA metabolic process (GO:0016073)	24	1	.32	+	3.09	2.78E-01
mitotic spindle organization (GO:0007052)	24	1	.32	+	3.09	2.78E-01
negative regulation of signal transduction (GO:0009968)	145	6	1.95	+	3.07	1.36E-02
regulation of protein kinase activity (GO:0045859)	74	3	1.00	+	3.01	7.79E-02
synaptic vesicle endocytosis (GO:0048488)	25	1	.34	+	2.97	2.88E-01
negative regulation of cell communication (GO:0010648)	151	6	2.04	+	2.95	1.63E-02
negative regulation of signaling (GO:0023057)	151	6	2.04	+	2.95	1.63E-02
synaptic vesicle recycling (GO:0036465)	26	1	.35	+	2.85	2.98E-01
protein targeting to membrane (GO:0006612)	26	1	.35	+	2.85	2.98E-01
cytoskeleton-dependent cytokinesis (GO:0061640)	26	1	.35	+	2.85	2.98E-01
microtubule polymerization or depolymerization (GO:0031109)	27	1	.36	+	2.75	3.07E-01
anterior/posterior pattern specification (GO:0009952)	27	1	.36	+	2.75	3.07E-01
cytokinesis (GO:0000910)	27	1	.36	+	2.75	3.07E-01
positive regulation of catalytic activity (GO:0043085)	139	5	1.87	+	2.67	3.97E-02
regulation of apoptotic process (GO:0042981)	84	3	1.13	+	2.65	1.04E-01
negative regulation of transport (GO:0051051)	28	1	.38	+	2.65	3.16E-01
proteoglycan metabolic process (GO:0006029)	28	1	.38	+	2.65	3.16E-01
protein polymerization (GO:0051258)	28	1	.38	+	2.65	3.16E-01
embryo development (GO:0009790)	57	2	.77	+	2.60	1.79E-01
regulation of vesicle-mediated transport (GO:0060627)	57	2	.77	+	2.60	1.79E-01
vacuole organization (GO:0007033)	57	2	.77	+	2.60	1.79E-01
regulation of protein phosphorylation (GO:0001932)	115	4	1.55	+	2.58	6.97E-02
regulation of intracellular signal transduction (GO:1902531)	230	8	3.10	+	2.58	1.26E-02
neurotransmitter secretion (GO:0007269)	29	1	.39	+	2.56	3.26E-01
regulation of chromosome organization (GO:0033044)	29	1	.39	+	2.56	3.26E-01
transition metal ion transport (GO:0000041)	29	1	.39	+	2.56	3.26E-01
dephosphorylation (GO:0016311)	87	3	1.17	+	2.56	1.13E-01
regulation of neurogenesis (GO:0050767)	29	1	.39	+	2.56	3.26E-01
signal release from synapse (GO:0099643)	29	1	.39	+	2.56	3.26E-01
regulation of programmed cell death (GO:0043067)	88	3	1.19	+	2.53	1.16E-01
protein-RNA complex assembly (GO:0022618)	59	2	.80	+	2.52	1.89E-01
chemical synaptic transmission (GO:0007268)	121	4	1.63	+	2.45	8.07E-02
anterograde trans-synaptic signaling (GO:0098916)	121	4	1.63	+	2.45	8.07E-02
trans-synaptic signaling (GO:0099537)	122	4	1.64	+	2.43	8.26E-02
mitotic cell cycle phase transition (GO:0044772)	31	1	.42	+	2.39	3.44E-01
cell cycle phase transition (GO:0044770)	31	1	.42	+	2.39	3.44E-01
regulation of defense response (GO:0031347)	31	1	.42	+	2.39	3.44E-01
protein-RNA complex organization (GO:0071826)	63	2	.85	+	2.36	2.08E-01
positive regulation of kinase activity (GO:0033674)	63	2	.85	+	2.36	2.08E-01
tissue development (GO:0009888)	126	4	1.70	+	2.36	9.04E-02
ribonucleoprotein complex biogenesis (GO:0022613)	158	5	2.13	+	2.35	6.24E-02
regulation of DNA metabolic process (GO:0051052)	32	1	.43	+	2.32	3.53E-01
positive regulation of transferase activity (GO:0051347)	64	2	.86	+	2.32	2.13E-01
positive regulation of MAPK cascade (GO:0043410)	64	2	.86	+	2.32	2.13E-01
glycosylation (GO:0070085)	96	3	1.29	+	2.32	1.40E-01
neurotransmitter transport (GO:0006836)	32	1	.43	+	2.32	3.53E-01
proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161)	97	3	1.31	+	2.29	1.43E-01
synaptic signaling (GO:0099536)	131	4	1.77	+	2.27	1.01E-01
protein-containing complex assembly (GO:0065003)	164	5	2.21	+	2.26	7.08E-02
import into nucleus (GO:0051170)	33	1	.44	+	2.25	3.61E-01
protein N-linked glycosylation (GO:0006487)	33	1	.44	+	2.25	3.61E-01
establishment of vesicle localization (GO:0051650)	33	1	.44	+	2.25	3.61E-01
regulation of response to stress (GO:0080134)	66	2	.89	+	2.25	2.23E-01
protein import into nucleus (GO:0006606)	33	1	.44	+	2.25	3.61E-01
organelle assembly (GO:0070925)	231	7	3.11	+	2.25	3.67E-02
regulation of protein modification process (GO:0031399)	133	4	1.79	+	2.23	1.05E-01
positive regulation of molecular function (GO:0044093)	167	5	2.25	+	2.22	7.52E-02
signal release (GO:0023061)	34	1	.46	+	2.18	3.70E-01
autophagy of mitochondrion (GO:0000422)	34	1	.46	+	2.18	3.70E-01
cell division (GO:0051301)	34	1	.46	+	2.18	3.70E-01
vesicle localization (GO:0051648)	34	1	.46	+	2.18	3.70E-01
response to abiotic stimulus (GO:0009628)	68	2	.92	+	2.18	2.33E-01
positive regulation of phosphorylation (GO:0042327)	103	3	1.39	+	2.16	1.62E-01
nuclear transport (GO:0051169)	69	2	.93	+	2.15	2.38E-01
nucleocytoplasmic transport (GO:0006913)	69	2	.93	+	2.15	2.38E-01
cell cycle process (GO:0022402)	209	6	2.82	+	2.13	6.34E-02
regulation of cell communication (GO:0010646)	490	14	6.60	+	2.12	7.43E-03
regulation of neuron projection development (GO:0010975)	35	1	.47	+	2.12	3.79E-01
microtubule cytoskeleton organization involved in mitosis (GO:1902850)	35	1	.47	+	2.12	3.79E-01
regulation of signaling (GO:0023051)	494	14	6.66	+	2.10	7.83E-03
positive regulation of cell communication (GO:0010647)	177	5	2.39	+	2.10	9.10E-02
positive regulation of signaling (GO:0023056)	177	5	2.39	+	2.10	9.10E-02
positive regulation of phosphorus metabolic process (GO:0010562)	107	3	1.44	+	2.08	1.75E-01
positive regulation of phosphate metabolic process (GO:0045937)	107	3	1.44	+	2.08	1.75E-01
regulation of cell adhesion (GO:0030155)	36	1	.49	+	2.06	3.87E-01
regionalization (GO:0003002)	36	1	.49	+	2.06	3.87E-01
spindle organization (GO:0007051)	36	1	.49	+	2.06	3.87E-01
endocytosis (GO:0006897)	108	3	1.46	+	2.06	1.78E-01
regulation of hydrolase activity (GO:0051336)	109	3	1.47	+	2.04	1.82E-01
mitotic cell cycle (GO:0000278)	148	4	1.99	+	2.01	1.39E-01
chromosome segregation (GO:0007059)	74	2	1.00	+	2.01	2.63E-01
peptide metabolic process (GO:0006518)	149	4	2.01	+	1.99	1.42E-01
regulation of mRNA metabolic process (GO:1903311)	75	2	1.01	+	1.98	2.68E-01
protein localization to nucleus (GO:0034504)	38	1	.51	+	1.95	4.03E-01
regulation of kinase activity (GO:0043549)	114	3	1.54	+	1.95	1.99E-01
cell cycle (GO:0007049)	230	6	3.10	+	1.94	1.33E-01
regulation of phosphorylation (GO:0042325)	156	4	2.10	+	1.90	1.59E-01
RNA 3'-end processing (GO:0031123)	39	1	.53	+	1.90	4.11E-01
ribosomal large subunit biogenesis (GO:0042273)	39	1	.53	+	1.90	4.11E-01
animal organ morphogenesis (GO:0009887)	78	2	1.05	+	1.90	2.83E-01
regulation of transferase activity (GO:0051338)	117	3	1.58	+	1.90	2.09E-01
ribosome biogenesis (GO:0042254)	117	3	1.58	+	1.90	2.09E-01
positive regulation of cellular component organization (GO:0051130)	79	2	1.06	+	1.88	2.88E-01
regulation of small GTPase mediated signal transduction (GO:0051056)	40	1	.54	+	1.85	4.19E-01
rRNA processing (GO:0006364)	80	2	1.08	+	1.85	2.93E-01
regulation of canonical Wnt signaling pathway (GO:0060828)	40	1	.54	+	1.85	4.19E-01
regulation of catalytic activity (GO:0050790)	242	6	3.26	+	1.84	1.45E-01
positive regulation of protein metabolic process (GO:0051247)	123	3	1.66	+	1.81	2.31E-01
establishment of organelle localization (GO:0051656)	82	2	1.11	+	1.81	3.03E-01
regulation of nervous system development (GO:0051960)	41	1	.55	+	1.81	4.27E-01
autophagosome assembly (GO:0000045)	41	1	.55	+	1.81	4.27E-01
mRNA splicing, via spliceosome (GO:0000398)	82	2	1.11	+	1.81	3.03E-01
RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)	82	2	1.11	+	1.81	3.03E-01
RNA splicing, via transesterification reactions (GO:0000375)	82	2	1.11	+	1.81	3.03E-01
vesicle organization (GO:0016050)	82	2	1.11	+	1.81	3.03E-01
positive regulation of cellular component biogenesis (GO:0044089)	41	1	.55	+	1.81	4.27E-01
regulation of response to stimulus (GO:0048583)	498	12	6.71	+	1.79	4.46E-02
regulation of cell differentiation (GO:0045595)	83	2	1.12	+	1.79	3.08E-01
potassium ion transmembrane transport (GO:0071805)	84	2	1.13	+	1.77	3.13E-01
cellular modified amino acid metabolic process (GO:0006575)	42	1	.57	+	1.77	4.35E-01
potassium ion transport (GO:0006813)	84	2	1.13	+	1.77	3.13E-01
proteasomal protein catabolic process (GO:0010498)	126	3	1.70	+	1.77	2.41E-01
regulation of signal transduction (GO:0009966)	422	10	5.69	+	1.76	7.93E-02
regulation of phosphorus metabolic process (GO:0051174)	169	4	2.28	+	1.76	2.93E-01
regulation of phosphate metabolic process (GO:0019220)	169	4	2.28	+	1.76	2.93E-01
synaptic vesicle cycle (GO:0099504)	43	1	.58	+	1.73	4.43E-01
regulation of cellular localization (GO:0060341)	43	1	.58	+	1.73	4.43E-01
pattern specification process (GO:0007389)	43	1	.58	+	1.73	4.43E-01
vesicle-mediated transport in synapse (GO:0099003)	43	1	.58	+	1.73	4.43E-01
nuclear export (GO:0051168)	44	1	.59	+	1.69	4.50E-01
organelle disassembly (GO:1903008)	44	1	.59	+	1.69	4.50E-01
rRNA metabolic process (GO:0016072)	89	2	1.20	+	1.67	3.38E-01
cellular component biogenesis (GO:0044085)	581	13	7.83	+	1.66	6.32E-02
establishment or maintenance of cell polarity (GO:0007163)	45	1	.61	+	1.65	4.58E-01
protein processing (GO:0016485)	45	1	.61	+	1.65	4.58E-01
membrane organization (GO:0061024)	135	3	1.82	+	1.65	4.32E-01
regulation of cell development (GO:0060284)	45	1	.61	+	1.65	4.58E-01
endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888)	45	1	.61	+	1.65	4.58E-01
RNA splicing (GO:0008380)	91	2	1.23	+	1.63	3.48E-01
intracellular signaling cassette (GO:0141124)	139	3	1.87	+	1.60	4.38E-01
protein-containing complex organization (GO:0043933)	280	6	3.77	+	1.59	2.82E-01
supramolecular fiber organization (GO:0097435)	188	4	2.53	+	1.58	3.24E-01
protein-containing complex localization (GO:0031503)	47	1	.63	+	1.58	4.72E-01
establishment of protein localization to membrane (GO:0090150)	47	1	.63	+	1.58	4.72E-01
protein localization to membrane (GO:0072657)	96	2	1.29	+	1.55	3.72E-01
actin cytoskeleton organization (GO:0030036)	193	4	2.60	+	1.54	3.34E-01
cellular component assembly (GO:0022607)	484	10	6.52	+	1.53	1.56E-01
cilium assembly (GO:0060271)	97	2	1.31	+	1.53	3.77E-01
actin filament-based process (GO:0030029)	199	4	2.68	+	1.49	3.46E-01
regulation of transport (GO:0051049)	150	3	2.02	+	1.48	4.58E-01
chromosome organization (GO:0051276)	100	2	1.35	+	1.48	3.91E-01
negative regulation of transcription by RNA polymerase II (GO:0000122)	101	2	1.36	+	1.47	3.96E-01
amide metabolic process (GO:0043603)	203	4	2.74	+	1.46	3.55E-01
macroautophagy (GO:0016236)	51	1	.69	+	1.45	5.00E-01
mRNA processing (GO:0006397)	102	2	1.37	+	1.45	4.01E-01
Golgi vesicle transport (GO:0048193)	103	2	1.39	+	1.44	4.06E-01
protein-DNA complex organization (GO:0071824)	104	2	1.40	+	1.43	6.53E-01
establishment of protein localization to organelle (GO:0072594)	104	2	1.40	+	1.43	6.53E-01
plasma membrane bounded cell projection assembly (GO:0120031)	104	2	1.40	+	1.43	6.53E-01
positive regulation of signal transduction (GO:0009967)	157	3	2.12	+	1.42	4.72E-01
regulation of molecular function (GO:0065009)	314	6	4.23	+	1.42	3.21E-01
ncRNA processing (GO:0034470)	158	3	2.13	+	1.41	4.74E-01
cytoskeleton organization (GO:0007010)	371	7	5.00	+	1.40	3.53E-01
cell-cell signaling (GO:0007267)	213	4	2.87	+	1.39	5.38E-01
regulation of actin filament organization (GO:0110053)	54	1	.73	+	1.37	5.20E-01
positive regulation of response to stimulus (GO:0048584)	216	4	2.91	+	1.37	5.40E-01
vacuolar transport (GO:0007034)	54	1	.73	+	1.37	5.20E-01
protein localization to organelle (GO:0033365)	163	3	2.20	+	1.37	4.85E-01
RNA processing (GO:0006396)	273	5	3.68	+	1.36	4.21E-01
glycoprotein biosynthetic process (GO:0009101)	110	2	1.48	+	1.35	6.61E-01
organelle localization (GO:0051640)	110	2	1.48	+	1.35	6.61E-01
regulation of developmental process (GO:0050793)	166	3	2.24	+	1.34	4.91E-01
cilium organization (GO:0044782)	111	2	1.50	+	1.34	6.63E-01
regulation of Wnt signaling pathway (GO:0030111)	56	1	.75	+	1.32	5.33E-01
regulation of monoatomic ion transmembrane transport (GO:0034765)	56	1	.75	+	1.32	5.33E-01
regulation of plasma membrane bounded cell projection organization (GO:0120035)	56	1	.75	+	1.32	5.33E-01
small GTPase-mediated signal transduction (GO:0007264)	57	1	.77	+	1.30	5.40E-01
translation (GO:0006412)	114	2	1.54	+	1.30	6.68E-01
cell projection assembly (GO:0030031)	114	2	1.54	+	1.30	6.68E-01
regulation of cell projection organization (GO:0031344)	57	1	.77	+	1.30	5.40E-01
organelle organization (GO:0006996)	861	15	11.60	+	1.29	2.81E-01
import into cell (GO:0098657)	175	3	2.36	+	1.27	5.12E-01
peptide biosynthetic process (GO:0043043)	117	2	1.58	+	1.27	6.73E-01
ubiquitin-dependent protein catabolic process (GO:0006511)	177	3	2.39	+	1.26	5.17E-01
mitotic cell cycle process (GO:1903047)	119	2	1.60	+	1.25	6.76E-01
intracellular signal transduction (GO:0035556)	300	5	4.04	+	1.24	6.05E-01
protein targeting (GO:0006605)	60	1	.81	+	1.24	5.58E-01
autophagy (GO:0006914)	60	1	.81	+	1.24	5.58E-01
process utilizing autophagic mechanism (GO:0061919)	60	1	.81	+	1.24	5.58E-01
modification-dependent protein catabolic process (GO:0019941)	181	3	2.44	+	1.23	7.38E-01
positive regulation of intracellular signal transduction (GO:1902533)	121	2	1.63	+	1.23	6.79E-01
positive regulation of nitrogen compound metabolic process (GO:0051173)	368	6	4.96	+	1.21	6.41E-01
modification-dependent macromolecule catabolic process (GO:0043632)	184	3	2.48	+	1.21	7.40E-01
regulation of supramolecular fiber organization (GO:1902903)	62	1	.84	+	1.20	5.70E-01
positive regulation of multicellular organismal process (GO:0051240)	62	1	.84	+	1.20	5.70E-01
regulation of protein metabolic process (GO:0051246)	249	4	3.36	+	1.19	5.80E-01
regulation of monoatomic ion transport (GO:0043269)	63	1	.85	+	1.18	5.76E-01
glycoprotein metabolic process (GO:0009100)	126	2	1.70	+	1.18	6.88E-01
regulation of cellular component organization (GO:0051128)	256	4	3.45	+	1.16	7.79E-01
positive regulation of macromolecule metabolic process (GO:0010604)	384	6	5.18	+	1.16	6.50E-01
regulation of localization (GO:0032879)	193	3	2.60	+	1.15	7.47E-01
Unclassified (UNCLASSIFIED)	3827	59	51.58	+	1.14	2.22E-01
ncRNA metabolic process (GO:0034660)	195	3	2.63	+	1.14	7.48E-01
vesicle-mediated transport (GO:0016192)	391	6	5.27	+	1.14	6.54E-01
anatomical structure morphogenesis (GO:0009653)	330	5	4.45	+	1.12	8.05E-01
regulation of transmembrane transport (GO:0034762)	66	1	.89	+	1.12	5.93E-01
exocytosis (GO:0006887)	66	1	.89	+	1.12	5.93E-01
cellular localization (GO:0051641)	661	10	8.91	+	1.12	7.26E-01
proteolysis (GO:0006508)	333	5	4.49	+	1.11	8.06E-01
localization within membrane (GO:0051668)	134	2	1.81	+	1.11	7.03E-01
positive regulation of cellular metabolic process (GO:0031325)	402	6	5.42	+	1.11	6.63E-01
protein polyubiquitination (GO:0000209)	68	1	.92	+	1.09	6.04E-01
negative regulation of DNA-templated transcription (GO:0045892)	136	2	1.83	+	1.09	7.06E-01
negative regulation of RNA biosynthetic process (GO:1902679)	136	2	1.83	+	1.09	7.06E-01
regulation of nitrogen compound metabolic process (GO:0051171)	1366	20	18.41	+	1.09	7.06E-01
gene expression (GO:0010467)	620	9	8.36	+	1.08	7.21E-01
regulation of primary metabolic process (GO:0080090)	1383	20	18.64	+	1.07	7.08E-01
negative regulation of cellular process (GO:0048523)	631	9	8.50	+	1.06	8.58E-01
regulation of nucleobase-containing compound metabolic process (GO:0019219)	1122	16	15.12	+	1.06	7.84E-01
metal ion transport (GO:0030001)	212	3	2.86	+	1.05	7.64E-01
amide biosynthetic process (GO:0043604)	142	2	1.91	+	1.05	7.17E-01
regulation of anatomical structure morphogenesis (GO:0022603)	71	1	.96	+	1.05	6.20E-01
carbohydrate metabolic process (GO:0005975)	72	1	.97	+	1.03	6.25E-01
regulation of RNA metabolic process (GO:0051252)	1085	15	14.62	+	1.03	8.89E-01
macromolecule biosynthetic process (GO:0009059)	800	11	10.78	+	1.02	8.74E-01
regulation of actin cytoskeleton organization (GO:0032956)	73	1	.98	+	1.02	1.00E00
proteolysis involved in protein catabolic process (GO:0051603)	221	3	2.98	+	1.01	1.00E00
DNA metabolic process (GO:0006259)	221	3	2.98	+	1.01	1.00E00
regulation of macromolecule metabolic process (GO:0060255)	1479	20	19.93	+	1.00	1.00E00
microtubule cytoskeleton organization (GO:0000226)	148	2	1.99	+	1.00	1.00E00
regulation of actin filament-based process (GO:0032970)	74	1	1.00	+	1.00	1.00E00
positive regulation of metabolic process (GO:0009893)	446	6	6.01	-	1.00	1.00E00
regulation of cellular metabolic process (GO:0031323)	1487	20	20.04	-	1.00	1.00E00
mRNA metabolic process (GO:0016071)	149	2	2.01	-	1.00	1.00E00
biological regulation (GO:0065007)	3360	45	45.28	-	.99	1.00E00
establishment of localization in cell (GO:0051649)	451	6	6.08	-	.99	1.00E00
negative regulation of biological process (GO:0048519)	677	9	9.12	-	.99	1.00E00
negative regulation of RNA metabolic process (GO:0051253)	151	2	2.04	-	.98	1.00E00
monoatomic cation transport (GO:0006812)	227	3	3.06	-	.98	1.00E00
cellular component organization or biogenesis (GO:0071840)	1532	20	20.65	-	.97	1.00E00
regulation of transcription by RNA polymerase II (GO:0006357)	843	11	11.36	-	.97	1.00E00
regulation of cellular process (GO:0050794)	3000	39	40.43	-	.96	8.52E-01
protein catabolic process (GO:0030163)	231	3	3.11	-	.96	1.00E00
cellular macromolecule localization (GO:0070727)	387	5	5.22	-	.96	1.00E00
protein localization (GO:0008104)	387	5	5.22	-	.96	1.00E00
DNA repair (GO:0006281)	155	2	2.09	-	.96	1.00E00
regulation of biological process (GO:0050789)	3178	41	42.83	-	.96	7.84E-01
cellular anatomical entity morphogenesis (GO:0032989)	156	2	2.10	-	.95	1.00E00
nucleic acid metabolic process (GO:0090304)	631	8	8.50	-	.94	1.00E00
cellular component disassembly (GO:0022411)	79	1	1.06	-	.94	1.00E00
regulation of metabolic process (GO:0019222)	1580	20	21.29	-	.94	9.06E-01
biological_process (GO:0008150)	7006	87	94.42	-	.92	2.22E-01
positive regulation of biological process (GO:0048518)	808	10	10.89	-	.92	1.00E00
positive regulation of cellular process (GO:0048522)	730	9	9.84	-	.91	1.00E00
localization (GO:0051179)	1300	16	17.52	-	.91	7.98E-01
positive regulation of transcription by RNA polymerase II (GO:0045944)	163	2	2.20	-	.91	1.00E00
positive regulation of nucleobase-containing compound metabolic process (GO:0045935)	245	3	3.30	-	.91	1.00E00
secretion by cell (GO:0032940)	82	1	1.11	-	.90	1.00E00
negative regulation of nucleobase-containing compound metabolic process (GO:0045934)	164	2	2.21	-	.90	1.00E00
regulation of multicellular organismal process (GO:0051239)	164	2	2.21	-	.90	1.00E00
regulation of multicellular organismal development (GO:2000026)	82	1	1.11	-	.90	1.00E00
regulation of DNA-templated transcription (GO:0006355)	987	12	13.30	-	.90	8.84E-01
regulation of RNA biosynthetic process (GO:2001141)	987	12	13.30	-	.90	8.84E-01
response to stress (GO:0006950)	414	5	5.58	-	.90	1.00E00
cellular metabolic process (GO:0044237)	1907	23	25.70	-	.89	6.61E-01
cellular nitrogen compound metabolic process (GO:0034641)	913	11	12.30	-	.89	8.80E-01
regulation of organelle organization (GO:0033043)	167	2	2.25	-	.89	1.00E00
organonitrogen compound catabolic process (GO:1901565)	334	4	4.50	-	.89	1.00E00
regulation of gene expression (GO:0010468)	1253	15	16.89	-	.89	6.97E-01
cellular process (GO:0009987)	5105	61	68.80	-	.89	2.11E-01
RNA metabolic process (GO:0016070)	419	5	5.65	-	.89	1.00E00
secretion (GO:0046903)	84	1	1.13	-	.88	1.00E00
nucleobase-containing compound metabolic process (GO:0006139)	759	9	10.23	-	.88	8.70E-01
cellular component organization (GO:0016043)	1437	17	19.37	-	.88	6.25E-01
regulation of macromolecule biosynthetic process (GO:0010556)	1273	15	17.16	-	.87	6.98E-01
protein glycosylation (GO:0006486)	85	1	1.15	-	.87	1.00E00
macromolecule glycosylation (GO:0043413)	85	1	1.15	-	.87	1.00E00
metabolic process (GO:0008152)	2466	29	33.24	-	.87	4.28E-01
regulation of cellular biosynthetic process (GO:0031326)	1280	15	17.25	-	.87	6.98E-01
regulation of biosynthetic process (GO:0009889)	1285	15	17.32	-	.87	6.98E-01
macromolecule metabolic process (GO:0043170)	1800	21	24.26	-	.87	5.75E-01
endosomal transport (GO:0016197)	88	1	1.19	-	.84	1.00E00
heterocycle metabolic process (GO:0046483)	795	9	10.71	-	.84	7.48E-01
animal organ development (GO:0048513)	266	3	3.58	-	.84	1.00E00
establishment of localization (GO:0051234)	1160	13	15.63	-	.83	5.89E-01
cellular aromatic compound metabolic process (GO:0006725)	805	9	10.85	-	.83	7.49E-01
cell development (GO:0048468)	272	3	3.67	-	.82	1.00E00
developmental process (GO:0032502)	910	10	12.26	-	.82	6.51E-01
transport (GO:0006810)	1099	12	14.81	-	.81	5.80E-01
purine-containing compound metabolic process (GO:0072521)	92	1	1.24	-	.81	1.00E00
monoatomic ion transport (GO:0006811)	277	3	3.73	-	.80	1.00E00
inorganic cation transmembrane transport (GO:0098662)	185	2	2.49	-	.80	1.00E00
monoatomic cation transmembrane transport (GO:0098655)	185	2	2.49	-	.80	1.00E00
intracellular transport (GO:0046907)	371	4	5.00	-	.80	8.20E-01
organic cyclic compound metabolic process (GO:1901360)	838	9	11.29	-	.80	6.38E-01
nitrogen compound metabolic process (GO:0006807)	2059	22	27.75	-	.79	2.44E-01
export from cell (GO:0140352)	94	1	1.27	-	.79	1.00E00
intracellular monoatomic cation homeostasis (GO:0030003)	94	1	1.27	-	.79	1.00E00
intracellular monoatomic ion homeostasis (GO:0006873)	94	1	1.27	-	.79	1.00E00
cellular biosynthetic process (GO:0044249)	1043	11	14.06	-	.78	4.80E-01
signaling (GO:0023052)	1138	12	15.34	-	.78	4.17E-01
DNA damage response (GO:0006974)	190	2	2.56	-	.78	1.00E00
multicellular organismal process (GO:0032501)	761	8	10.26	-	.78	6.23E-01
macromolecule catabolic process (GO:0009057)	286	3	3.85	-	.78	1.00E00
cell communication (GO:0007154)	1159	12	15.62	-	.77	4.18E-01
protein metabolic process (GO:0019538)	1162	12	15.66	-	.77	4.18E-01
organic substance biosynthetic process (GO:1901576)	1068	11	14.39	-	.76	4.03E-01
biosynthetic process (GO:0009058)	1071	11	14.43	-	.76	4.03E-01
carbohydrate derivative biosynthetic process (GO:1901137)	195	2	2.63	-	.76	1.00E00
positive regulation of DNA-templated transcription (GO:0045893)	195	2	2.63	-	.76	1.00E00
positive regulation of RNA biosynthetic process (GO:1902680)	195	2	2.63	-	.76	1.00E00
macromolecule localization (GO:0033036)	489	5	6.59	-	.76	6.88E-01
endomembrane system organization (GO:0010256)	98	1	1.32	-	.76	1.00E00
regulation of cytoskeleton organization (GO:0051493)	100	1	1.35	-	.74	1.00E00
anatomical structure development (GO:0048856)	807	8	10.88	-	.74	4.30E-01
mitochondrion organization (GO:0007005)	101	1	1.36	-	.73	1.00E00
multicellular organism development (GO:0007275)	607	6	8.18	-	.73	5.85E-01
organic substance metabolic process (GO:0071704)	2360	23	31.81	-	.72	8.56E-02
catabolic process (GO:0009056)	517	5	6.97	-	.72	5.59E-01
intracellular chemical homeostasis (GO:0055082)	104	1	1.40	-	.71	1.00E00
organonitrogen compound metabolic process (GO:1901564)	1457	14	19.64	-	.71	2.20E-01
inorganic ion transmembrane transport (GO:0098660)	214	2	2.88	-	.69	1.00E00
organonitrogen compound biosynthetic process (GO:1901566)	428	4	5.77	-	.69	6.66E-01
primary metabolic process (GO:0044238)	2248	21	30.30	-	.69	6.37E-02
regulation of cellular component biogenesis (GO:0044087)	109	1	1.47	-	.68	1.00E00
response to stimulus (GO:0050896)	1421	13	19.15	-	.68	1.39E-01
cell differentiation (GO:0030154)	550	5	7.41	-	.67	4.50E-01
cellular developmental process (GO:0048869)	550	5	7.41	-	.67	4.50E-01
G protein-coupled receptor signaling pathway (GO:0007186)	221	2	2.98	-	.67	7.72E-01
monoatomic cation homeostasis (GO:0055080)	112	1	1.51	-	.66	1.00E00
microtubule-based process (GO:0007017)	224	2	3.02	-	.66	7.72E-01
positive regulation of RNA metabolic process (GO:0051254)	225	2	3.03	-	.66	7.72E-01
actin filament organization (GO:0007015)	113	1	1.52	-	.66	1.00E00
organic substance catabolic process (GO:1901575)	454	4	6.12	-	.65	5.31E-01
monoatomic ion transmembrane transport (GO:0034220)	230	2	3.10	-	.65	7.73E-01
organic anion transport (GO:0015711)	115	1	1.55	-	.65	1.00E00
monoatomic ion homeostasis (GO:0050801)	115	1	1.55	-	.65	1.00E00
establishment of protein localization (GO:0045184)	232	2	3.13	-	.64	7.73E-01
negative regulation of macromolecule biosynthetic process (GO:0010558)	237	2	3.19	-	.63	7.74E-01
negative regulation of biosynthetic process (GO:0009890)	238	2	3.21	-	.62	7.74E-01
negative regulation of cellular biosynthetic process (GO:0031327)	238	2	3.21	-	.62	7.74E-01
negative regulation of nitrogen compound metabolic process (GO:0051172)	245	2	3.30	-	.61	7.76E-01
phosphate-containing compound metabolic process (GO:0006796)	497	4	6.70	-	.60	4.21E-01
system development (GO:0048731)	497	4	6.70	-	.60	4.21E-01
phosphorus metabolic process (GO:0006793)	499	4	6.73	-	.59	4.22E-01
transmembrane transport (GO:0055085)	375	3	5.05	-	.59	4.93E-01
cellular homeostasis (GO:0019725)	126	1	1.70	-	.59	1.00E00
regulation of cell cycle (GO:0051726)	127	1	1.71	-	.58	1.00E00
signal transduction (GO:0007165)	1022	8	13.77	-	.58	1.16E-01
positive regulation of macromolecule biosynthetic process (GO:0010557)	256	2	3.45	-	.58	5.88E-01
nucleobase-containing small molecule metabolic process (GO:0055086)	128	1	1.73	-	.58	1.00E00
macromolecule modification (GO:0043412)	776	6	10.46	-	.57	1.94E-01
cellular response to stimulus (GO:0051716)	1299	10	17.51	-	.57	5.41E-02
cell surface receptor signaling pathway (GO:0007166)	390	3	5.26	-	.57	4.97E-01
positive regulation of cellular biosynthetic process (GO:0031328)	261	2	3.52	-	.57	5.88E-01
positive regulation of biosynthetic process (GO:0009891)	262	2	3.53	-	.57	5.89E-01
cellular catabolic process (GO:0044248)	270	2	3.64	-	.55	5.90E-01
protein modification process (GO:0036211)	699	5	9.42	-	.53	1.72E-01
protein maturation (GO:0051604)	140	1	1.89	-	.53	1.00E00
intracellular protein transport (GO:0006886)	144	1	1.94	-	.52	1.00E00
carbohydrate derivative metabolic process (GO:1901135)	289	2	3.89	-	.51	4.43E-01
plasma membrane bounded cell projection organization (GO:0120036)	289	2	3.89	-	.51	4.43E-01
chemical homeostasis (GO:0048878)	147	1	1.98	-	.50	7.26E-01
cell projection organization (GO:0030030)	295	2	3.98	-	.50	4.43E-01
protein ubiquitination (GO:0016567)	151	1	2.04	-	.49	7.26E-01
transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169)	152	1	2.05	-	.49	7.26E-01
negative regulation of cellular metabolic process (GO:0031324)	305	2	4.11	-	.49	4.46E-01
cellular response to stress (GO:0033554)	309	2	4.16	-	.48	4.47E-01
negative regulation of macromolecule metabolic process (GO:0010605)	321	2	4.33	-	.46	3.31E-01
cellular nitrogen compound biosynthetic process (GO:0044271)	323	2	4.35	-	.46	3.31E-01
negative regulation of metabolic process (GO:0009892)	332	2	4.47	-	.45	3.32E-01
homeostatic process (GO:0042592)	173	1	2.33	-	.43	7.33E-01
protein modification by small protein conjugation (GO:0032446)	176	1	2.37	-	.42	7.34E-01
peptidyl-amino acid modification (GO:0018193)	178	1	2.40	-	.42	7.36E-01
enzyme-linked receptor protein signaling pathway (GO:0007167)	185	1	2.49	-	.40	5.23E-01
regulation of biological quality (GO:0065008)	374	2	5.04	-	.40	2.48E-01
protein transport (GO:0015031)	190	1	2.56	-	.39	5.24E-01
organic substance transport (GO:0071702)	404	2	5.44	-	.37	1.82E-01
cell adhesion (GO:0007155)	205	1	2.76	-	.36	5.31E-01
protein modification by small protein conjugation or removal (GO:0070647)	235	1	3.17	-	.32	3.81E-01
post-translational protein modification (GO:0043687)	249	1	3.36	-	.30	2.67E-01
nitrogen compound transport (GO:0071705)	305	1	4.11	-	.24	1.98E-01
small molecule metabolic process (GO:0044281)	351	1	4.73	-	.21	9.48E-02
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460)	2	0	.03	-	 < 0.01	1.00E00
ribonucleoside triphosphate metabolic process (GO:0009199)	21	0	.28	-	 < 0.01	1.00E00
mononuclear cell migration (GO:0071674)	3	0	.04	-	 < 0.01	1.00E00
intermediate filament organization (GO:0045109)	8	0	.11	-	 < 0.01	1.00E00
cellular response to organic substance (GO:0071310)	142	0	1.91	-	 < 0.01	2.69E-01
negative regulation of supramolecular fiber organization (GO:1902904)	30	0	.40	-	 < 0.01	1.00E00
intermediate filament cytoskeleton organization (GO:0045104)	12	0	.16	-	 < 0.01	1.00E00
intermediate filament-based process (GO:0045103)	12	0	.16	-	 < 0.01	1.00E00
vitamin transport (GO:0051180)	10	0	.13	-	 < 0.01	1.00E00
calcium ion transmembrane transport (GO:0070588)	55	0	.74	-	 < 0.01	1.00E00
TOR signaling (GO:0031929)	9	0	.12	-	 < 0.01	1.00E00
nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289)	4	0	.05	-	 < 0.01	1.00E00
protein localization to mitochondrion (GO:0070585)	19	0	.26	-	 < 0.01	1.00E00
nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)	20	0	.27	-	 < 0.01	1.00E00
establishment or maintenance of bipolar cell polarity (GO:0061245)	14	0	.19	-	 < 0.01	1.00E00
mitotic cytokinesis (GO:0000281)	11	0	.15	-	 < 0.01	1.00E00
nuclear division (GO:0000280)	65	0	.88	-	 < 0.01	1.00E00
negative regulation of actin filament polymerization (GO:0030837)	21	0	.28	-	 < 0.01	1.00E00
sperm-egg recognition (GO:0035036)	1	0	.01	-	 < 0.01	1.00E00
negative regulation of actin filament depolymerization (GO:0030835)	17	0	.23	-	 < 0.01	1.00E00
regulation of actin filament depolymerization (GO:0030834)	19	0	.26	-	 < 0.01	1.00E00
regulation of actin filament polymerization (GO:0030833)	38	0	.51	-	 < 0.01	1.00E00
regulation of actin filament length (GO:0030832)	41	0	.55	-	 < 0.01	1.00E00
meiotic sister chromatid cohesion (GO:0051177)	2	0	.03	-	 < 0.01	1.00E00
cyclic nucleotide metabolic process (GO:0009187)	7	0	.09	-	 < 0.01	1.00E00
regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281)	16	0	.22	-	 < 0.01	1.00E00
positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280)	14	0	.19	-	 < 0.01	1.00E00
positive regulation of proteasomal protein catabolic process (GO:1901800)	15	0	.20	-	 < 0.01	1.00E00
lymphocyte mediated immunity (GO:0002449)	2	0	.03	-	 < 0.01	1.00E00
regulation of Rho protein signal transduction (GO:0035023)	20	0	.27	-	 < 0.01	1.00E00
leukocyte mediated immunity (GO:0002443)	2	0	.03	-	 < 0.01	1.00E00
apoptotic cell clearance (GO:0043277)	4	0	.05	-	 < 0.01	1.00E00
oligodendrocyte differentiation (GO:0048709)	4	0	.05	-	 < 0.01	1.00E00
negative regulation of monoatomic ion transport (GO:0043271)	16	0	.22	-	 < 0.01	1.00E00
regulation of lipid biosynthetic process (GO:0046890)	6	0	.08	-	 < 0.01	1.00E00
vesicle-mediated transport to the plasma membrane (GO:0098876)	46	0	.62	-	 < 0.01	1.00E00
endothelial cell differentiation (GO:0045446)	4	0	.05	-	 < 0.01	1.00E00
neutrophil migration (GO:1990266)	3	0	.04	-	 < 0.01	1.00E00
fat cell differentiation (GO:0045444)	2	0	.03	-	 < 0.01	1.00E00
programmed cell death (GO:0012501)	55	0	.74	-	 < 0.01	1.00E00
axo-dendritic transport (GO:0008088)	16	0	.22	-	 < 0.01	1.00E00
regulation of establishment of protein localization (GO:0070201)	12	0	.16	-	 < 0.01	1.00E00
mitochondrial fission (GO:0000266)	8	0	.11	-	 < 0.01	1.00E00
positive regulation of hormone secretion (GO:0046887)	1	0	.01	-	 < 0.01	1.00E00
regulation of potassium ion transport (GO:0043266)	15	0	.20	-	 < 0.01	1.00E00
membrane invagination (GO:0010324)	8	0	.11	-	 < 0.01	1.00E00
regulation of peptide secretion (GO:0002791)	3	0	.04	-	 < 0.01	1.00E00
peptide secretion (GO:0002790)	3	0	.04	-	 < 0.01	1.00E00
regulation of hormone secretion (GO:0046883)	5	0	.07	-	 < 0.01	1.00E00
purine ribonucleoside monophosphate metabolic process (GO:0009167)	13	0	.18	-	 < 0.01	1.00E00
glucose 6-phosphate metabolic process (GO:0051156)	8	0	.11	-	 < 0.01	1.00E00
nucleotide catabolic process (GO:0009166)	23	0	.31	-	 < 0.01	1.00E00
regulation of cell projection assembly (GO:0060491)	22	0	.30	-	 < 0.01	1.00E00
nucleotide biosynthetic process (GO:0009165)	53	0	.71	-	 < 0.01	1.00E00
nucleoside catabolic process (GO:0009164)	8	0	.11	-	 < 0.01	1.00E00
ribonucleoside monophosphate metabolic process (GO:0009161)	14	0	.19	-	 < 0.01	1.00E00
negative regulation of protein catabolic process (GO:0042177)	11	0	.15	-	 < 0.01	1.00E00
regulation of protein catabolic process (GO:0042176)	40	0	.54	-	 < 0.01	1.00E00
response to interleukin-1 (GO:0070555)	1	0	.01	-	 < 0.01	1.00E00
cellular response to fibroblast growth factor stimulus (GO:0044344)	24	0	.32	-	 < 0.01	1.00E00
immune response-activating cell surface receptor signaling pathway (GO:0002429)	26	0	.35	-	 < 0.01	1.00E00
cytokine-mediated signaling pathway (GO:0019221)	32	0	.43	-	 < 0.01	1.00E00
actin filament bundle organization (GO:0061572)	19	0	.26	-	 < 0.01	1.00E00
hormone secretion (GO:0046879)	3	0	.04	-	 < 0.01	1.00E00
mesenchyme development (GO:0060485)	26	0	.35	-	 < 0.01	1.00E00
ceramide biosynthetic process (GO:0046513)	20	0	.27	-	 < 0.01	1.00E00
regulation of protein-containing complex assembly (GO:0043254)	49	0	.66	-	 < 0.01	1.00E00
heterocycle biosynthetic process (GO:0018130)	170	0	2.29	-	 < 0.01	1.78E-01
purine ribonucleotide catabolic process (GO:0009154)	16	0	.22	-	 < 0.01	1.00E00
purine ribonucleotide biosynthetic process (GO:0009152)	30	0	.40	-	 < 0.01	1.00E00
heme metabolic process (GO:0042168)	7	0	.09	-	 < 0.01	1.00E00
positive regulation of cell cycle (GO:0045787)	22	0	.30	-	 < 0.01	1.00E00
purine ribonucleotide metabolic process (GO:0009150)	62	0	.84	-	 < 0.01	1.00E00
negative regulation of cell cycle (GO:0045786)	53	0	.71	-	 < 0.01	1.00E00
positive regulation of cell adhesion (GO:0045785)	19	0	.26	-	 < 0.01	1.00E00
response to fatty acid (GO:0070542)	1	0	.01	-	 < 0.01	1.00E00
regulation of actin polymerization or depolymerization (GO:0008064)	39	0	.53	-	 < 0.01	1.00E00
regulation of lipid metabolic process (GO:0019216)	10	0	.13	-	 < 0.01	1.00E00
axon development (GO:0061564)	122	0	1.64	-	 < 0.01	4.16E-01
respiratory electron transport chain (GO:0022904)	11	0	.15	-	 < 0.01	1.00E00
protein hydroxylation (GO:0018126)	12	0	.16	-	 < 0.01	1.00E00
electron transport chain (GO:0022900)	14	0	.19	-	 < 0.01	1.00E00
glycerolipid catabolic process (GO:0046503)	14	0	.19	-	 < 0.01	1.00E00
regulation of protein-containing complex disassembly (GO:0043244)	31	0	.42	-	 < 0.01	1.00E00
negative regulation of protein-containing complex disassembly (GO:0043242)	24	0	.32	-	 < 0.01	1.00E00
purine nucleoside triphosphate biosynthetic process (GO:0009145)	1	0	.01	-	 < 0.01	1.00E00
purine nucleoside triphosphate metabolic process (GO:0009144)	18	0	.24	-	 < 0.01	1.00E00
nucleoside triphosphate catabolic process (GO:0009143)	5	0	.07	-	 < 0.01	1.00E00
negative regulation of cytoskeleton organization (GO:0051494)	31	0	.42	-	 < 0.01	1.00E00
nucleoside triphosphate biosynthetic process (GO:0009142)	6	0	.08	-	 < 0.01	1.00E00
lipoprotein biosynthetic process (GO:0042158)	48	0	.65	-	 < 0.01	1.00E00
chaperone-mediated protein complex assembly (GO:0051131)	2	0	.03	-	 < 0.01	1.00E00
nucleoside triphosphate metabolic process (GO:0009141)	28	0	.38	-	 < 0.01	1.00E00
lipoprotein metabolic process (GO:0042157)	54	0	.73	-	 < 0.01	1.00E00
regulation of stress fiber assembly (GO:0051492)	5	0	.07	-	 < 0.01	1.00E00
negative regulation of blood pressure (GO:0045776)	6	0	.08	-	 < 0.01	1.00E00
protein K63-linked deubiquitination (GO:0070536)	5	0	.07	-	 < 0.01	1.00E00
mitochondrial fusion (GO:0008053)	8	0	.11	-	 < 0.01	1.00E00
immune response-regulating cell surface receptor signaling pathway (GO:0002768)	27	0	.36	-	 < 0.01	1.00E00
negative regulation of NF-kappaB transcription factor activity (GO:0032088)	6	0	.08	-	 < 0.01	1.00E00
immune response-regulating signaling pathway (GO:0002764)	33	0	.44	-	 < 0.01	1.00E00
phosphatidylinositol dephosphorylation (GO:0046856)	22	0	.30	-	 < 0.01	1.00E00
negative regulation of cellular component organization (GO:0051129)	60	0	.81	-	 < 0.01	1.00E00
phosphatidylinositol phosphate biosynthetic process (GO:0046854)	31	0	.42	-	 < 0.01	1.00E00
regulation of filopodium assembly (GO:0051489)	6	0	.08	-	 < 0.01	1.00E00
intracellular glucose homeostasis (GO:0001678)	5	0	.07	-	 < 0.01	1.00E00
regulation of bone remodeling (GO:0046850)	3	0	.04	-	 < 0.01	1.00E00
nucleoside diphosphate catabolic process (GO:0009134)	18	0	.24	-	 < 0.01	1.00E00
RNA polymerase II preinitiation complex assembly (GO:0051123)	5	0	.07	-	 < 0.01	1.00E00
long-chain fatty acid metabolic process (GO:0001676)	10	0	.13	-	 < 0.01	1.00E00
nucleoside diphosphate metabolic process (GO:0009132)	21	0	.28	-	 < 0.01	1.00E00
retrograde transport, endosome to Golgi (GO:0042147)	31	0	.42	-	 < 0.01	1.00E00
platelet aggregation (GO:0070527)	5	0	.07	-	 < 0.01	1.00E00
regulation of angiogenesis (GO:0045765)	21	0	.28	-	 < 0.01	1.00E00
regulation of cytosolic calcium ion concentration (GO:0051480)	17	0	.23	-	 < 0.01	1.00E00
tRNA threonylcarbamoyladenosine metabolic process (GO:0070525)	1	0	.01	-	 < 0.01	1.00E00
cellular response to chemical stimulus (GO:0070887)	199	0	2.68	-	 < 0.01	1.18E-01
positive regulation of adenylate cyclase activity (GO:0045762)	5	0	.07	-	 < 0.01	1.00E00
regulation of adenylate cyclase activity (GO:0045761)	7	0	.09	-	 < 0.01	1.00E00
regulation of sodium ion transmembrane transporter activity (GO:2000649)	13	0	.18	-	 < 0.01	1.00E00
motor neuron axon guidance (GO:0008045)	6	0	.08	-	 < 0.01	1.00E00
positive regulation of proteolysis involved in protein catabolic process (GO:1903052)	15	0	.20	-	 < 0.01	1.00E00
negative regulation of proteolysis involved in protein catabolic process (GO:1903051)	5	0	.07	-	 < 0.01	1.00E00
regulation of proteolysis involved in protein catabolic process (GO:1903050)	29	0	.39	-	 < 0.01	1.00E00
innate immune response-activating signaling pathway (GO:0002758)	11	0	.15	-	 < 0.01	1.00E00
immune response-activating signaling pathway (GO:0002757)	32	0	.43	-	 < 0.01	1.00E00
peptidyl-tyrosine phosphorylation (GO:0018108)	5	0	.07	-	 < 0.01	1.00E00
peptidyl-threonine phosphorylation (GO:0018107)	16	0	.22	-	 < 0.01	1.00E00
peptidyl-tyrosine dephosphorylation (GO:0035335)	14	0	.19	-	 < 0.01	1.00E00
peptidyl-serine phosphorylation (GO:0018105)	72	0	.97	-	 < 0.01	1.00E00
filopodium assembly (GO:0046847)	3	0	.04	-	 < 0.01	1.00E00
cytoplasmic pattern recognition receptor signaling pathway (GO:0002753)	4	0	.05	-	 < 0.01	1.00E00
skin development (GO:0043588)	2	0	.03	-	 < 0.01	1.00E00
purine nucleoside monophosphate metabolic process (GO:0009126)	13	0	.18	-	 < 0.01	1.00E00
ear development (GO:0043583)	2	0	.03	-	 < 0.01	1.00E00
regulation of amide metabolic process (GO:0034248)	44	0	.59	-	 < 0.01	1.00E00
ameboidal-type cell migration (GO:0001667)	29	0	.39	-	 < 0.01	1.00E00
response to hypoxia (GO:0001666)	15	0	.20	-	 < 0.01	1.00E00
nucleoside monophosphate metabolic process (GO:0009123)	16	0	.22	-	 < 0.01	1.00E00
meiotic DNA double-strand break formation (GO:0042138)	3	0	.04	-	 < 0.01	1.00E00
regulation of transforming growth factor beta receptor signaling pathway (GO:0017015)	7	0	.09	-	 < 0.01	1.00E00
regulation of transcription elongation by RNA polymerase II (GO:0034243)	7	0	.09	-	 < 0.01	1.00E00
cell recognition (GO:0008037)	11	0	.15	-	 < 0.01	1.00E00
potassium ion import across plasma membrane (GO:1990573)	28	0	.38	-	 < 0.01	1.00E00
negative regulation of T cell proliferation (GO:0042130)	2	0	.03	-	 < 0.01	1.00E00
meiotic cell cycle process (GO:1903046)	40	0	.54	-	 < 0.01	1.00E00
tRNA processing (GO:0008033)	46	0	.62	-	 < 0.01	1.00E00
V(D)J recombination (GO:0033151)	2	0	.03	-	 < 0.01	1.00E00
phospholipid dephosphorylation (GO:0046839)	29	0	.39	-	 < 0.01	1.00E00
negative regulation of organelle organization (GO:0010639)	50	0	.67	-	 < 0.01	1.00E00
carbohydrate phosphorylation (GO:0046835)	5	0	.07	-	 < 0.01	1.00E00
nucleotide metabolic process (GO:0009117)	96	0	1.29	-	 < 0.01	6.42E-01
nucleoside metabolic process (GO:0009116)	14	0	.19	-	 < 0.01	1.00E00
cellular response to oxidative stress (GO:0034599)	8	0	.11	-	 < 0.01	1.00E00
regulation of T cell proliferation (GO:0042129)	3	0	.04	-	 < 0.01	1.00E00
eye development (GO:0001654)	27	0	.36	-	 < 0.01	1.00E00
calcium ion import (GO:0070509)	11	0	.15	-	 < 0.01	1.00E00
regulation of cell population proliferation (GO:0042127)	85	0	1.15	-	 < 0.01	6.32E-01
cytochrome complex assembly (GO:0017004)	2	0	.03	-	 < 0.01	1.00E00
nuclear chromosome segregation (GO:0098813)	48	0	.65	-	 < 0.01	1.00E00
negative regulation of Notch signaling pathway (GO:0045746)	3	0	.04	-	 < 0.01	1.00E00
regulation of microtubule cytoskeleton organization (GO:0070507)	26	0	.35	-	 < 0.01	1.00E00
positive regulation of leukocyte cell-cell adhesion (GO:1903039)	3	0	.04	-	 < 0.01	1.00E00
negative regulation of leukocyte cell-cell adhesion (GO:1903038)	4	0	.05	-	 < 0.01	1.00E00
regulation of leukocyte cell-cell adhesion (GO:1903037)	6	0	.08	-	 < 0.01	1.00E00
sperm motility (GO:0097722)	1	0	.01	-	 < 0.01	1.00E00
regulation of endopeptidase activity (GO:0052548)	40	0	.54	-	 < 0.01	1.00E00
regulation of peptidase activity (GO:0052547)	40	0	.54	-	 < 0.01	1.00E00
negative regulation of gene expression (GO:0010629)	95	0	1.28	-	 < 0.01	6.41E-01
positive regulation of gene expression (GO:0010628)	62	0	.84	-	 < 0.01	1.00E00
response to external biotic stimulus (GO:0043207)	36	0	.49	-	 < 0.01	1.00E00
oligopeptide transmembrane transport (GO:0035672)	2	0	.03	-	 < 0.01	1.00E00
osteoblast differentiation (GO:0001649)	3	0	.04	-	 < 0.01	1.00E00
neutrophil activation (GO:0042119)	1	0	.01	-	 < 0.01	1.00E00
positive regulation of DNA repair (GO:0045739)	9	0	.12	-	 < 0.01	1.00E00
piRNA processing (GO:0034587)	3	0	.04	-	 < 0.01	1.00E00
negative regulation of DNA repair (GO:0045738)	5	0	.07	-	 < 0.01	1.00E00
intracellular pH reduction (GO:0051452)	9	0	.12	-	 < 0.01	1.00E00
odontogenesis (GO:0042476)	2	0	.03	-	 < 0.01	1.00E00
B cell activation (GO:0042113)	6	0	.08	-	 < 0.01	1.00E00
odontogenesis of dentin-containing tooth (GO:0042475)	2	0	.03	-	 < 0.01	1.00E00
positive regulation of protein catabolic process (GO:0045732)	21	0	.28	-	 < 0.01	1.00E00
regulation of heart contraction (GO:0008016)	16	0	.22	-	 < 0.01	1.00E00
blood circulation (GO:0008015)	35	0	.47	-	 < 0.01	1.00E00
T cell activation (GO:0042110)	5	0	.07	-	 < 0.01	1.00E00
inner ear morphogenesis (GO:0042472)	2	0	.03	-	 < 0.01	1.00E00
chromosome localization (GO:0050000)	12	0	.16	-	 < 0.01	1.00E00
vesicle targeting, trans-Golgi to periciliary membrane compartment (GO:0097712)	1	0	.01	-	 < 0.01	1.00E00
protein localization to cilium (GO:0061512)	11	0	.15	-	 < 0.01	1.00E00
antigen processing and presentation (GO:0019882)	3	0	.04	-	 < 0.01	1.00E00
sperm axoneme assembly (GO:0007288)	1	0	.01	-	 < 0.01	1.00E00
cardiolipin biosynthetic process (GO:0032049)	2	0	.03	-	 < 0.01	1.00E00
epithelium development (GO:0060429)	30	0	.40	-	 < 0.01	1.00E00
spermatid development (GO:0007286)	4	0	.05	-	 < 0.01	1.00E00
regulation of dephosphorylation (GO:0035303)	7	0	.09	-	 < 0.01	1.00E00
spermatogenesis (GO:0007283)	14	0	.19	-	 < 0.01	1.00E00
germ cell development (GO:0007281)	14	0	.19	-	 < 0.01	1.00E00
mitochondrial DNA metabolic process (GO:0032042)	4	0	.05	-	 < 0.01	1.00E00
carbohydrate transmembrane transport (GO:0034219)	6	0	.08	-	 < 0.01	1.00E00
negative regulation of G2/M transition of mitotic cell cycle (GO:0010972)	13	0	.18	-	 < 0.01	1.00E00
regulation of meiotic cell cycle (GO:0051445)	10	0	.13	-	 < 0.01	1.00E00
transport along microtubule (GO:0010970)	48	0	.65	-	 < 0.01	1.00E00
purine nucleotide catabolic process (GO:0006195)	17	0	.23	-	 < 0.01	1.00E00
positive regulation of translation (GO:0045727)	17	0	.23	-	 < 0.01	1.00E00
RNA modification (GO:0009451)	70	0	.94	-	 < 0.01	1.00E00
response to growth factor (GO:0070848)	73	0	.98	-	 < 0.01	6.28E-01
positive regulation of T cell proliferation (GO:0042102)	2	0	.03	-	 < 0.01	1.00E00
mitochondrial transmembrane transport (GO:1990542)	33	0	.44	-	 < 0.01	1.00E00
regulation of cell size (GO:0008361)	12	0	.16	-	 < 0.01	1.00E00
regulation of cell shape (GO:0008360)	24	0	.32	-	 < 0.01	1.00E00
regulation of natural killer cell mediated immunity (GO:0002715)	1	0	.01	-	 < 0.01	1.00E00
gamete generation (GO:0007276)	24	0	.32	-	 < 0.01	1.00E00
post-transcriptional regulation of gene expression (GO:0010608)	91	0	1.23	-	 < 0.01	6.37E-01
neuromuscular synaptic transmission (GO:0007274)	10	0	.13	-	 < 0.01	1.00E00
regulation of mitotic sister chromatid separation (GO:0010965)	15	0	.20	-	 < 0.01	1.00E00
DNA geometric change (GO:0032392)	9	0	.12	-	 < 0.01	1.00E00
protein acylation (GO:0043543)	27	0	.36	-	 < 0.01	1.00E00
endothelial cell migration (GO:0043542)	3	0	.04	-	 < 0.01	1.00E00
IMP biosynthetic process (GO:0006188)	6	0	.08	-	 < 0.01	1.00E00
regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092)	32	0	.43	-	 < 0.01	1.00E00
negative regulation of canonical Wnt signaling pathway (GO:0090090)	15	0	.20	-	 < 0.01	1.00E00
lipid translocation (GO:0034204)	21	0	.28	-	 < 0.01	1.00E00
cGMP biosynthetic process (GO:0006182)	3	0	.04	-	 < 0.01	1.00E00
response to organic cyclic compound (GO:0014070)	27	0	.36	-	 < 0.01	1.00E00
negative regulation of macroautophagy (GO:0016242)	4	0	.05	-	 < 0.01	1.00E00
regulation of macroautophagy (GO:0016241)	14	0	.19	-	 < 0.01	1.00E00
regulation of lymphocyte mediated immunity (GO:0002706)	3	0	.04	-	 < 0.01	1.00E00
Rho protein signal transduction (GO:0007266)	21	0	.28	-	 < 0.01	1.00E00
Ras protein signal transduction (GO:0007265)	24	0	.32	-	 < 0.01	1.00E00
regulation of response to endoplasmic reticulum stress (GO:1905897)	6	0	.08	-	 < 0.01	1.00E00
regulation of leukocyte mediated immunity (GO:0002703)	3	0	.04	-	 < 0.01	1.00E00
regulation of metal ion transport (GO:0010959)	48	0	.65	-	 < 0.01	1.00E00
regulation of chromatin organization (GO:1902275)	3	0	.04	-	 < 0.01	1.00E00
regulation of peptide transport (GO:0090087)	3	0	.04	-	 < 0.01	1.00E00
tyrosine phosphorylation of STAT protein (GO:0007260)	1	0	.01	-	 < 0.01	1.00E00
positive regulation of peptidase activity (GO:0010952)	18	0	.24	-	 < 0.01	1.00E00
negative regulation of endopeptidase activity (GO:0010951)	22	0	.30	-	 < 0.01	1.00E00
positive regulation of endopeptidase activity (GO:0010950)	18	0	.24	-	 < 0.01	1.00E00
negative regulation of nuclear division (GO:0051784)	13	0	.18	-	 < 0.01	1.00E00
replication fork processing (GO:0031297)	14	0	.19	-	 < 0.01	1.00E00
regulation of nuclear division (GO:0051783)	24	0	.32	-	 < 0.01	1.00E00
heterochromatin organization (GO:0070828)	18	0	.24	-	 < 0.01	1.00E00
regulation of ERBB signaling pathway (GO:1901184)	11	0	.15	-	 < 0.01	1.00E00
hormone biosynthetic process (GO:0042446)	1	0	.01	-	 < 0.01	1.00E00
positive regulation of cell division (GO:0051781)	2	0	.03	-	 < 0.01	1.00E00
hormone metabolic process (GO:0042445)	11	0	.15	-	 < 0.01	1.00E00
mitochondrial respiratory chain complex III assembly (GO:0034551)	1	0	.01	-	 < 0.01	1.00E00
mitochondrial respiratory chain complex assembly (GO:0033108)	10	0	.13	-	 < 0.01	1.00E00
positive regulation of macroautophagy (GO:0016239)	9	0	.12	-	 < 0.01	1.00E00
pigment metabolic process (GO:0042440)	12	0	.16	-	 < 0.01	1.00E00
antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844)	1	0	.01	-	 < 0.01	1.00E00
telomere capping (GO:0016233)	2	0	.03	-	 < 0.01	1.00E00
receptor signaling pathway via JAK-STAT (GO:0007259)	5	0	.07	-	 < 0.01	1.00E00
JNK cascade (GO:0007254)	6	0	.08	-	 < 0.01	1.00E00
negative regulation of cell cycle process (GO:0010948)	44	0	.59	-	 < 0.01	1.00E00
purine nucleotide biosynthetic process (GO:0006164)	43	0	.58	-	 < 0.01	1.00E00
purine nucleotide metabolic process (GO:0006163)	82	0	1.11	-	 < 0.01	6.31E-01
positive regulation of cytokine-mediated signaling pathway (GO:0001961)	3	0	.04	-	 < 0.01	1.00E00
positive regulation of cyclase activity (GO:0031281)	9	0	.12	-	 < 0.01	1.00E00
acetylcholine receptor signaling pathway (GO:0095500)	18	0	.24	-	 < 0.01	1.00E00
snRNA transcription by RNA polymerase II (GO:0042795)	3	0	.04	-	 < 0.01	1.00E00
negative regulation of cyclase activity (GO:0031280)	2	0	.03	-	 < 0.01	1.00E00
collagen fibril organization (GO:0030199)	9	0	.12	-	 < 0.01	1.00E00
endosome to lysosome transport (GO:0008333)	14	0	.19	-	 < 0.01	1.00E00
extracellular matrix organization (GO:0030198)	95	0	1.28	-	 < 0.01	6.41E-01
iron-sulfur cluster assembly (GO:0016226)	8	0	.11	-	 < 0.01	1.00E00
nucleolar large rRNA transcription by RNA polymerase I (GO:0042790)	5	0	.07	-	 < 0.01	1.00E00
negative regulation of blood coagulation (GO:0030195)	4	0	.05	-	 < 0.01	1.00E00
canonical NF-kappaB signal transduction (GO:0007249)	3	0	.04	-	 < 0.01	1.00E00
positive regulation of TOR signaling (GO:0032008)	14	0	.19	-	 < 0.01	1.00E00
negative regulation of TOR signaling (GO:0032007)	8	0	.11	-	 < 0.01	1.00E00
non-motile cilium assembly (GO:1905515)	12	0	.16	-	 < 0.01	1.00E00
regulation of TOR signaling (GO:0032006)	25	0	.34	-	 < 0.01	1.00E00
intracellular sterol transport (GO:0032366)	3	0	.04	-	 < 0.01	1.00E00
intracellular lipid transport (GO:0032365)	5	0	.07	-	 < 0.01	1.00E00
positive regulation of cell cycle process (GO:0090068)	21	0	.28	-	 < 0.01	1.00E00
regulation of anatomical structure size (GO:0090066)	61	0	.82	-	 < 0.01	1.00E00
regulation of cyclase activity (GO:0031279)	12	0	.16	-	 < 0.01	1.00E00
neuron apoptotic process (GO:0051402)	4	0	.05	-	 < 0.01	1.00E00
purine nucleoside catabolic process (GO:0006152)	3	0	.04	-	 < 0.01	1.00E00
regulation of cell-matrix adhesion (GO:0001952)	4	0	.05	-	 < 0.01	1.00E00
positive regulation of epithelial cell proliferation (GO:0050679)	7	0	.09	-	 < 0.01	1.00E00
protein deubiquitination (GO:0016579)	51	0	.69	-	 < 0.01	1.00E00
tRNA 3'-end processing (GO:0042780)	1	0	.01	-	 < 0.01	1.00E00
epithelial cell proliferation (GO:0050673)	1	0	.01	-	 < 0.01	1.00E00
regulation of lymphocyte proliferation (GO:0050670)	5	0	.07	-	 < 0.01	1.00E00
B cell differentiation (GO:0030183)	3	0	.04	-	 < 0.01	1.00E00
neuron differentiation (GO:0030182)	250	0	3.37	-	 < 0.01	5.21E-02
developmental pigmentation (GO:0048066)	6	0	.08	-	 < 0.01	1.00E00
response to cold (GO:0009409)	1	0	.01	-	 < 0.01	1.00E00
response to heat (GO:0009408)	11	0	.15	-	 < 0.01	1.00E00
regulation of phosphatase activity (GO:0010921)	5	0	.07	-	 < 0.01	1.00E00
vasculature development (GO:0001944)	36	0	.49	-	 < 0.01	1.00E00
neural crest cell differentiation (GO:0014033)	24	0	.32	-	 < 0.01	1.00E00
neural crest cell development (GO:0014032)	24	0	.32	-	 < 0.01	1.00E00
mitochondrial ATP synthesis coupled electron transport (GO:0042775)	6	0	.08	-	 < 0.01	1.00E00
ATP synthesis coupled electron transport (GO:0042773)	6	0	.08	-	 < 0.01	1.00E00
negative regulation of Wnt signaling pathway (GO:0030178)	28	0	.38	-	 < 0.01	1.00E00
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771)	3	0	.04	-	 < 0.01	1.00E00
signal transduction in response to DNA damage (GO:0042770)	17	0	.23	-	 < 0.01	1.00E00
integrin-mediated signaling pathway (GO:0007229)	24	0	.32	-	 < 0.01	1.00E00
smoothened signaling pathway (GO:0007224)	13	0	.18	-	 < 0.01	1.00E00
digestion (GO:0007586)	1	0	.01	-	 < 0.01	1.00E00
cellular response to topologically incorrect protein (GO:0035967)	24	0	.32	-	 < 0.01	1.00E00
response to topologically incorrect protein (GO:0035966)	24	0	.32	-	 < 0.01	1.00E00
protein lipidation (GO:0006497)	48	0	.65	-	 < 0.01	1.00E00
hormone-mediated signaling pathway (GO:0009755)	23	0	.31	-	 < 0.01	1.00E00
endothelial cell proliferation (GO:0001935)	1	0	.01	-	 < 0.01	1.00E00
negative regulation of protein phosphorylation (GO:0001933)	32	0	.43	-	 < 0.01	1.00E00
protein O-linked glycosylation (GO:0006493)	39	0	.53	-	 < 0.01	1.00E00
RNA transport (GO:0050658)	34	0	.46	-	 < 0.01	1.00E00
nucleic acid transport (GO:0050657)	34	0	.46	-	 < 0.01	1.00E00
protein import into peroxisome matrix (GO:0016558)	11	0	.15	-	 < 0.01	1.00E00
positive regulation of mRNA metabolic process (GO:1903313)	30	0	.40	-	 < 0.01	1.00E00
isoprenoid catabolic process (GO:0008300)	4	0	.05	-	 < 0.01	1.00E00
mRNA modification (GO:0016556)	8	0	.11	-	 < 0.01	1.00E00
chondroitin sulfate proteoglycan biosynthetic process (GO:0050650)	10	0	.13	-	 < 0.01	1.00E00
neuropeptide signaling pathway (GO:0007218)	28	0	.38	-	 < 0.01	1.00E00
regulation of proteolysis (GO:0030162)	71	0	.96	-	 < 0.01	1.00E00
dopamine receptor signaling pathway (GO:0007212)	6	0	.08	-	 < 0.01	1.00E00
response to glucose (GO:0009749)	4	0	.05	-	 < 0.01	1.00E00
carbohydrate derivative catabolic process (GO:1901136)	55	0	.74	-	 < 0.01	1.00E00
mitochondrial electron transport, succinate to ubiquinone (GO:0006121)	1	0	.01	-	 < 0.01	1.00E00
mitochondrial electron transport, NADH to ubiquinone (GO:0006120)	3	0	.04	-	 < 0.01	1.00E00
protein localization to kinetochore (GO:0034501)	5	0	.07	-	 < 0.01	1.00E00
regulation of circadian rhythm (GO:0042752)	8	0	.11	-	 < 0.01	1.00E00
phospholipid biosynthetic process (GO:0008654)	66	0	.89	-	 < 0.01	1.00E00
amino acid biosynthetic process (GO:0008652)	22	0	.30	-	 < 0.01	1.00E00
protein import into mitochondrial matrix (GO:0030150)	9	0	.12	-	 < 0.01	1.00E00
alanine transport (GO:0032328)	3	0	.04	-	 < 0.01	1.00E00
positive regulation of cytosolic calcium ion concentration (GO:0007204)	17	0	.23	-	 < 0.01	1.00E00
oxidative phosphorylation (GO:0006119)	6	0	.08	-	 < 0.01	1.00E00
energy reserve metabolic process (GO:0006112)	5	0	.07	-	 < 0.01	1.00E00
protein acetylation (GO:0006473)	5	0	.07	-	 < 0.01	1.00E00
regulation of leukocyte mediated cytotoxicity (GO:0001910)	1	0	.01	-	 < 0.01	1.00E00
sphingolipid catabolic process (GO:0030149)	10	0	.13	-	 < 0.01	1.00E00
defense response to bacterium (GO:0042742)	5	0	.07	-	 < 0.01	1.00E00
sphingolipid biosynthetic process (GO:0030148)	35	0	.47	-	 < 0.01	1.00E00
carbohydrate transport (GO:0008643)	6	0	.08	-	 < 0.01	1.00E00
negative regulation of protein kinase activity (GO:0006469)	31	0	.42	-	 < 0.01	1.00E00
protein phosphorylation (GO:0006468)	187	0	2.52	-	 < 0.01	1.86E-01
response to hormone (GO:0009725)	69	0	.93	-	 < 0.01	1.00E00
cell-substrate adhesion (GO:0031589)	43	0	.58	-	 < 0.01	1.00E00
signal peptide processing (GO:0006465)	4	0	.05	-	 < 0.01	1.00E00
sister chromatid segregation (GO:0000819)	37	0	.50	-	 < 0.01	1.00E00
apoptotic mitochondrial changes (GO:0008637)	9	0	.12	-	 < 0.01	1.00E00
proteinogenic amino acid metabolic process (GO:0170039)	37	0	.50	-	 < 0.01	1.00E00
proteinogenic amino acid biosynthetic process (GO:0170038)	20	0	.27	-	 < 0.01	1.00E00
negative regulation of angiogenesis (GO:0016525)	8	0	.11	-	 < 0.01	1.00E00
detection of mechanical stimulus (GO:0050982)	8	0	.11	-	 < 0.01	1.00E00
intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630)	11	0	.15	-	 < 0.01	1.00E00
L-amino acid biosynthetic process (GO:0170034)	20	0	.27	-	 < 0.01	1.00E00
L-amino acid metabolic process (GO:0170033)	44	0	.59	-	 < 0.01	1.00E00
negative regulation of chromosome separation (GO:1905819)	9	0	.12	-	 < 0.01	1.00E00
sex differentiation (GO:0007548)	4	0	.05	-	 < 0.01	1.00E00
regulation of chromosome separation (GO:1905818)	15	0	.20	-	 < 0.01	1.00E00
response to endogenous stimulus (GO:0009719)	161	0	2.17	-	 < 0.01	2.83E-01
response to other organism (GO:0051707)	36	0	.49	-	 < 0.01	1.00E00
'de novo' protein folding (GO:0006458)	7	0	.09	-	 < 0.01	1.00E00
protein folding (GO:0006457)	78	0	1.05	-	 < 0.01	6.29E-01
vascular endothelial growth factor receptor signaling pathway (GO:0048010)	9	0	.12	-	 < 0.01	1.00E00
biological process involved in interaction with host (GO:0051701)	1	0	.01	-	 < 0.01	1.00E00
RNA decapping (GO:0110154)	8	0	.11	-	 < 0.01	1.00E00
biomineral tissue development (GO:0031214)	4	0	.05	-	 < 0.01	1.00E00
mitotic intra-S DNA damage checkpoint signaling (GO:0031573)	4	0	.05	-	 < 0.01	1.00E00
DNA integrity checkpoint signaling (GO:0031570)	19	0	.26	-	 < 0.01	1.00E00
extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625)	2	0	.03	-	 < 0.01	1.00E00
tRNA methylation (GO:0030488)	15	0	.20	-	 < 0.01	1.00E00
insulin-like growth factor receptor signaling pathway (GO:0048009)	4	0	.05	-	 < 0.01	1.00E00
regulation of translational initiation (GO:0006446)	9	0	.12	-	 < 0.01	1.00E00
nucleotide-sugar transmembrane transport (GO:0015780)	3	0	.04	-	 < 0.01	1.00E00
post-translational protein targeting to membrane, translocation (GO:0031204)	5	0	.07	-	 < 0.01	1.00E00
tRNA wobble uridine modification (GO:0002098)	6	0	.08	-	 < 0.01	1.00E00
lipid biosynthetic process (GO:0008610)	151	0	2.04	-	 < 0.01	2.74E-01
neuromuscular junction development (GO:0007528)	9	0	.12	-	 < 0.01	1.00E00
attachment of spindle microtubules to kinetochore (GO:0008608)	7	0	.09	-	 < 0.01	1.00E00
lens development in camera-type eye (GO:0002088)	16	0	.22	-	 < 0.01	1.00E00
organelle transport along microtubule (GO:0072384)	25	0	.34	-	 < 0.01	1.00E00
sensory perception of mechanical stimulus (GO:0050954)	9	0	.12	-	 < 0.01	1.00E00
skeletal muscle tissue development (GO:0007519)	13	0	.18	-	 < 0.01	1.00E00
positive regulation of innate immune response (GO:0045089)	17	0	.23	-	 < 0.01	1.00E00
positive regulation of cysteine-type endopeptidase activity (GO:2001056)	16	0	.22	-	 < 0.01	1.00E00
regulation of innate immune response (GO:0045088)	22	0	.30	-	 < 0.01	1.00E00
innate immune response (GO:0045087)	22	0	.30	-	 < 0.01	1.00E00
negative regulation of proteasomal protein catabolic process (GO:1901799)	5	0	.07	-	 < 0.01	1.00E00
heme biosynthetic process (GO:0006783)	4	0	.05	-	 < 0.01	1.00E00
protein activation cascade (GO:0072376)	5	0	.07	-	 < 0.01	1.00E00
alcohol biosynthetic process (GO:0046165)	27	0	.36	-	 < 0.01	1.00E00
generation of neurons (GO:0048699)	261	0	3.52	-	 < 0.01	5.26E-02
protein-containing complex disassembly (GO:0032984)	38	0	.51	-	 < 0.01	1.00E00
regulation of translation (GO:0006417)	41	0	.55	-	 < 0.01	1.00E00
mitochondrial respiratory chain complex I assembly (GO:0032981)	6	0	.08	-	 < 0.01	1.00E00
mesoderm morphogenesis (GO:0048332)	7	0	.09	-	 < 0.01	1.00E00
porphyrin-containing compound metabolic process (GO:0006778)	9	0	.12	-	 < 0.01	1.00E00
translational termination (GO:0006415)	3	0	.04	-	 < 0.01	1.00E00
translational elongation (GO:0006414)	17	0	.23	-	 < 0.01	1.00E00
chromosome organization involved in meiotic cell cycle (GO:0070192)	9	0	.12	-	 < 0.01	1.00E00
regulation of complement activation (GO:0030449)	1	0	.01	-	 < 0.01	1.00E00
organophosphate ester transport (GO:0015748)	41	0	.55	-	 < 0.01	1.00E00
citrate transport (GO:0015746)	2	0	.03	-	 < 0.01	1.00E00
succinate transport (GO:0015744)	2	0	.03	-	 < 0.01	1.00E00
mRNA export from nucleus (GO:0006406)	24	0	.32	-	 < 0.01	1.00E00
C4-dicarboxylate transport (GO:0015740)	11	0	.15	-	 < 0.01	1.00E00
RNA export from nucleus (GO:0006405)	30	0	.40	-	 < 0.01	1.00E00
RNA localization (GO:0006403)	37	0	.50	-	 < 0.01	1.00E00
mRNA catabolic process (GO:0006402)	41	0	.55	-	 < 0.01	1.00E00
RNA catabolic process (GO:0006401)	45	0	.61	-	 < 0.01	1.00E00
tRNA modification (GO:0006400)	34	0	.46	-	 < 0.01	1.00E00
folic acid-containing compound metabolic process (GO:0006760)	8	0	.11	-	 < 0.01	1.00E00
pigment biosynthetic process (GO:0046148)	9	0	.12	-	 < 0.01	1.00E00
positive regulation of chemotaxis (GO:0050921)	7	0	.09	-	 < 0.01	1.00E00
regulation of chemotaxis (GO:0050920)	7	0	.09	-	 < 0.01	1.00E00
positive regulation of transcription elongation by RNA polymerase II (GO:0032968)	5	0	.07	-	 < 0.01	1.00E00
mitotic spindle assembly (GO:0090307)	11	0	.15	-	 < 0.01	1.00E00
axon extension (GO:0048675)	2	0	.03	-	 < 0.01	1.00E00
nucleoside phosphate metabolic process (GO:0006753)	102	0	1.37	-	 < 0.01	6.50E-01
regulation of membrane lipid distribution (GO:0097035)	24	0	.32	-	 < 0.01	1.00E00
positive chemotaxis (GO:0050918)	2	0	.03	-	 < 0.01	1.00E00
regulation of transmembrane transporter activity (GO:0022898)	38	0	.51	-	 < 0.01	1.00E00
sensory perception of bitter taste (GO:0050913)	1	0	.01	-	 < 0.01	1.00E00
detection of chemical stimulus involved in sensory perception of taste (GO:0050912)	1	0	.01	-	 < 0.01	1.00E00
chemical synaptic transmission, postsynaptic (GO:0099565)	4	0	.05	-	 < 0.01	1.00E00
nicotinamide nucleotide metabolic process (GO:0046496)	27	0	.36	-	 < 0.01	1.00E00
sprouting angiogenesis (GO:0002040)	8	0	.11	-	 < 0.01	1.00E00
synaptic membrane adhesion (GO:0099560)	5	0	.07	-	 < 0.01	1.00E00
protein insertion into ER membrane (GO:0045048)	3	0	.04	-	 < 0.01	1.00E00
cell morphogenesis involved in neuron differentiation (GO:0048667)	112	0	1.51	-	 < 0.01	4.09E-01
neuron development (GO:0048666)	187	0	2.52	-	 < 0.01	1.86E-01
bile acid and bile salt transport (GO:0015721)	5	0	.07	-	 < 0.01	1.00E00
heterochromatin formation (GO:0031507)	15	0	.20	-	 < 0.01	1.00E00
ubiquinone biosynthetic process (GO:0006744)	5	0	.07	-	 < 0.01	1.00E00
sensory perception of taste (GO:0050909)	1	0	.01	-	 < 0.01	1.00E00
detection of chemical stimulus involved in sensory perception (GO:0050907)	2	0	.03	-	 < 0.01	1.00E00
detection of stimulus involved in sensory perception (GO:0050906)	6	0	.08	-	 < 0.01	1.00E00
intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332)	4	0	.05	-	 < 0.01	1.00E00
signal transduction by p53 class mediator (GO:0072331)	5	0	.07	-	 < 0.01	1.00E00
monocarboxylic acid biosynthetic process (GO:0072330)	25	0	.34	-	 < 0.01	1.00E00
phosphatidylinositol metabolic process (GO:0046488)	81	0	1.09	-	 < 0.01	6.30E-01
leukocyte migration (GO:0050900)	7	0	.09	-	 < 0.01	1.00E00
glycerolipid metabolic process (GO:0046486)	122	0	1.64	-	 < 0.01	4.16E-01
monocarboxylic acid transport (GO:0015718)	33	0	.44	-	 < 0.01	1.00E00
protein insertion into mitochondrial inner membrane (GO:0045039)	3	0	.04	-	 < 0.01	1.00E00
regulation of mononuclear cell proliferation (GO:0032944)	5	0	.07	-	 < 0.01	1.00E00
mononuclear cell proliferation (GO:0032943)	1	0	.01	-	 < 0.01	1.00E00
NADP metabolic process (GO:0006739)	4	0	.05	-	 < 0.01	1.00E00
monocarboxylic acid catabolic process (GO:0072329)	31	0	.42	-	 < 0.01	1.00E00
regulation of sodium ion transport (GO:0002028)	19	0	.26	-	 < 0.01	1.00E00
glycerophospholipid catabolic process (GO:0046475)	8	0	.11	-	 < 0.01	1.00E00
glycerophospholipid biosynthetic process (GO:0046474)	60	0	.81	-	 < 0.01	1.00E00
phosphatidylcholine metabolic process (GO:0046470)	7	0	.09	-	 < 0.01	1.00E00
SREBP signaling pathway (GO:0032933)	6	0	.08	-	 < 0.01	1.00E00
early endosome to late endosome transport (GO:0045022)	4	0	.05	-	 < 0.01	1.00E00
terpenoid metabolic process (GO:0006721)	6	0	.08	-	 < 0.01	1.00E00
isoprenoid metabolic process (GO:0006720)	13	0	.18	-	 < 0.01	1.00E00
lymphocyte migration (GO:0072676)	2	0	.03	-	 < 0.01	1.00E00
immune system process (GO:0002376)	100	0	1.35	-	 < 0.01	6.47E-01
monosaccharide metabolic process (GO:0005996)	24	0	.32	-	 < 0.01	1.00E00
regulation of postsynaptic membrane potential (GO:0060078)	11	0	.15	-	 < 0.01	1.00E00
membrane lipid biosynthetic process (GO:0046467)	51	0	.69	-	 < 0.01	1.00E00
acylglycerol catabolic process (GO:0046464)	9	0	.12	-	 < 0.01	1.00E00
canonical Wnt signaling pathway (GO:0060070)	48	0	.65	-	 < 0.01	1.00E00
cellular response to lipopolysaccharide (GO:0071222)	7	0	.09	-	 < 0.01	1.00E00
neutral lipid catabolic process (GO:0046461)	9	0	.12	-	 < 0.01	1.00E00
activin receptor signaling pathway (GO:0032924)	3	0	.04	-	 < 0.01	1.00E00
glycerolipid biosynthetic process (GO:0045017)	69	0	.93	-	 < 0.01	1.00E00
positive regulation of developmental process (GO:0051094)	67	0	.90	-	 < 0.01	1.00E00
circadian regulation of gene expression (GO:0032922)	18	0	.24	-	 < 0.01	1.00E00
positive regulation of NF-kappaB transcription factor activity (GO:0051092)	10	0	.13	-	 < 0.01	1.00E00
positive regulation of DNA-binding transcription factor activity (GO:0051091)	15	0	.20	-	 < 0.01	1.00E00
regulation of DNA-binding transcription factor activity (GO:0051090)	22	0	.30	-	 < 0.01	1.00E00
mRNA destabilization (GO:0061157)	24	0	.32	-	 < 0.01	1.00E00
morphogenesis of an epithelium (GO:0002009)	10	0	.13	-	 < 0.01	1.00E00
establishment of protein localization to vacuole (GO:0072666)	20	0	.27	-	 < 0.01	1.00E00
autophagosome maturation (GO:0097352)	5	0	.07	-	 < 0.01	1.00E00
protein localization to vacuole (GO:0072665)	22	0	.30	-	 < 0.01	1.00E00
small molecule biosynthetic process (GO:0044283)	99	0	1.33	-	 < 0.01	6.46E-01
small molecule catabolic process (GO:0044282)	79	0	1.06	-	 < 0.01	6.29E-01
leukocyte activation involved in immune response (GO:0002366)	2	0	.03	-	 < 0.01	1.00E00
TORC2 signaling (GO:0038203)	4	0	.05	-	 < 0.01	1.00E00
cellular response to molecule of bacterial origin (GO:0071219)	7	0	.09	-	 < 0.01	1.00E00
TORC1 signaling (GO:0038202)	1	0	.01	-	 < 0.01	1.00E00
icosanoid biosynthetic process (GO:0046456)	5	0	.07	-	 < 0.01	1.00E00
cellular response to biotic stimulus (GO:0071216)	7	0	.09	-	 < 0.01	1.00E00
positive regulation of cell cycle G1/S phase transition (GO:1902808)	8	0	.11	-	 < 0.01	1.00E00
leucine biosynthetic process (GO:0009098)	1	0	.01	-	 < 0.01	1.00E00
regulation of cell cycle G1/S phase transition (GO:1902806)	18	0	.24	-	 < 0.01	1.00E00
chaperone cofactor-dependent protein refolding (GO:0051085)	5	0	.07	-	 < 0.01	1.00E00
response to oxygen levels (GO:0070482)	16	0	.22	-	 < 0.01	1.00E00
protein localization to plasma membrane (GO:0072659)	41	0	.55	-	 < 0.01	1.00E00
nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)	10	0	.13	-	 < 0.01	1.00E00
establishment of protein localization to mitochondrion (GO:0072655)	19	0	.26	-	 < 0.01	1.00E00
sulfur compound catabolic process (GO:0044273)	7	0	.09	-	 < 0.01	1.00E00
glycogen biosynthetic process (GO:0005978)	1	0	.01	-	 < 0.01	1.00E00
vesicle cytoskeletal trafficking (GO:0099518)	16	0	.22	-	 < 0.01	1.00E00
glycogen metabolic process (GO:0005977)	5	0	.07	-	 < 0.01	1.00E00
cellular nitrogen compound catabolic process (GO:0044270)	99	0	1.33	-	 < 0.01	6.46E-01
tube development (GO:0035295)	37	0	.50	-	 < 0.01	1.00E00
response to organonitrogen compound (GO:0010243)	74	0	1.00	-	 < 0.01	6.28E-01
lysine biosynthetic process (GO:0009085)	1	0	.01	-	 < 0.01	1.00E00
cellular response to transforming growth factor beta stimulus (GO:0071560)	18	0	.24	-	 < 0.01	1.00E00
branched-chain amino acid biosynthetic process (GO:0009082)	2	0	.03	-	 < 0.01	1.00E00
branched-chain amino acid metabolic process (GO:0009081)	9	0	.12	-	 < 0.01	1.00E00
rRNA base methylation (GO:0070475)	5	0	.07	-	 < 0.01	1.00E00
ncRNA transcription (GO:0098781)	12	0	.16	-	 < 0.01	1.00E00
regulation of proteasomal protein catabolic process (GO:0061136)	28	0	.38	-	 < 0.01	1.00E00
cellular response to oxygen-containing compound (GO:1901701)	76	0	1.02	-	 < 0.01	6.29E-01
receptor signaling pathway via STAT (GO:0097696)	5	0	.07	-	 < 0.01	1.00E00
response to oxygen-containing compound (GO:1901700)	94	0	1.27	-	 < 0.01	6.40E-01
cardiac muscle contraction (GO:0060048)	14	0	.19	-	 < 0.01	1.00E00
heart contraction (GO:0060047)	18	0	.24	-	 < 0.01	1.00E00
response to transforming growth factor beta (GO:0071559)	18	0	.24	-	 < 0.01	1.00E00
organophosphate catabolic process (GO:0046434)	40	0	.54	-	 < 0.01	1.00E00
vesicle fusion to plasma membrane (GO:0099500)	6	0	.08	-	 < 0.01	1.00E00
multicellular organismal reproductive process (GO:0048609)	26	0	.35	-	 < 0.01	1.00E00
cellular response to amino acid starvation (GO:0034198)	8	0	.11	-	 < 0.01	1.00E00
reproductive structure development (GO:0048608)	2	0	.03	-	 < 0.01	1.00E00
aromatic amino acid family catabolic process (GO:0009074)	9	0	.12	-	 < 0.01	1.00E00
aromatic amino acid metabolic process (GO:0009072)	12	0	.16	-	 < 0.01	1.00E00
inorganic ion homeostasis (GO:0098771)	86	0	1.16	-	 < 0.01	6.33E-01
MAPK cascade (GO:0000165)	18	0	.24	-	 < 0.01	1.00E00
cellular lipid metabolic process (GO:0044255)	267	0	3.60	-	 < 0.01	5.35E-02
regulation of immune effector process (GO:0002697)	4	0	.05	-	 < 0.01	1.00E00
positive regulation of leukocyte activation (GO:0002696)	5	0	.07	-	 < 0.01	1.00E00
positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427)	2	0	.03	-	 < 0.01	1.00E00
negative regulation of leukocyte activation (GO:0002695)	6	0	.08	-	 < 0.01	1.00E00
regulation of leukocyte activation (GO:0002694)	11	0	.15	-	 < 0.01	1.00E00
regulation of receptor signaling pathway via JAK-STAT (GO:0046425)	6	0	.08	-	 < 0.01	1.00E00
negative regulation of small GTPase mediated signal transduction (GO:0051058)	9	0	.12	-	 < 0.01	1.00E00
positive regulation of leukocyte chemotaxis (GO:0002690)	7	0	.09	-	 < 0.01	1.00E00
aspartate family amino acid biosynthetic process (GO:0009067)	8	0	.11	-	 < 0.01	1.00E00
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162)	8	0	.11	-	 < 0.01	1.00E00
aspartate family amino acid metabolic process (GO:0009066)	12	0	.16	-	 < 0.01	1.00E00
negative regulation of DNA metabolic process (GO:0051053)	12	0	.16	-	 < 0.01	1.00E00
amino acid catabolic process (GO:0009063)	31	0	.42	-	 < 0.01	1.00E00
fatty acid catabolic process (GO:0009062)	28	0	.38	-	 < 0.01	1.00E00
positive regulation of transport (GO:0051050)	33	0	.44	-	 < 0.01	1.00E00
aerobic respiration (GO:0009060)	21	0	.28	-	 < 0.01	1.00E00
cellular respiration (GO:0045333)	26	0	.35	-	 < 0.01	1.00E00
phospholipid translocation (GO:0045332)	20	0	.27	-	 < 0.01	1.00E00
intraciliary transport (GO:0042073)	15	0	.20	-	 < 0.01	1.00E00
rRNA modification (GO:0000154)	17	0	.23	-	 < 0.01	1.00E00
mitochondrial gene expression (GO:0140053)	23	0	.31	-	 < 0.01	1.00E00
protein O-linked mannosylation (GO:0035269)	5	0	.07	-	 < 0.01	1.00E00
cellular lipid catabolic process (GO:0044242)	58	0	.78	-	 < 0.01	1.00E00
protein mannosylation (GO:0035268)	8	0	.11	-	 < 0.01	1.00E00
positive regulation of leukocyte migration (GO:0002687)	10	0	.13	-	 < 0.01	1.00E00
cytoskeleton-dependent intracellular transport (GO:0030705)	54	0	.73	-	 < 0.01	1.00E00
regulation of leukocyte migration (GO:0002685)	13	0	.18	-	 < 0.01	1.00E00
positive regulation of immune system process (GO:0002684)	61	0	.82	-	 < 0.01	1.00E00
negative regulation of immune system process (GO:0002683)	16	0	.22	-	 < 0.01	1.00E00
regulation of immune system process (GO:0002682)	90	0	1.21	-	 < 0.01	6.36E-01
DNA biosynthetic process (GO:0071897)	17	0	.23	-	 < 0.01	1.00E00
positive regulation of secretion (GO:0051047)	6	0	.08	-	 < 0.01	1.00E00
regulation of secretion (GO:0051046)	40	0	.54	-	 < 0.01	1.00E00
regulation of monoatomic cation transmembrane transport (GO:1904062)	43	0	.58	-	 < 0.01	1.00E00
detoxification (GO:0098754)	6	0	.08	-	 < 0.01	1.00E00
gliogenesis (GO:0042063)	11	0	.15	-	 < 0.01	1.00E00
leukocyte activation (GO:0045321)	14	0	.19	-	 < 0.01	1.00E00
protein localization to lysosome (GO:0061462)	6	0	.08	-	 < 0.01	1.00E00
stress fiber assembly (GO:0043149)	5	0	.07	-	 < 0.01	1.00E00
regulation of double-strand break repair via homologous recombination (GO:0010569)	6	0	.08	-	 < 0.01	1.00E00
regulation of cell cycle process (GO:0010564)	93	0	1.25	-	 < 0.01	6.39E-01
negative regulation of phosphorus metabolic process (GO:0010563)	35	0	.47	-	 < 0.01	1.00E00
neuron projection extension (GO:1990138)	5	0	.07	-	 < 0.01	1.00E00
regulation of epidermal growth factor receptor signaling pathway (GO:0042058)	10	0	.13	-	 < 0.01	1.00E00
cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742)	60	0	.81	-	 < 0.01	1.00E00
detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580)	1	0	.01	-	 < 0.01	1.00E00
reproductive system development (GO:0061458)	2	0	.03	-	 < 0.01	1.00E00
establishment of mitotic spindle orientation (GO:0000132)	9	0	.12	-	 < 0.01	1.00E00
mRNA transport (GO:0051028)	26	0	.35	-	 < 0.01	1.00E00
import across plasma membrane (GO:0098739)	64	0	.86	-	 < 0.01	1.00E00
microtubule bundle formation (GO:0001578)	18	0	.24	-	 < 0.01	1.00E00
phosphatidylinositol 3-kinase/protein kinase B signal transduction (GO:0043491)	7	0	.09	-	 < 0.01	1.00E00
phospholipid catabolic process (GO:0009395)	12	0	.16	-	 < 0.01	1.00E00
fluid transport (GO:0042044)	4	0	.05	-	 < 0.01	1.00E00
vasculogenesis (GO:0001570)	3	0	.04	-	 < 0.01	1.00E00
exocytic process (GO:0140029)	11	0	.15	-	 < 0.01	1.00E00
tube morphogenesis (GO:0035239)	35	0	.47	-	 < 0.01	1.00E00
RNA stabilization (GO:0043489)	11	0	.15	-	 < 0.01	1.00E00
regulation of mRNA stability (GO:0043488)	45	0	.61	-	 < 0.01	1.00E00
regulation of RNA stability (GO:0043487)	45	0	.61	-	 < 0.01	1.00E00
establishment of protein localization to extracellular region (GO:0035592)	15	0	.20	-	 < 0.01	1.00E00
negative regulation of canonical NF-kappaB signal transduction (GO:0043124)	5	0	.07	-	 < 0.01	1.00E00
positive regulation of canonical NF-kappaB signal transduction (GO:0043123)	21	0	.28	-	 < 0.01	1.00E00
actin filament bundle assembly (GO:0051017)	18	0	.24	-	 < 0.01	1.00E00
regulation of canonical NF-kappaB signal transduction (GO:0043122)	30	0	.40	-	 < 0.01	1.00E00
barbed-end actin filament capping (GO:0051016)	16	0	.22	-	 < 0.01	1.00E00
blood vessel development (GO:0001568)	35	0	.47	-	 < 0.01	1.00E00
toll-like receptor 4 signaling pathway (GO:0034142)	4	0	.05	-	 < 0.01	1.00E00
isoprenoid biosynthetic process (GO:0008299)	8	0	.11	-	 < 0.01	1.00E00
endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)	4	0	.05	-	 < 0.01	1.00E00
regulation of membrane potential (GO:0042391)	82	0	1.11	-	 < 0.01	6.31E-01
mitotic nuclear division (GO:0140014)	37	0	.50	-	 < 0.01	1.00E00
meiotic nuclear division (GO:0140013)	31	0	.42	-	 < 0.01	1.00E00
maturation of LSU-rRNA (GO:0000470)	16	0	.22	-	 < 0.01	1.00E00
bone development (GO:0060348)	4	0	.05	-	 < 0.01	1.00E00
regulation of protein localization to membrane (GO:1905475)	10	0	.13	-	 < 0.01	1.00E00
receptor clustering (GO:0043113)	7	0	.09	-	 < 0.01	1.00E00
pigmentation (GO:0043473)	10	0	.13	-	 < 0.01	1.00E00
regulation of cell growth (GO:0001558)	10	0	.13	-	 < 0.01	1.00E00
negative regulation of mitotic sister chromatid segregation (GO:0033048)	9	0	.12	-	 < 0.01	1.00E00
aromatic compound catabolic process (GO:0019439)	105	0	1.42	-	 < 0.01	4.07E-01
regulation of mitotic sister chromatid segregation (GO:0033047)	10	0	.13	-	 < 0.01	1.00E00
insulin receptor signaling pathway (GO:0008286)	7	0	.09	-	 < 0.01	1.00E00
aromatic compound biosynthetic process (GO:0019438)	174	0	2.35	-	 < 0.01	1.79E-01
negative regulation of sister chromatid segregation (GO:0033046)	9	0	.12	-	 < 0.01	1.00E00
maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)	7	0	.09	-	 < 0.01	1.00E00
negative regulation of cell population proliferation (GO:0008285)	14	0	.19	-	 < 0.01	1.00E00
regulation of sister chromatid segregation (GO:0033045)	19	0	.26	-	 < 0.01	1.00E00
positive regulation of cell population proliferation (GO:0008284)	52	0	.70	-	 < 0.01	1.00E00
cell population proliferation (GO:0008283)	7	0	.09	-	 < 0.01	1.00E00
maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)	11	0	.15	-	 < 0.01	1.00E00
triglyceride catabolic process (GO:0019433)	3	0	.04	-	 < 0.01	1.00E00
triglyceride biosynthetic process (GO:0019432)	9	0	.12	-	 < 0.01	1.00E00
maturation of 5.8S rRNA (GO:0000460)	14	0	.19	-	 < 0.01	1.00E00
secondary metabolite biosynthetic process (GO:0044550)	4	0	.05	-	 < 0.01	1.00E00
type I interferon-mediated signaling pathway (GO:0060337)	1	0	.01	-	 < 0.01	1.00E00
negative regulation of adenylate cyclase activity (GO:0007194)	2	0	.03	-	 < 0.01	1.00E00
adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193)	16	0	.22	-	 < 0.01	1.00E00
protein palmitoylation (GO:0018345)	20	0	.27	-	 < 0.01	1.00E00
positive regulation of myeloid cell differentiation (GO:0045639)	4	0	.05	-	 < 0.01	1.00E00
regulation of myeloid cell differentiation (GO:0045637)	6	0	.08	-	 < 0.01	1.00E00
negative regulation of lyase activity (GO:0051350)	2	0	.03	-	 < 0.01	1.00E00
regulation of G protein-coupled receptor signaling pathway (GO:0008277)	16	0	.22	-	 < 0.01	1.00E00
adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189)	59	0	.80	-	 < 0.01	1.00E00
adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188)	87	0	1.17	-	 < 0.01	6.34E-01
non-canonical Wnt signaling pathway (GO:0035567)	22	0	.30	-	 < 0.01	1.00E00
cell chemotaxis (GO:0060326)	14	0	.19	-	 < 0.01	1.00E00
regulation of phospholipase activity (GO:0010517)	1	0	.01	-	 < 0.01	1.00E00
lipid localization (GO:0010876)	76	0	1.02	-	 < 0.01	6.29E-01
positive regulation of lyase activity (GO:0051349)	9	0	.12	-	 < 0.01	1.00E00
head development (GO:0060322)	44	0	.59	-	 < 0.01	1.00E00
cilium or flagellum-dependent cell motility (GO:0001539)	11	0	.15	-	 < 0.01	1.00E00
tricarboxylic acid cycle (GO:0006099)	12	0	.16	-	 < 0.01	1.00E00
negative regulation of hydrolase activity (GO:0051346)	24	0	.32	-	 < 0.01	1.00E00
glycolytic process (GO:0006096)	14	0	.19	-	 < 0.01	1.00E00
retina homeostasis (GO:0001895)	2	0	.03	-	 < 0.01	1.00E00
tissue homeostasis (GO:0001894)	4	0	.05	-	 < 0.01	1.00E00
amino acid import across plasma membrane (GO:0089718)	9	0	.12	-	 < 0.01	1.00E00
generation of precursor metabolites and energy (GO:0006091)	54	0	.73	-	 < 0.01	1.00E00
endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000447)	2	0	.03	-	 < 0.01	1.00E00
transforming growth factor beta receptor signaling pathway (GO:0007179)	18	0	.24	-	 < 0.01	1.00E00
transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178)	28	0	.38	-	 < 0.01	1.00E00
positive regulation of autophagy (GO:0010508)	15	0	.20	-	 < 0.01	1.00E00
negative regulation of autophagy (GO:0010507)	9	0	.12	-	 < 0.01	1.00E00
epidermal growth factor receptor signaling pathway (GO:0007173)	8	0	.11	-	 < 0.01	1.00E00
regulation of autophagy (GO:0010506)	34	0	.46	-	 < 0.01	1.00E00
regulation of lyase activity (GO:0051339)	12	0	.16	-	 < 0.01	1.00E00
homotypic cell-cell adhesion (GO:0034109)	7	0	.09	-	 < 0.01	1.00E00
heterocycle catabolic process (GO:0046700)	99	0	1.33	-	 < 0.01	6.46E-01
liver development (GO:0001889)	2	0	.03	-	 < 0.01	1.00E00
angiogenesis (GO:0001525)	31	0	.42	-	 < 0.01	1.00E00
regulation of tissue remodeling (GO:0034103)	3	0	.04	-	 < 0.01	1.00E00
retinoid metabolic process (GO:0001523)	4	0	.05	-	 < 0.01	1.00E00
regulation of autophagosome maturation (GO:1901096)	5	0	.07	-	 < 0.01	1.00E00
pseudouridine synthesis (GO:0001522)	10	0	.13	-	 < 0.01	1.00E00
organic acid metabolic process (GO:0006082)	186	0	2.51	-	 < 0.01	1.85E-01
tetrapyrrole metabolic process (GO:0033013)	11	0	.15	-	 < 0.01	1.00E00
negative regulation of cell adhesion (GO:0007162)	9	0	.12	-	 < 0.01	1.00E00
oxoacid metabolic process (GO:0043436)	186	0	2.51	-	 < 0.01	1.85E-01
cell-matrix adhesion (GO:0007160)	29	0	.39	-	 < 0.01	1.00E00
response to peptide hormone (GO:0043434)	24	0	.32	-	 < 0.01	1.00E00
negative regulation of DNA-binding transcription factor activity (GO:0043433)	7	0	.09	-	 < 0.01	1.00E00
meiotic cell cycle (GO:0051321)	47	0	.63	-	 < 0.01	1.00E00
glycerol-3-phosphate metabolic process (GO:0006072)	3	0	.04	-	 < 0.01	1.00E00
RNA methylation (GO:0001510)	36	0	.49	-	 < 0.01	1.00E00
secretory granule organization (GO:0033363)	2	0	.03	-	 < 0.01	1.00E00
leukocyte cell-cell adhesion (GO:0007159)	1	0	.01	-	 < 0.01	1.00E00
carboxylic acid metabolic process (GO:0019752)	184	0	2.48	-	 < 0.01	1.84E-01
heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157)	13	0	.18	-	 < 0.01	1.00E00
homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156)	19	0	.26	-	 < 0.01	1.00E00
positive regulation of protein polymerization (GO:0032273)	12	0	.16	-	 < 0.01	1.00E00
protein transmembrane transport (GO:0071806)	27	0	.36	-	 < 0.01	1.00E00
negative regulation of protein polymerization (GO:0032272)	21	0	.28	-	 < 0.01	1.00E00
regulation of protein polymerization (GO:0032271)	44	0	.59	-	 < 0.01	1.00E00
action potential (GO:0001508)	29	0	.39	-	 < 0.01	1.00E00
attachment of mitotic spindle microtubules to kinetochore (GO:0051315)	5	0	.07	-	 < 0.01	1.00E00
alcohol metabolic process (GO:0006066)	45	0	.61	-	 < 0.01	1.00E00
substrate adhesion-dependent cell spreading (GO:0034446)	13	0	.18	-	 < 0.01	1.00E00
ossification (GO:0001503)	9	0	.12	-	 < 0.01	1.00E00
metaphase chromosome alignment (GO:0051310)	9	0	.12	-	 < 0.01	1.00E00
skeletal system development (GO:0001501)	24	0	.32	-	 < 0.01	1.00E00
protein localization to cell periphery (GO:1990778)	48	0	.65	-	 < 0.01	1.00E00
replication-born double-strand break repair via sister chromatid exchange (GO:1990414)	3	0	.04	-	 < 0.01	1.00E00
lipid oxidation (GO:0034440)	21	0	.28	-	 < 0.01	1.00E00
positive regulation of natural killer cell mediated cytotoxicity (GO:0045954)	1	0	.01	-	 < 0.01	1.00E00
taxis (GO:0042330)	30	0	.40	-	 < 0.01	1.00E00
phytosteroid metabolic process (GO:0016128)	1	0	.01	-	 < 0.01	1.00E00
secondary metabolic process (GO:0019748)	5	0	.07	-	 < 0.01	1.00E00
lymphocyte differentiation (GO:0030098)	7	0	.09	-	 < 0.01	1.00E00
protein peptidyl-prolyl isomerization (GO:0000413)	12	0	.16	-	 < 0.01	1.00E00
sterol biosynthetic process (GO:0016126)	11	0	.15	-	 < 0.01	1.00E00
regulation of Notch signaling pathway (GO:0008593)	12	0	.16	-	 < 0.01	1.00E00
sterol metabolic process (GO:0016125)	16	0	.22	-	 < 0.01	1.00E00
cytosolic transport (GO:0016482)	35	0	.47	-	 < 0.01	1.00E00
male meiotic nuclear division (GO:0007140)	4	0	.05	-	 < 0.01	1.00E00
macromolecule methylation (GO:0043414)	48	0	.65	-	 < 0.01	1.00E00
telomere maintenance via telomere lengthening (GO:0010833)	5	0	.07	-	 < 0.01	1.00E00
chromosome separation (GO:0051304)	1	0	.01	-	 < 0.01	1.00E00
establishment of chromosome localization (GO:0051303)	12	0	.16	-	 < 0.01	1.00E00
regulation of cell division (GO:0051302)	6	0	.08	-	 < 0.01	1.00E00
oligosaccharide biosynthetic process (GO:0009312)	2	0	.03	-	 < 0.01	1.00E00
neuron projection development (GO:0031175)	172	0	2.32	-	 < 0.01	1.78E-01
negative regulation of phosphorylation (GO:0042326)	32	0	.43	-	 < 0.01	1.00E00
positive regulation of transcription by RNA polymerase I (GO:0045943)	3	0	.04	-	 < 0.01	1.00E00
syncytium formation by plasma membrane fusion (GO:0000768)	3	0	.04	-	 < 0.01	1.00E00
carotenoid biosynthetic process (GO:0016117)	1	0	.01	-	 < 0.01	1.00E00
male gonad development (GO:0008584)	1	0	.01	-	 < 0.01	1.00E00
cholesterol efflux (GO:0033344)	5	0	.07	-	 < 0.01	1.00E00
cell migration (GO:0016477)	153	0	2.06	-	 < 0.01	2.75E-01
terpenoid biosynthetic process (GO:0016114)	2	0	.03	-	 < 0.01	1.00E00
antimicrobial humoral response (GO:0019730)	1	0	.01	-	 < 0.01	1.00E00
methylation (GO:0032259)	48	0	.65	-	 < 0.01	1.00E00
mesoderm development (GO:0007498)	7	0	.09	-	 < 0.01	1.00E00
reciprocal meiotic recombination (GO:0007131)	20	0	.27	-	 < 0.01	1.00E00
amine metabolic process (GO:0009308)	17	0	.23	-	 < 0.01	1.00E00
regulation of centrosome duplication (GO:0010824)	5	0	.07	-	 < 0.01	1.00E00
protein secretion (GO:0009306)	15	0	.20	-	 < 0.01	1.00E00
steroid hormone mediated signaling pathway (GO:0043401)	3	0	.04	-	 < 0.01	1.00E00
UDP-N-acetylglucosamine metabolic process (GO:0006047)	3	0	.04	-	 < 0.01	1.00E00
regulation of mitochondrion organization (GO:0010821)	8	0	.11	-	 < 0.01	1.00E00
rRNA transcription (GO:0009303)	6	0	.08	-	 < 0.01	1.00E00
rRNA methylation (GO:0031167)	10	0	.13	-	 < 0.01	1.00E00
phagolysosome assembly (GO:0001845)	9	0	.12	-	 < 0.01	1.00E00
spindle localization (GO:0051653)	17	0	.23	-	 < 0.01	1.00E00
negative regulation of phosphate metabolic process (GO:0045936)	35	0	.47	-	 < 0.01	1.00E00
maintenance of location in cell (GO:0051651)	18	0	.24	-	 < 0.01	1.00E00
amino sugar metabolic process (GO:0006040)	12	0	.16	-	 < 0.01	1.00E00
cell death (GO:0008219)	55	0	.74	-	 < 0.01	1.00E00
regulation of blood pressure (GO:0008217)	11	0	.15	-	 < 0.01	1.00E00
positive regulation of mitotic cell cycle (GO:0045931)	15	0	.20	-	 < 0.01	1.00E00
negative regulation of mitotic cell cycle (GO:0045930)	36	0	.49	-	 < 0.01	1.00E00
negative regulation of mitotic sister chromatid separation (GO:2000816)	9	0	.12	-	 < 0.01	1.00E00
insulin secretion (GO:0030073)	2	0	.03	-	 < 0.01	1.00E00
homologous chromosome pairing at meiosis (GO:0007129)	5	0	.07	-	 < 0.01	1.00E00
peptide hormone secretion (GO:0030072)	3	0	.04	-	 < 0.01	1.00E00
diterpenoid metabolic process (GO:0016101)	4	0	.05	-	 < 0.01	1.00E00
regulation of mitotic metaphase/anaphase transition (GO:0030071)	16	0	.22	-	 < 0.01	1.00E00
cell cycle G1/S phase transition (GO:0044843)	17	0	.23	-	 < 0.01	1.00E00
meiosis I (GO:0007127)	24	0	.32	-	 < 0.01	1.00E00
regulation of hormone levels (GO:0010817)	19	0	.26	-	 < 0.01	1.00E00
tRNA metabolic process (GO:0006399)	77	0	1.04	-	 < 0.01	6.29E-01
positive regulation of cell-substrate adhesion (GO:0010811)	10	0	.13	-	 < 0.01	1.00E00
regulation of cell-substrate adhesion (GO:0010810)	12	0	.16	-	 < 0.01	1.00E00
release of cytochrome c from mitochondria (GO:0001836)	4	0	.05	-	 < 0.01	1.00E00
positive regulation of growth (GO:0045927)	3	0	.04	-	 < 0.01	1.00E00
centrosome localization (GO:0051642)	8	0	.11	-	 < 0.01	1.00E00
mitochondrial transcription (GO:0006390)	6	0	.08	-	 < 0.01	1.00E00
reticulophagy (GO:0061709)	8	0	.11	-	 < 0.01	1.00E00
cholesterol metabolic process (GO:0008203)	10	0	.13	-	 < 0.01	1.00E00
cell cycle G2/M phase transition (GO:0044839)	3	0	.04	-	 < 0.01	1.00E00
steroid metabolic process (GO:0008202)	22	0	.30	-	 < 0.01	1.00E00
left/right pattern formation (GO:0060972)	2	0	.03	-	 < 0.01	1.00E00
glucose transmembrane transport (GO:1904659)	5	0	.07	-	 < 0.01	1.00E00
tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)	4	0	.05	-	 < 0.01	1.00E00
glycosaminoglycan biosynthetic process (GO:0006024)	13	0	.18	-	 < 0.01	1.00E00
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146)	13	0	.18	-	 < 0.01	1.00E00
aminoglycan biosynthetic process (GO:0006023)	17	0	.23	-	 < 0.01	1.00E00
anaphase-promoting complex-dependent catabolic process (GO:0031145)	8	0	.11	-	 < 0.01	1.00E00
aminoglycan metabolic process (GO:0006022)	24	0	.32	-	 < 0.01	1.00E00
kidney development (GO:0001822)	8	0	.11	-	 < 0.01	1.00E00
transcription by RNA polymerase III (GO:0006383)	13	0	.18	-	 < 0.01	1.00E00
adenosine to inosine editing (GO:0006382)	3	0	.04	-	 < 0.01	1.00E00
negative regulation of DNA recombination (GO:0045910)	5	0	.07	-	 < 0.01	1.00E00
mitotic DNA replication checkpoint signaling (GO:0033314)	3	0	.04	-	 < 0.01	1.00E00
DNA synthesis involved in DNA repair (GO:0000731)	13	0	.18	-	 < 0.01	1.00E00
somatic cell DNA recombination (GO:0016444)	2	0	.03	-	 < 0.01	1.00E00
regulation of organelle assembly (GO:1902115)	20	0	.27	-	 < 0.01	1.00E00
chloride transmembrane transport (GO:1902476)	32	0	.43	-	 < 0.01	1.00E00
L-alpha-amino acid transmembrane transport (GO:1902475)	13	0	.18	-	 < 0.01	1.00E00
regulation of cellular response to growth factor stimulus (GO:0090287)	43	0	.58	-	 < 0.01	1.00E00
positive regulation of cytokine production (GO:0001819)	9	0	.12	-	 < 0.01	1.00E00
regulation of cytokine production (GO:0001817)	23	0	.31	-	 < 0.01	1.00E00
mRNA polyadenylation (GO:0006378)	5	0	.07	-	 < 0.01	1.00E00
response to toxic substance (GO:0009636)	8	0	.11	-	 < 0.01	1.00E00
negative regulation of chromosome segregation (GO:0051985)	9	0	.12	-	 < 0.01	1.00E00
iron ion transmembrane transport (GO:0034755)	4	0	.05	-	 < 0.01	1.00E00
regulation of chromosome segregation (GO:0051983)	21	0	.28	-	 < 0.01	1.00E00
response to extracellular stimulus (GO:0009991)	31	0	.42	-	 < 0.01	1.00E00
DNA double-strand break processing (GO:0000729)	4	0	.05	-	 < 0.01	1.00E00
double-strand break repair via break-induced replication (GO:0000727)	9	0	.12	-	 < 0.01	1.00E00
actin filament-based movement (GO:0030048)	13	0	.18	-	 < 0.01	1.00E00
recombinational repair (GO:0000725)	49	0	.66	-	 < 0.01	1.00E00
epidermis development (GO:0008544)	3	0	.04	-	 < 0.01	1.00E00
mitotic G2/M transition checkpoint (GO:0044818)	11	0	.15	-	 < 0.01	1.00E00
double-strand break repair via homologous recombination (GO:0000724)	49	0	.66	-	 < 0.01	1.00E00
fibroblast growth factor receptor signaling pathway (GO:0008543)	24	0	.32	-	 < 0.01	1.00E00
telomere maintenance (GO:0000723)	23	0	.31	-	 < 0.01	1.00E00
actin filament depolymerization (GO:0030042)	8	0	.11	-	 < 0.01	1.00E00
actin filament polymerization (GO:0030041)	10	0	.13	-	 < 0.01	1.00E00
regulation of peptide hormone secretion (GO:0090276)	3	0	.04	-	 < 0.01	1.00E00
negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100)	9	0	.12	-	 < 0.01	1.00E00
organelle fission (GO:0048285)	75	0	1.01	-	 < 0.01	6.28E-01
organelle fusion (GO:0048284)	49	0	.66	-	 < 0.01	1.00E00
glucose metabolic process (GO:0006006)	14	0	.19	-	 < 0.01	1.00E00
transcription elongation by RNA polymerase II (GO:0006368)	9	0	.12	-	 < 0.01	1.00E00
cell-cell recognition (GO:0009988)	1	0	.01	-	 < 0.01	1.00E00
transcription initiation at RNA polymerase II promoter (GO:0006367)	19	0	.26	-	 < 0.01	1.00E00
regulation of potassium ion transmembrane transport (GO:1901379)	13	0	.18	-	 < 0.01	1.00E00
transcription by RNA polymerase II (GO:0006366)	44	0	.59	-	 < 0.01	1.00E00
mRNA 3'-end processing (GO:0031124)	15	0	.20	-	 < 0.01	1.00E00
transcription elongation by RNA polymerase I (GO:0006362)	2	0	.03	-	 < 0.01	1.00E00
cytoplasmic microtubule organization (GO:0031122)	20	0	.27	-	 < 0.01	1.00E00
transcription by RNA polymerase I (GO:0006360)	10	0	.13	-	 < 0.01	1.00E00
lipid homeostasis (GO:0055088)	19	0	.26	-	 < 0.01	1.00E00
cholesterol homeostasis (GO:0042632)	7	0	.09	-	 < 0.01	1.00E00
contractile actin filament bundle assembly (GO:0030038)	5	0	.07	-	 < 0.01	1.00E00
respiratory chain complex IV assembly (GO:0008535)	1	0	.01	-	 < 0.01	1.00E00
resolution of meiotic recombination intermediates (GO:0000712)	11	0	.15	-	 < 0.01	1.00E00
regulation of postsynapse organization (GO:0099175)	7	0	.09	-	 < 0.01	1.00E00
postsynapse organization (GO:0099173)	4	0	.05	-	 < 0.01	1.00E00
homologous recombination (GO:0035825)	20	0	.27	-	 < 0.01	1.00E00
inorganic anion transport (GO:0015698)	45	0	.61	-	 < 0.01	1.00E00
quaternary ammonium group transport (GO:0015697)	5	0	.07	-	 < 0.01	1.00E00
telomere organization (GO:0032200)	23	0	.31	-	 < 0.01	1.00E00
organic cation transport (GO:0015695)	6	0	.08	-	 < 0.01	1.00E00
defense response to virus (GO:0051607)	4	0	.05	-	 < 0.01	1.00E00
response to bacterium (GO:0009617)	13	0	.18	-	 < 0.01	1.00E00
detection of stimulus (GO:0051606)	21	0	.28	-	 < 0.01	1.00E00
response to virus (GO:0009615)	4	0	.05	-	 < 0.01	1.00E00
regulation of transcription by RNA polymerase I (GO:0006356)	4	0	.05	-	 < 0.01	1.00E00
positive regulation of synapse assembly (GO:0051965)	9	0	.12	-	 < 0.01	1.00E00
DNA-templated transcription elongation (GO:0006354)	11	0	.15	-	 < 0.01	1.00E00
response to mechanical stimulus (GO:0009612)	9	0	.12	-	 < 0.01	1.00E00
positive regulation of nervous system development (GO:0051962)	24	0	.32	-	 < 0.01	1.00E00
DNA-templated transcription initiation (GO:0006352)	30	0	.40	-	 < 0.01	1.00E00
DNA-templated transcription (GO:0006351)	73	0	.98	-	 < 0.01	6.28E-01
organic cyclic compound biosynthetic process (GO:1901362)	192	0	2.59	-	 < 0.01	1.18E-01
regulation of microtubule polymerization or depolymerization (GO:0031110)	15	0	.20	-	 < 0.01	1.00E00
organic cyclic compound catabolic process (GO:1901361)	110	0	1.48	-	 < 0.01	4.08E-01
sodium ion homeostasis (GO:0055078)	11	0	.15	-	 < 0.01	1.00E00
nervous system process (GO:0050877)	55	0	.74	-	 < 0.01	1.00E00
calcium ion homeostasis (GO:0055074)	55	0	.74	-	 < 0.01	1.00E00
positive regulation of secretion by cell (GO:1903532)	6	0	.08	-	 < 0.01	1.00E00
positive regulation of T cell activation (GO:0050870)	3	0	.04	-	 < 0.01	1.00E00
regulation of secretion by cell (GO:1903530)	39	0	.53	-	 < 0.01	1.00E00
regulation of muscle system process (GO:0090257)	9	0	.12	-	 < 0.01	1.00E00
response to biotic stimulus (GO:0009607)	37	0	.50	-	 < 0.01	1.00E00
nucleosome organization (GO:0034728)	9	0	.12	-	 < 0.01	1.00E00
response to external stimulus (GO:0009605)	121	0	1.63	-	 < 0.01	4.15E-01
DNA methylation-dependent heterochromatin formation (GO:0006346)	2	0	.03	-	 < 0.01	1.00E00
negative regulation of T cell activation (GO:0050868)	4	0	.05	-	 < 0.01	1.00E00
positive regulation of cell activation (GO:0050867)	5	0	.07	-	 < 0.01	1.00E00
negative regulation of cell activation (GO:0050866)	6	0	.08	-	 < 0.01	1.00E00
regulation of cell activation (GO:0050865)	13	0	.18	-	 < 0.01	1.00E00
regulation of T cell activation (GO:0050863)	6	0	.08	-	 < 0.01	1.00E00
response to lipid (GO:0033993)	31	0	.42	-	 < 0.01	1.00E00
adenosine metabolic process (GO:0046085)	4	0	.05	-	 < 0.01	1.00E00
establishment of cell polarity (GO:0030010)	22	0	.30	-	 < 0.01	1.00E00
regulation of receptor-mediated endocytosis (GO:0048259)	6	0	.08	-	 < 0.01	1.00E00
sensory organ development (GO:0007423)	42	0	.57	-	 < 0.01	1.00E00
peripheral nervous system development (GO:0007422)	1	0	.01	-	 < 0.01	1.00E00
brain development (GO:0007420)	44	0	.59	-	 < 0.01	1.00E00
mitochondrial translation (GO:0032543)	12	0	.16	-	 < 0.01	1.00E00
mRNA stabilization (GO:0048255)	11	0	.15	-	 < 0.01	1.00E00
chromatin remodeling (GO:0006338)	80	0	1.08	-	 < 0.01	6.30E-01
nucleosome assembly (GO:0006334)	7	0	.09	-	 < 0.01	1.00E00
cholesterol biosynthetic process (GO:0006695)	6	0	.08	-	 < 0.01	1.00E00
dorsal/ventral pattern formation (GO:0009953)	7	0	.09	-	 < 0.01	1.00E00
steroid biosynthetic process (GO:0006694)	14	0	.19	-	 < 0.01	1.00E00
regulation of systemic arterial blood pressure (GO:0003073)	7	0	.09	-	 < 0.01	1.00E00
prostaglandin metabolic process (GO:0006693)	3	0	.04	-	 < 0.01	1.00E00
regulation of vasculature development (GO:1901342)	21	0	.28	-	 < 0.01	1.00E00
icosanoid metabolic process (GO:0006690)	8	0	.11	-	 < 0.01	1.00E00
cell adhesion mediated by integrin (GO:0033627)	20	0	.27	-	 < 0.01	1.00E00
B cell receptor signaling pathway (GO:0050853)	6	0	.08	-	 < 0.01	1.00E00
T cell receptor signaling pathway (GO:0050852)	17	0	.23	-	 < 0.01	1.00E00
antigen receptor-mediated signaling pathway (GO:0050851)	19	0	.26	-	 < 0.01	1.00E00
central nervous system development (GO:0007417)	68	0	.92	-	 < 0.01	1.00E00
synapse assembly (GO:0007416)	20	0	.27	-	 < 0.01	1.00E00
regulation of cellular component size (GO:0032535)	51	0	.69	-	 < 0.01	1.00E00
axon guidance (GO:0007411)	92	0	1.24	-	 < 0.01	6.38E-01
macrophage chemotaxis (GO:0048246)	1	0	.01	-	 < 0.01	1.00E00
sensory organ morphogenesis (GO:0090596)	6	0	.08	-	 < 0.01	1.00E00
glycosphingolipid biosynthetic process (GO:0006688)	10	0	.13	-	 < 0.01	1.00E00
cellular response to nitrogen compound (GO:1901699)	60	0	.81	-	 < 0.01	1.00E00
chromatin organization (GO:0006325)	87	0	1.17	-	 < 0.01	6.34E-01
sperm capacitation (GO:0048240)	1	0	.01	-	 < 0.01	1.00E00
response to nitrogen compound (GO:1901698)	94	0	1.27	-	 < 0.01	6.40E-01
positive regulation of establishment of protein localization (GO:1904951)	4	0	.05	-	 < 0.01	1.00E00
liposaccharide metabolic process (GO:1903509)	34	0	.46	-	 < 0.01	1.00E00
membrane protein proteolysis (GO:0033619)	13	0	.18	-	 < 0.01	1.00E00
mitochondrial cytochrome c oxidase assembly (GO:0033617)	1	0	.01	-	 < 0.01	1.00E00
mitochondrial proton-transporting ATP synthase complex assembly (GO:0033615)	3	0	.04	-	 < 0.01	1.00E00
axonogenesis (GO:0007409)	107	0	1.44	-	 < 0.01	4.08E-01
protein localization to cell junction (GO:1902414)	16	0	.22	-	 < 0.01	1.00E00
regulation of microtubule-based process (GO:0032886)	38	0	.51	-	 < 0.01	1.00E00
mitotic cytokinetic process (GO:1902410)	1	0	.01	-	 < 0.01	1.00E00
male gamete generation (GO:0048232)	15	0	.20	-	 < 0.01	1.00E00
regulation of protein localization (GO:0032880)	33	0	.44	-	 < 0.01	1.00E00
camera-type eye morphogenesis (GO:0048593)	3	0	.04	-	 < 0.01	1.00E00
eye morphogenesis (GO:0048592)	4	0	.05	-	 < 0.01	1.00E00
regulation of calcium ion transport (GO:0051924)	18	0	.24	-	 < 0.01	1.00E00
mitotic recombination (GO:0006312)	6	0	.08	-	 < 0.01	1.00E00
ceramide metabolic process (GO:0006672)	32	0	.43	-	 < 0.01	1.00E00
DNA recombination (GO:0006310)	72	0	.97	-	 < 0.01	1.00E00
P-body assembly (GO:0033962)	6	0	.08	-	 < 0.01	1.00E00
developmental growth (GO:0048589)	7	0	.09	-	 < 0.01	1.00E00
developmental cell growth (GO:0048588)	5	0	.07	-	 < 0.01	1.00E00
DNA catabolic process (GO:0006308)	4	0	.05	-	 < 0.01	1.00E00
cellular response to hormone stimulus (GO:0032870)	57	0	.77	-	 < 0.01	1.00E00
DNA methylation (GO:0006306)	3	0	.04	-	 < 0.01	1.00E00
DNA alkylation (GO:0006305)	3	0	.04	-	 < 0.01	1.00E00
sphingolipid metabolic process (GO:0006665)	48	0	.65	-	 < 0.01	1.00E00
double-strand break repair via nonhomologous end joining (GO:0006303)	16	0	.22	-	 < 0.01	1.00E00
glycolipid metabolic process (GO:0006664)	33	0	.44	-	 < 0.01	1.00E00
double-strand break repair (GO:0006302)	87	0	1.17	-	 < 0.01	6.34E-01
postreplication repair (GO:0006301)	14	0	.19	-	 < 0.01	1.00E00
dipeptide transport (GO:0042938)	2	0	.03	-	 < 0.01	1.00E00
phosphatidylinositol biosynthetic process (GO:0006661)	47	0	.63	-	 < 0.01	1.00E00
vesicle transport along microtubule (GO:0047496)	16	0	.22	-	 < 0.01	1.00E00
defense response to Gram-negative bacterium (GO:0050829)	1	0	.01	-	 < 0.01	1.00E00
negative regulation of cell migration (GO:0030336)	10	0	.13	-	 < 0.01	1.00E00
positive regulation of cell migration (GO:0030335)	42	0	.57	-	 < 0.01	1.00E00
regulation of cell migration (GO:0030334)	83	0	1.12	-	 < 0.01	6.31E-01
protein stabilization (GO:0050821)	11	0	.15	-	 < 0.01	1.00E00
microtubule-based transport (GO:0099111)	50	0	.67	-	 < 0.01	1.00E00
DNA duplex unwinding (GO:0032508)	9	0	.12	-	 < 0.01	1.00E00
cellular response to insulin stimulus (GO:0032869)	16	0	.22	-	 < 0.01	1.00E00
cytokinetic process (GO:0032506)	8	0	.11	-	 < 0.01	1.00E00
response to insulin (GO:0032868)	16	0	.22	-	 < 0.01	1.00E00
IMP metabolic process (GO:0046040)	9	0	.12	-	 < 0.01	1.00E00
multicellular organism reproduction (GO:0032504)	26	0	.35	-	 < 0.01	1.00E00
negative regulation of cell cycle G2/M phase transition (GO:1902750)	15	0	.20	-	 < 0.01	1.00E00
hormone transport (GO:0009914)	3	0	.04	-	 < 0.01	1.00E00
phosphatidylcholine biosynthetic process (GO:0006656)	2	0	.03	-	 < 0.01	1.00E00
epidermal cell differentiation (GO:0009913)	1	0	.01	-	 < 0.01	1.00E00
glycerophospholipid metabolic process (GO:0006650)	106	0	1.43	-	 < 0.01	4.07E-01
negative regulation of coagulation (GO:0050819)	5	0	.07	-	 < 0.01	1.00E00
regulation of cellular response to stress (GO:0080135)	29	0	.39	-	 < 0.01	1.00E00
ATP metabolic process (GO:0046034)	16	0	.22	-	 < 0.01	1.00E00
carboxylic acid catabolic process (GO:0046395)	66	0	.89	-	 < 0.01	1.00E00
carboxylic acid biosynthetic process (GO:0046394)	53	0	.71	-	 < 0.01	1.00E00
regulation of cell cycle G2/M phase transition (GO:1902749)	21	0	.28	-	 < 0.01	1.00E00
ribose phosphate biosynthetic process (GO:0046390)	37	0	.50	-	 < 0.01	1.00E00
embryonic organ development (GO:0048568)	21	0	.28	-	 < 0.01	1.00E00
glycosyl compound catabolic process (GO:1901658)	13	0	.18	-	 < 0.01	1.00E00
energy derivation by oxidation of organic compounds (GO:0015980)	31	0	.42	-	 < 0.01	1.00E00
glycosyl compound metabolic process (GO:1901657)	23	0	.31	-	 < 0.01	1.00E00
phospholipid metabolic process (GO:0006644)	129	0	1.74	-	 < 0.01	4.24E-01
membrane lipid metabolic process (GO:0006643)	66	0	.89	-	 < 0.01	1.00E00
triglyceride metabolic process (GO:0006641)	15	0	.20	-	 < 0.01	1.00E00
cellular response to peptide (GO:1901653)	22	0	.30	-	 < 0.01	1.00E00
response to peptide (GO:1901652)	24	0	.32	-	 < 0.01	1.00E00
synapse organization (GO:0050808)	60	0	.81	-	 < 0.01	1.00E00
negative regulation of protein modification process (GO:0031400)	40	0	.54	-	 < 0.01	1.00E00
cardiac muscle cell differentiation (GO:0055007)	7	0	.09	-	 < 0.01	1.00E00
regulation of synapse organization (GO:0050807)	16	0	.22	-	 < 0.01	1.00E00
positive regulation of protein localization (GO:1903829)	10	0	.13	-	 < 0.01	1.00E00
melanocyte differentiation (GO:0030318)	1	0	.01	-	 < 0.01	1.00E00
flagellated sperm motility (GO:0030317)	1	0	.01	-	 < 0.01	1.00E00
organic acid transmembrane transport (GO:1903825)	52	0	.70	-	 < 0.01	1.00E00
regulation of synapse structure or activity (GO:0050803)	17	0	.23	-	 < 0.01	1.00E00
osteoclast differentiation (GO:0030316)	3	0	.04	-	 < 0.01	1.00E00
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059)	3	0	.04	-	 < 0.01	1.00E00
acylglycerol metabolic process (GO:0006639)	21	0	.28	-	 < 0.01	1.00E00
neutral lipid metabolic process (GO:0006638)	21	0	.28	-	 < 0.01	1.00E00
acyl-CoA metabolic process (GO:0006637)	16	0	.22	-	 < 0.01	1.00E00
nuclear envelope organization (GO:0006998)	8	0	.11	-	 < 0.01	1.00E00
unsaturated fatty acid biosynthetic process (GO:0006636)	4	0	.05	-	 < 0.01	1.00E00
fatty acid beta-oxidation (GO:0006635)	19	0	.26	-	 < 0.01	1.00E00
heart process (GO:0003015)	19	0	.26	-	 < 0.01	1.00E00
mRNA cis splicing, via spliceosome (GO:0045292)	4	0	.05	-	 < 0.01	1.00E00
fatty acid biosynthetic process (GO:0006633)	25	0	.34	-	 < 0.01	1.00E00
circulatory system process (GO:0003013)	38	0	.51	-	 < 0.01	1.00E00
muscle system process (GO:0003012)	28	0	.38	-	 < 0.01	1.00E00
chaperone-mediated protein folding (GO:0061077)	10	0	.13	-	 < 0.01	1.00E00
fatty acid metabolic process (GO:0006631)	73	0	.98	-	 < 0.01	6.28E-01
reproductive process (GO:0022414)	70	0	.94	-	 < 0.01	1.00E00
ERBB signaling pathway (GO:0038127)	9	0	.12	-	 < 0.01	1.00E00
cellular process involved in reproduction in multicellular organism (GO:0022412)	21	0	.28	-	 < 0.01	1.00E00
clathrin-dependent endocytosis (GO:0072583)	10	0	.13	-	 < 0.01	1.00E00
T cell activation involved in immune response (GO:0002286)	2	0	.03	-	 < 0.01	1.00E00
lymphocyte activation involved in immune response (GO:0002285)	2	0	.03	-	 < 0.01	1.00E00
cholesterol transport (GO:0030301)	8	0	.11	-	 < 0.01	1.00E00
cellular response to external stimulus (GO:0071496)	22	0	.30	-	 < 0.01	1.00E00
cellular response to endogenous stimulus (GO:0071495)	149	0	2.01	-	 < 0.01	2.72E-01
positive regulation of cation channel activity (GO:2001259)	4	0	.05	-	 < 0.01	1.00E00
response to steroid hormone (GO:0048545)	8	0	.11	-	 < 0.01	1.00E00
lipid metabolic process (GO:0006629)	302	0	4.07	-	 < 0.01	3.66E-02
skeletal muscle contraction (GO:0003009)	8	0	.11	-	 < 0.01	1.00E00
system process (GO:0003008)	98	0	1.32	-	 < 0.01	6.45E-01
negative regulation of chromosome organization (GO:2001251)	10	0	.13	-	 < 0.01	1.00E00
transforming growth factor beta receptor superfamily signaling pathway (GO:0141091)	28	0	.38	-	 < 0.01	1.00E00
protein processing involved in protein targeting to mitochondrion (GO:0006627)	1	0	.01	-	 < 0.01	1.00E00
protein targeting to mitochondrion (GO:0006626)	18	0	.24	-	 < 0.01	1.00E00
developmental process involved in reproduction (GO:0003006)	23	0	.31	-	 < 0.01	1.00E00
response to unfolded protein (GO:0006986)	18	0	.24	-	 < 0.01	1.00E00
protein targeting to vacuole (GO:0006623)	11	0	.15	-	 < 0.01	1.00E00
protein targeting to lysosome (GO:0006622)	2	0	.03	-	 < 0.01	1.00E00
positive regulation of cell-cell adhesion (GO:0022409)	9	0	.12	-	 < 0.01	1.00E00
post-translational protein targeting to endoplasmic reticulum membrane (GO:0006620)	6	0	.08	-	 < 0.01	1.00E00
negative regulation of cell-cell adhesion (GO:0022408)	7	0	.09	-	 < 0.01	1.00E00
regulation of cell-cell adhesion (GO:0022407)	15	0	.20	-	 < 0.01	1.00E00
negative regulation of mitotic cell cycle phase transition (GO:1901991)	28	0	.38	-	 < 0.01	1.00E00
regulation of mitotic cell cycle phase transition (GO:1901990)	52	0	.70	-	 < 0.01	1.00E00
myeloid leukocyte activation (GO:0002274)	1	0	.01	-	 < 0.01	1.00E00
visual system development (GO:0150063)	27	0	.36	-	 < 0.01	1.00E00
cellular response to light stimulus (GO:0071482)	6	0	.08	-	 < 0.01	1.00E00
negative regulation of intrinsic apoptotic signaling pathway (GO:2001243)	4	0	.05	-	 < 0.01	1.00E00
regulation of intrinsic apoptotic signaling pathway (GO:2001242)	7	0	.09	-	 < 0.01	1.00E00
negative regulation of cell cycle phase transition (GO:1901988)	41	0	.55	-	 < 0.01	1.00E00
interstrand cross-link repair (GO:0036297)	10	0	.13	-	 < 0.01	1.00E00
regulation of cell cycle phase transition (GO:1901987)	69	0	.93	-	 < 0.01	1.00E00
protein export from nucleus (GO:0006611)	7	0	.09	-	 < 0.01	1.00E00
epithelial cilium movement involved in extracellular fluid movement (GO:0003351)	2	0	.03	-	 < 0.01	1.00E00
response to osmotic stress (GO:0006970)	4	0	.05	-	 < 0.01	1.00E00
cell activation involved in immune response (GO:0002263)	2	0	.03	-	 < 0.01	1.00E00
positive regulation of extrinsic apoptotic signaling pathway (GO:2001238)	4	0	.05	-	 < 0.01	1.00E00
negative regulation of extrinsic apoptotic signaling pathway (GO:2001237)	11	0	.15	-	 < 0.01	1.00E00
regulation of extrinsic apoptotic signaling pathway (GO:2001236)	15	0	.20	-	 < 0.01	1.00E00
negative regulation of apoptotic signaling pathway (GO:2001234)	15	0	.20	-	 < 0.01	1.00E00
organic hydroxy compound biosynthetic process (GO:1901617)	38	0	.51	-	 < 0.01	1.00E00
organic hydroxy compound metabolic process (GO:1901615)	66	0	.89	-	 < 0.01	1.00E00
sensory system development (GO:0048880)	27	0	.36	-	 < 0.01	1.00E00
positive regulation of cell motility (GO:2000147)	45	0	.61	-	 < 0.01	1.00E00
G2/M transition of mitotic cell cycle (GO:0000086)	3	0	.04	-	 < 0.01	1.00E00
negative regulation of cell motility (GO:2000146)	10	0	.13	-	 < 0.01	1.00E00
regulation of cell motility (GO:2000145)	86	0	1.16	-	 < 0.01	6.33E-01
cilium movement (GO:0003341)	17	0	.23	-	 < 0.01	1.00E00
G1/S transition of mitotic cell cycle (GO:0000082)	17	0	.23	-	 < 0.01	1.00E00
miRNA processing (GO:0035196)	11	0	.15	-	 < 0.01	1.00E00
amino sugar catabolic process (GO:0046348)	3	0	.04	-	 < 0.01	1.00E00
activation of immune response (GO:0002253)	36	0	.49	-	 < 0.01	1.00E00
protein K48-linked deubiquitination (GO:0071108)	2	0	.03	-	 < 0.01	1.00E00
immune effector process (GO:0002252)	7	0	.09	-	 < 0.01	1.00E00
regulatory ncRNA-mediated post-transcriptional gene silencing (GO:0035194)	9	0	.12	-	 < 0.01	1.00E00
negative regulation of catalytic activity (GO:0043086)	59	0	.80	-	 < 0.01	1.00E00
adaptive immune response (GO:0002250)	8	0	.11	-	 < 0.01	1.00E00
DNA conformation change (GO:0071103)	12	0	.16	-	 < 0.01	1.00E00
spermatid differentiation (GO:0048515)	4	0	.05	-	 < 0.01	1.00E00
blood vessel morphogenesis (GO:0048514)	34	0	.46	-	 < 0.01	1.00E00
humoral immune response (GO:0006959)	6	0	.08	-	 < 0.01	1.00E00
nucleobase-containing compound transport (GO:0015931)	51	0	.69	-	 < 0.01	1.00E00
rhythmic process (GO:0048511)	20	0	.27	-	 < 0.01	1.00E00
alpha-amino acid biosynthetic process (GO:1901607)	23	0	.31	-	 < 0.01	1.00E00
positive regulation of ERK1 and ERK2 cascade (GO:0070374)	12	0	.16	-	 < 0.01	1.00E00
multicellular organismal-level homeostasis (GO:0048871)	12	0	.16	-	 < 0.01	1.00E00
complement activation (GO:0006956)	3	0	.04	-	 < 0.01	1.00E00
alpha-amino acid metabolic process (GO:1901605)	70	0	.94	-	 < 0.01	1.00E00
immune response (GO:0006955)	48	0	.65	-	 < 0.01	1.00E00
cell motility (GO:0048870)	173	0	2.33	-	 < 0.01	1.78E-01
DNA damage checkpoint signaling (GO:0000077)	16	0	.22	-	 < 0.01	1.00E00
regulation of ERK1 and ERK2 cascade (GO:0070372)	16	0	.22	-	 < 0.01	1.00E00
DNA replication checkpoint signaling (GO:0000076)	7	0	.09	-	 < 0.01	1.00E00
inflammatory response (GO:0006954)	19	0	.26	-	 < 0.01	1.00E00
amino acid transmembrane transport (GO:0003333)	42	0	.57	-	 < 0.01	1.00E00
cell cycle checkpoint signaling (GO:0000075)	32	0	.43	-	 < 0.01	1.00E00
defense response (GO:0006952)	51	0	.69	-	 < 0.01	1.00E00
negative regulation of G1/S transition of mitotic cell cycle (GO:2000134)	6	0	.08	-	 < 0.01	1.00E00
mitotic sister chromatid segregation (GO:0000070)	33	0	.44	-	 < 0.01	1.00E00
hematopoietic progenitor cell differentiation (GO:0002244)	1	0	.01	-	 < 0.01	1.00E00
positive regulation of JNK cascade (GO:0046330)	7	0	.09	-	 < 0.01	1.00E00
response to cytokine (GO:0034097)	43	0	.58	-	 < 0.01	1.00E00
stem cell development (GO:0048864)	24	0	.32	-	 < 0.01	1.00E00
syncytium formation (GO:0006949)	3	0	.04	-	 < 0.01	1.00E00
stem cell differentiation (GO:0048863)	24	0	.32	-	 < 0.01	1.00E00
membrane fusion (GO:0061025)	46	0	.62	-	 < 0.01	1.00E00
striated muscle contraction (GO:0006941)	19	0	.26	-	 < 0.01	1.00E00
response to molecule of bacterial origin (GO:0002237)	11	0	.15	-	 < 0.01	1.00E00
regulation of JNK cascade (GO:0046328)	10	0	.13	-	 < 0.01	1.00E00
negative regulation of programmed cell death (GO:0043069)	45	0	.61	-	 < 0.01	1.00E00
negative regulation of apoptotic process (GO:0043066)	44	0	.59	-	 < 0.01	1.00E00
cilium movement involved in cell motility (GO:0060294)	9	0	.12	-	 < 0.01	1.00E00
extracellular structure organization (GO:0043062)	95	0	1.28	-	 < 0.01	6.41E-01
sterol transport (GO:0015918)	13	0	.18	-	 < 0.01	1.00E00
cell projection morphogenesis (GO:0048858)	132	0	1.78	-	 < 0.01	4.28E-01
phospholipid transport (GO:0015914)	26	0	.35	-	 < 0.01	1.00E00
positive regulation of cell differentiation (GO:0045597)	45	0	.61	-	 < 0.01	1.00E00
inorganic anion transmembrane transport (GO:0098661)	36	0	.49	-	 < 0.01	1.00E00
regulation of muscle contraction (GO:0006937)	7	0	.09	-	 < 0.01	1.00E00
muscle contraction (GO:0006936)	27	0	.36	-	 < 0.01	1.00E00
chemotaxis (GO:0006935)	30	0	.40	-	 < 0.01	1.00E00
negative regulation of cysteine-type endopeptidase activity (GO:2000117)	3	0	.04	-	 < 0.01	1.00E00
regulation of cysteine-type endopeptidase activity (GO:2000116)	19	0	.26	-	 < 0.01	1.00E00
positive regulation of mRNA catabolic process (GO:0061014)	27	0	.36	-	 < 0.01	1.00E00
pyrimidine-containing compound metabolic process (GO:0072527)	23	0	.31	-	 < 0.01	1.00E00
regulation of mRNA catabolic process (GO:0061013)	48	0	.65	-	 < 0.01	1.00E00
pyridine-containing compound metabolic process (GO:0072524)	28	0	.38	-	 < 0.01	1.00E00
purine-containing compound catabolic process (GO:0072523)	22	0	.30	-	 < 0.01	1.00E00
purine-containing compound biosynthetic process (GO:0072522)	48	0	.65	-	 < 0.01	1.00E00
endoplasmic reticulum unfolded protein response (GO:0030968)	17	0	.23	-	 < 0.01	1.00E00
toll-like receptor signaling pathway (GO:0002224)	4	0	.05	-	 < 0.01	1.00E00
pattern recognition receptor signaling pathway (GO:0002221)	11	0	.15	-	 < 0.01	1.00E00
cilium-dependent cell motility (GO:0060285)	11	0	.15	-	 < 0.01	1.00E00
long-chain fatty acid transport (GO:0015909)	3	0	.04	-	 < 0.01	1.00E00
fatty acid transport (GO:0015908)	18	0	.24	-	 < 0.01	1.00E00
external encapsulating structure organization (GO:0045229)	95	0	1.28	-	 < 0.01	6.41E-01
monoatomic anion transmembrane transport (GO:0098656)	37	0	.50	-	 < 0.01	1.00E00
activation of innate immune response (GO:0002218)	12	0	.16	-	 < 0.01	1.00E00
negative regulation of peptidase activity (GO:0010466)	22	0	.30	-	 < 0.01	1.00E00
endoplasmic reticulum tubular network organization (GO:0071786)	9	0	.12	-	 < 0.01	1.00E00
male sex differentiation (GO:0046661)	1	0	.01	-	 < 0.01	1.00E00
protein localization to Golgi apparatus (GO:0034067)	9	0	.12	-	 < 0.01	1.00E00
inner ear development (GO:0048839)	2	0	.03	-	 < 0.01	1.00E00
establishment of spindle orientation (GO:0051294)	10	0	.13	-	 < 0.01	1.00E00
cell-cell junction organization (GO:0045216)	40	0	.54	-	 < 0.01	1.00E00
establishment of spindle localization (GO:0051293)	17	0	.23	-	 < 0.01	1.00E00
activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919)	11	0	.15	-	 < 0.01	1.00E00
apoptotic process (GO:0006915)	50	0	.67	-	 < 0.01	1.00E00
phagocytosis, engulfment (GO:0006911)	4	0	.05	-	 < 0.01	1.00E00
calcium ion transmembrane import into cytosol (GO:0097553)	28	0	.38	-	 < 0.01	1.00E00
carboxylic acid transmembrane transport (GO:1905039)	52	0	.70	-	 < 0.01	1.00E00
pyridine nucleotide metabolic process (GO:0019362)	27	0	.36	-	 < 0.01	1.00E00
protein N-linked glycosylation via asparagine (GO:0018279)	10	0	.13	-	 < 0.01	1.00E00
cellular response to organonitrogen compound (GO:0071417)	41	0	.55	-	 < 0.01	1.00E00
somatic diversification of immune receptors via germline recombination within a single locus (GO:0002562)	2	0	.03	-	 < 0.01	1.00E00
somatic diversification of immune receptors (GO:0002200)	2	0	.03	-	 < 0.01	1.00E00
response to fibroblast growth factor (GO:0071774)	24	0	.32	-	 < 0.01	1.00E00
lymphocyte proliferation (GO:0046651)	1	0	.01	-	 < 0.01	1.00E00
regulation of macrophage activation (GO:0043030)	1	0	.01	-	 < 0.01	1.00E00
cellular response to BMP stimulus (GO:0071773)	14	0	.19	-	 < 0.01	1.00E00
response to BMP (GO:0071772)	14	0	.19	-	 < 0.01	1.00E00
negative regulation of sequestering of calcium ion (GO:0051283)	21	0	.28	-	 < 0.01	1.00E00
triglyceride homeostasis (GO:0070328)	4	0	.05	-	 < 0.01	1.00E00
regulation of sequestering of calcium ion (GO:0051282)	25	0	.34	-	 < 0.01	1.00E00
phagocytosis (GO:0006909)	16	0	.22	-	 < 0.01	1.00E00
vesicle fusion (GO:0006906)	39	0	.53	-	 < 0.01	1.00E00
ribosomal large subunit assembly (GO:0000027)	7	0	.09	-	 < 0.01	1.00E00
spliceosomal snRNP assembly (GO:0000387)	13	0	.18	-	 < 0.01	1.00E00
alternative mRNA splicing, via spliceosome (GO:0000380)	5	0	.07	-	 < 0.01	1.00E00
lymphocyte activation (GO:0046649)	12	0	.16	-	 < 0.01	1.00E00
cellular response to organic cyclic compound (GO:0071407)	23	0	.31	-	 < 0.01	1.00E00
regulation of release of sequestered calcium ion into cytosol (GO:0051279)	4	0	.05	-	 < 0.01	1.00E00
nuclear membrane organization (GO:0071763)	4	0	.05	-	 < 0.01	1.00E00
central nervous system neuron differentiation (GO:0021953)	6	0	.08	-	 < 0.01	1.00E00
dendrite morphogenesis (GO:0048813)	2	0	.03	-	 < 0.01	1.00E00
neuron projection morphogenesis (GO:0048812)	131	0	1.77	-	 < 0.01	4.27E-01
regulation of DNA recombination (GO:0000018)	6	0	.08	-	 < 0.01	1.00E00
granulocyte migration (GO:0097530)	3	0	.04	-	 < 0.01	1.00E00
anatomical structure homeostasis (GO:0060249)	4	0	.05	-	 < 0.01	1.00E00
camera-type eye development (GO:0043010)	21	0	.28	-	 < 0.01	1.00E00
protein depolymerization (GO:0051261)	22	0	.30	-	 < 0.01	1.00E00
myeloid leukocyte migration (GO:0097529)	3	0	.04	-	 < 0.01	1.00E00
regulation of leukocyte proliferation (GO:0070663)	5	0	.07	-	 < 0.01	1.00E00
reproduction (GO:0000003)	70	0	.94	-	 < 0.01	1.00E00
leukocyte proliferation (GO:0070661)	1	0	.01	-	 < 0.01	1.00E00
motile cilium assembly (GO:0044458)	4	0	.05	-	 < 0.01	1.00E00
mitochondrial genome maintenance (GO:0000002)	6	0	.08	-	 < 0.01	1.00E00
ribose phosphate metabolic process (GO:0019693)	74	0	1.00	-	 < 0.01	6.28E-01
nuclear migration (GO:0007097)	9	0	.12	-	 < 0.01	1.00E00
negative regulation of double-strand break repair (GO:2000780)	5	0	.07	-	 < 0.01	1.00E00
chordate embryonic development (GO:0043009)	16	0	.22	-	 < 0.01	1.00E00
mitotic G2 DNA damage checkpoint signaling (GO:0007095)	8	0	.11	-	 < 0.01	1.00E00
mitotic spindle assembly checkpoint signaling (GO:0007094)	9	0	.12	-	 < 0.01	1.00E00
regulation of mitotic spindle organization (GO:0060236)	2	0	.03	-	 < 0.01	1.00E00
mitotic cell cycle checkpoint signaling (GO:0007093)	24	0	.32	-	 < 0.01	1.00E00
metaphase/anaphase transition of mitotic cell cycle (GO:0007091)	2	0	.03	-	 < 0.01	1.00E00
cell-cell adhesion (GO:0098609)	137	0	1.85	-	 < 0.01	2.68E-01
cellular response to starvation (GO:0009267)	21	0	.28	-	 < 0.01	1.00E00
Golgi to plasma membrane protein transport (GO:0043001)	6	0	.08	-	 < 0.01	1.00E00
response to temperature stimulus (GO:0009266)	12	0	.16	-	 < 0.01	1.00E00
neurotransmitter receptor transport to postsynaptic membrane (GO:0098969)	7	0	.09	-	 < 0.01	1.00E00
regulation of exocytosis (GO:0017157)	25	0	.34	-	 < 0.01	1.00E00
ribonucleotide catabolic process (GO:0009261)	18	0	.24	-	 < 0.01	1.00E00
positive regulation of lymphocyte activation (GO:0051251)	5	0	.07	-	 < 0.01	1.00E00
purine nucleoside metabolic process (GO:0042278)	7	0	.09	-	 < 0.01	1.00E00
ribonucleotide biosynthetic process (GO:0009260)	34	0	.46	-	 < 0.01	1.00E00
negative regulation of lymphocyte activation (GO:0051250)	5	0	.07	-	 < 0.01	1.00E00
regulation of double-strand break repair (GO:2000779)	7	0	.09	-	 < 0.01	1.00E00
cardiac muscle cell action potential involved in contraction (GO:0086002)	4	0	.05	-	 < 0.01	1.00E00
cell-cell fusion (GO:0140253)	3	0	.04	-	 < 0.01	1.00E00
immunoglobulin mediated immune response (GO:0016064)	2	0	.03	-	 < 0.01	1.00E00
regulation of mitotic nuclear division (GO:0007088)	21	0	.28	-	 < 0.01	1.00E00
regulation of metaphase/anaphase transition of cell cycle (GO:1902099)	16	0	.22	-	 < 0.01	1.00E00
leukocyte differentiation (GO:0002521)	12	0	.16	-	 < 0.01	1.00E00
immune system development (GO:0002520)	5	0	.07	-	 < 0.01	1.00E00
forebrain development (GO:0030900)	11	0	.15	-	 < 0.01	1.00E00
ribonucleotide metabolic process (GO:0009259)	68	0	.92	-	 < 0.01	1.00E00
regulation of lymphocyte activation (GO:0051249)	10	0	.13	-	 < 0.01	1.00E00
mitotic metaphase chromosome alignment (GO:0007080)	5	0	.07	-	 < 0.01	1.00E00
negative regulation of protein metabolic process (GO:0051248)	82	0	1.11	-	 < 0.01	6.31E-01
negative regulation of translation (GO:0017148)	11	0	.15	-	 < 0.01	1.00E00
regulation of natural killer cell mediated cytotoxicity (GO:0042269)	1	0	.01	-	 < 0.01	1.00E00
negative regulation of multicellular organismal process (GO:0051241)	33	0	.44	-	 < 0.01	1.00E00
positive regulation of TORC1 signaling (GO:1904263)	12	0	.16	-	 < 0.01	1.00E00
negative regulation of TORC1 signaling (GO:1904262)	5	0	.07	-	 < 0.01	1.00E00
glucan biosynthetic process (GO:0009250)	1	0	.01	-	 < 0.01	1.00E00
protein modification by small protein removal (GO:0070646)	59	0	.80	-	 < 0.01	1.00E00
hexose biosynthetic process (GO:0019319)	7	0	.09	-	 < 0.01	1.00E00
hexose metabolic process (GO:0019318)	20	0	.27	-	 < 0.01	1.00E00
Wnt signaling pathway (GO:0016055)	49	0	.66	-	 < 0.01	1.00E00
organic acid catabolic process (GO:0016054)	66	0	.89	-	 < 0.01	1.00E00
mannosylation (GO:0097502)	8	0	.11	-	 < 0.01	1.00E00
organic acid biosynthetic process (GO:0016053)	53	0	.71	-	 < 0.01	1.00E00
regulation of lymphocyte migration (GO:2000401)	3	0	.04	-	 < 0.01	1.00E00
carbohydrate catabolic process (GO:0016052)	26	0	.35	-	 < 0.01	1.00E00
mitotic chromosome condensation (GO:0007076)	6	0	.08	-	 < 0.01	1.00E00
regulation of centrosome cycle (GO:0046605)	5	0	.07	-	 < 0.01	1.00E00
glycolipid biosynthetic process (GO:0009247)	26	0	.35	-	 < 0.01	1.00E00
establishment of RNA localization (GO:0051236)	34	0	.46	-	 < 0.01	1.00E00
maintenance of location (GO:0051235)	25	0	.34	-	 < 0.01	1.00E00
spindle elongation (GO:0051231)	5	0	.07	-	 < 0.01	1.00E00
cell growth (GO:0016049)	5	0	.07	-	 < 0.01	1.00E00
actin polymerization or depolymerization (GO:0008154)	29	0	.39	-	 < 0.01	1.00E00
cell cycle DNA replication (GO:0044786)	11	0	.15	-	 < 0.01	1.00E00
lipid catabolic process (GO:0016042)	64	0	.86	-	 < 0.01	1.00E00
metaphase/anaphase transition of cell cycle (GO:0044784)	2	0	.03	-	 < 0.01	1.00E00
mitotic sister chromatid cohesion (GO:0007064)	6	0	.08	-	 < 0.01	1.00E00
sister chromatid cohesion (GO:0007062)	14	0	.19	-	 < 0.01	1.00E00
septin cytoskeleton organization (GO:0032185)	2	0	.03	-	 < 0.01	1.00E00
peptidyl-tyrosine modification (GO:0018212)	8	0	.11	-	 < 0.01	1.00E00
spindle assembly (GO:0051225)	20	0	.27	-	 < 0.01	1.00E00
developmental growth involved in morphogenesis (GO:0060560)	5	0	.07	-	 < 0.01	1.00E00
regeneration (GO:0031099)	2	0	.03	-	 < 0.01	1.00E00
regulation of protein transport (GO:0051223)	10	0	.13	-	 < 0.01	1.00E00
positive regulation of protein transport (GO:0051222)	2	0	.03	-	 < 0.01	1.00E00
detection of chemical stimulus (GO:0009593)	5	0	.07	-	 < 0.01	1.00E00
tissue regeneration (GO:0042246)	2	0	.03	-	 < 0.01	1.00E00
plasma membrane phospholipid scrambling (GO:0017121)	5	0	.07	-	 < 0.01	1.00E00
positive regulation of proteolysis (GO:0045862)	36	0	.49	-	 < 0.01	1.00E00
negative regulation of proteolysis (GO:0045861)	27	0	.36	-	 < 0.01	1.00E00
biological process involved in interspecies interaction between organisms (GO:0044419)	37	0	.50	-	 < 0.01	1.00E00
nuclear DNA replication (GO:0033260)	11	0	.15	-	 < 0.01	1.00E00
mitotic DNA integrity checkpoint signaling (GO:0044774)	13	0	.18	-	 < 0.01	1.00E00
peptidyl-serine modification (GO:0018209)	72	0	.97	-	 < 0.01	1.00E00
mitotic DNA damage checkpoint signaling (GO:0044773)	13	0	.18	-	 < 0.01	1.00E00
protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043328)	5	0	.07	-	 < 0.01	1.00E00
membrane assembly (GO:0071709)	11	0	.15	-	 < 0.01	1.00E00
carboxylic acid transport (GO:0046942)	94	0	1.27	-	 < 0.01	6.40E-01
cartilage development (GO:0051216)	8	0	.11	-	 < 0.01	1.00E00
nucleotide-sugar metabolic process (GO:0009225)	5	0	.07	-	 < 0.01	1.00E00
neuron migration (GO:0001764)	9	0	.12	-	 < 0.01	1.00E00
morphogenesis of a branching structure (GO:0001763)	1	0	.01	-	 < 0.01	1.00E00
protein K11-linked ubiquitination (GO:0070979)	7	0	.09	-	 < 0.01	1.00E00
response to starvation (GO:0042594)	28	0	.38	-	 < 0.01	1.00E00
glucose homeostasis (GO:0042593)	7	0	.09	-	 < 0.01	1.00E00
aerobic electron transport chain (GO:0019646)	4	0	.05	-	 < 0.01	1.00E00
cell-substrate junction assembly (GO:0007044)	1	0	.01	-	 < 0.01	1.00E00
cell-cell junction assembly (GO:0007043)	35	0	.47	-	 < 0.01	1.00E00
lysosomal transport (GO:0007041)	19	0	.26	-	 < 0.01	1.00E00
release of sequestered calcium ion into cytosol (GO:0051209)	19	0	.26	-	 < 0.01	1.00E00
protein insertion into membrane (GO:0051205)	4	0	.05	-	 < 0.01	1.00E00
neural crest cell migration (GO:0001755)	22	0	.30	-	 < 0.01	1.00E00
adherens junction organization (GO:0034332)	23	0	.31	-	 < 0.01	1.00E00
mitochondrial calcium ion homeostasis (GO:0051560)	8	0	.11	-	 < 0.01	1.00E00
cell junction organization (GO:0034330)	99	0	1.33	-	 < 0.01	6.46E-01
negative regulation of mitotic metaphase/anaphase transition (GO:0045841)	9	0	.12	-	 < 0.01	1.00E00
response to chemical (GO:0042221)	275	0	3.71	-	 < 0.01	5.54E-02
positive regulation of mitotic nuclear division (GO:0045840)	6	0	.08	-	 < 0.01	1.00E00
organophosphate metabolic process (GO:0019637)	242	0	3.26	-	 < 0.01	8.14E-02
ERAD pathway (GO:0036503)	31	0	.42	-	 < 0.01	1.00E00
response to reactive oxygen species (GO:0000302)	7	0	.09	-	 < 0.01	1.00E00
mononuclear cell differentiation (GO:1903131)	8	0	.11	-	 < 0.01	1.00E00
nervous system development (GO:0007399)	367	0	4.95	-	 < 0.01	1.03E-02
meiosis I cell cycle process (GO:0061982)	26	0	.35	-	 < 0.01	1.00E00
protein localization to synapse (GO:0035418)	12	0	.16	-	 < 0.01	1.00E00
vacuolar acidification (GO:0007035)	9	0	.12	-	 < 0.01	1.00E00
skeletal muscle organ development (GO:0060538)	15	0	.20	-	 < 0.01	1.00E00
regulation of neurotransmitter secretion (GO:0046928)	13	0	.18	-	 < 0.01	1.00E00
endosome organization (GO:0007032)	12	0	.16	-	 < 0.01	1.00E00
positive regulation of response to biotic stimulus (GO:0002833)	19	0	.26	-	 < 0.01	1.00E00
peroxisome organization (GO:0007031)	20	0	.27	-	 < 0.01	1.00E00
Golgi organization (GO:0007030)	37	0	.50	-	 < 0.01	1.00E00
regulation of response to biotic stimulus (GO:0002831)	24	0	.32	-	 < 0.01	1.00E00
regulation of phosphoprotein phosphatase activity (GO:0043666)	4	0	.05	-	 < 0.01	1.00E00
cell junction assembly (GO:0034329)	55	0	.74	-	 < 0.01	1.00E00
purine ribonucleoside triphosphate biosynthetic process (GO:0009206)	1	0	.01	-	 < 0.01	1.00E00
purine ribonucleoside triphosphate metabolic process (GO:0009205)	17	0	.23	-	 < 0.01	1.00E00
positive regulation of cell development (GO:0010720)	27	0	.36	-	 < 0.01	1.00E00
fertilization (GO:0009566)	5	0	.07	-	 < 0.01	1.00E00
negative regulation of mitotic nuclear division (GO:0045839)	9	0	.12	-	 < 0.01	1.00E00
ribonucleoside triphosphate biosynthetic process (GO:0009201)	3	0	.04	-	 < 0.01	1.00E00
retinol metabolic process (GO:0042572)	1	0	.01	-	 < 0.01	1.00E00
translesion synthesis (GO:0019985)	10	0	.13	-	 < 0.01	1.00E00
endoplasmic reticulum organization (GO:0007029)	21	0	.28	-	 < 0.01	1.00E00
protein transmembrane import into intracellular organelle (GO:0044743)	21	0	.28	-	 < 0.01	1.00E00
activation of protein kinase activity (GO:0032147)	5	0	.07	-	 < 0.01	1.00E00
microtubule nucleation (GO:0007020)	15	0	.20	-	 < 0.01	1.00E00
positive regulation of adaptive immune response (GO:0002821)	1	0	.01	-	 < 0.01	1.00E00
mismatch repair (GO:0006298)	10	0	.13	-	 < 0.01	1.00E00
Arp2/3 complex-mediated actin nucleation (GO:0034314)	12	0	.16	-	 < 0.01	1.00E00
pre-miRNA processing (GO:0031054)	6	0	.08	-	 < 0.01	1.00E00
primary miRNA processing (GO:0031053)	2	0	.03	-	 < 0.01	1.00E00
negative regulation of innate immune response (GO:0045824)	3	0	.04	-	 < 0.01	1.00E00
defense response to symbiont (GO:0140546)	24	0	.32	-	 < 0.01	1.00E00
dendrite development (GO:0016358)	6	0	.08	-	 < 0.01	1.00E00
microtubule depolymerization (GO:0007019)	9	0	.12	-	 < 0.01	1.00E00
microtubule-based movement (GO:0007018)	93	0	1.25	-	 < 0.01	6.39E-01
epigenetic regulation of gene expression (GO:0040029)	25	0	.34	-	 < 0.01	1.00E00
dicarboxylic acid metabolic process (GO:0043648)	12	0	.16	-	 < 0.01	1.00E00
response to lipopolysaccharide (GO:0032496)	11	0	.15	-	 < 0.01	1.00E00
nucleotide-excision repair (GO:0006289)	17	0	.23	-	 < 0.01	1.00E00
membrane depolarization (GO:0051899)	16	0	.22	-	 < 0.01	1.00E00
positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction (GO:0051897)	11	0	.15	-	 < 0.01	1.00E00
regulatory ncRNA-mediated gene silencing (GO:0031047)	23	0	.31	-	 < 0.01	1.00E00
regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction (GO:0051896)	13	0	.18	-	 < 0.01	1.00E00
base-excision repair (GO:0006284)	10	0	.13	-	 < 0.01	1.00E00
regulation of DNA repair (GO:0006282)	15	0	.20	-	 < 0.01	1.00E00
negative regulation of gene expression, epigenetic (GO:0045814)	19	0	.26	-	 < 0.01	1.00E00
nucleoside phosphate biosynthetic process (GO:1901293)	54	0	.73	-	 < 0.01	1.00E00
nucleoside phosphate catabolic process (GO:1901292)	28	0	.38	-	 < 0.01	1.00E00
protein K48-linked ubiquitination (GO:0070936)	8	0	.11	-	 < 0.01	1.00E00
myelination (GO:0042552)	10	0	.13	-	 < 0.01	1.00E00
inner mitochondrial membrane organization (GO:0007007)	11	0	.15	-	 < 0.01	1.00E00
mitochondrial membrane organization (GO:0007006)	14	0	.19	-	 < 0.01	1.00E00
determination of left/right symmetry (GO:0007368)	2	0	.03	-	 < 0.01	1.00E00
regulation of cilium assembly (GO:1902017)	5	0	.07	-	 < 0.01	1.00E00
telomere maintenance via telomerase (GO:0007004)	4	0	.05	-	 < 0.01	1.00E00
positive regulation of locomotion (GO:0040017)	45	0	.61	-	 < 0.01	1.00E00
polyadenylation-dependent ncRNA catabolic process (GO:0043634)	3	0	.04	-	 < 0.01	1.00E00
negative regulation of locomotion (GO:0040013)	10	0	.13	-	 < 0.01	1.00E00
positive regulation of type I interferon production (GO:0032481)	2	0	.03	-	 < 0.01	1.00E00
regulation of locomotion (GO:0040012)	86	0	1.16	-	 < 0.01	6.33E-01
locomotion (GO:0040011)	30	0	.40	-	 < 0.01	1.00E00
positive regulation of catabolic process (GO:0009896)	63	0	.85	-	 < 0.01	1.00E00
negative regulation of catabolic process (GO:0009895)	33	0	.44	-	 < 0.01	1.00E00
nucleobase-containing small molecule catabolic process (GO:0034656)	8	0	.11	-	 < 0.01	1.00E00
regulation of catabolic process (GO:0009894)	124	0	1.67	-	 < 0.01	4.18E-01
nucleobase-containing compound catabolic process (GO:0034655)	85	0	1.15	-	 < 0.01	6.32E-01
positive regulation of endocytosis (GO:0045807)	2	0	.03	-	 < 0.01	1.00E00
negative regulation of protein ubiquitination (GO:0031397)	5	0	.07	-	 < 0.01	1.00E00
nucleobase-containing compound biosynthetic process (GO:0034654)	153	0	2.06	-	 < 0.01	2.75E-01
negative regulation of endocytosis (GO:0045806)	3	0	.04	-	 < 0.01	1.00E00
DNA strand elongation involved in DNA replication (GO:0006271)	8	0	.11	-	 < 0.01	1.00E00
DNA replication initiation (GO:0006270)	15	0	.20	-	 < 0.01	1.00E00
tumor necrosis factor-mediated signaling pathway (GO:0033209)	4	0	.05	-	 < 0.01	1.00E00
reciprocal homologous recombination (GO:0140527)	20	0	.27	-	 < 0.01	1.00E00
plasma membrane bounded cell projection morphogenesis (GO:0120039)	132	0	1.78	-	 < 0.01	4.28E-01
regulation of insulin secretion (GO:0050796)	3	0	.04	-	 < 0.01	1.00E00
sexual reproduction (GO:0019953)	67	0	.90	-	 < 0.01	1.00E00
regulation of plasma membrane bounded cell projection assembly (GO:0120032)	22	0	.30	-	 < 0.01	1.00E00
negative regulation of RNA catabolic process (GO:1902369)	12	0	.16	-	 < 0.01	1.00E00
intraciliary transport involved in cilium assembly (GO:0035735)	3	0	.04	-	 < 0.01	1.00E00
regulation of growth (GO:0040008)	15	0	.20	-	 < 0.01	1.00E00
growth (GO:0040007)	7	0	.09	-	 < 0.01	1.00E00
organelle membrane fusion (GO:0090174)	40	0	.54	-	 < 0.01	1.00E00
cell fate specification (GO:0001708)	25	0	.34	-	 < 0.01	1.00E00
DNA unwinding involved in DNA replication (GO:0006268)	4	0	.05	-	 < 0.01	1.00E00
mesoderm formation (GO:0001707)	7	0	.09	-	 < 0.01	1.00E00
establishment of mitotic spindle localization (GO:0040001)	13	0	.18	-	 < 0.01	1.00E00
regulatory ncRNA processing (GO:0070918)	15	0	.20	-	 < 0.01	1.00E00
DNA-templated DNA replication (GO:0006261)	55	0	.74	-	 < 0.01	1.00E00
DNA replication (GO:0006260)	61	0	.82	-	 < 0.01	1.00E00
regulation of receptor signaling pathway via STAT (GO:1904892)	6	0	.08	-	 < 0.01	1.00E00
unsaturated fatty acid metabolic process (GO:0033559)	7	0	.09	-	 < 0.01	1.00E00
positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531)	3	0	.04	-	 < 0.01	1.00E00
post-transcriptional tethering of RNA polymerase II gene DNA at nuclear periphery (GO:0000973)	2	0	.03	-	 < 0.01	1.00E00
transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery (GO:0000972)	4	0	.05	-	 < 0.01	1.00E00
regulation of postsynaptic membrane neurotransmitter receptor levels (GO:0099072)	14	0	.19	-	 < 0.01	1.00E00
regulation of mitotic cell cycle (GO:0007346)	73	0	.98	-	 < 0.01	6.28E-01
sodium ion transmembrane transport (GO:0035725)	41	0	.55	-	 < 0.01	1.00E00
positive regulation of response to external stimulus (GO:0032103)	27	0	.36	-	 < 0.01	1.00E00
regulation of cytokinesis (GO:0032465)	5	0	.07	-	 < 0.01	1.00E00
intraciliary retrograde transport (GO:0035721)	5	0	.07	-	 < 0.01	1.00E00
carbohydrate derivative transport (GO:1901264)	19	0	.26	-	 < 0.01	1.00E00
amide transport (GO:0042886)	9	0	.12	-	 < 0.01	1.00E00
RNA destabilization (GO:0050779)	24	0	.32	-	 < 0.01	1.00E00
positive regulation of immune response (GO:0050778)	44	0	.59	-	 < 0.01	1.00E00
regulation of immune response (GO:0050776)	53	0	.71	-	 < 0.01	1.00E00
regulation of dendrite development (GO:0050773)	11	0	.15	-	 < 0.01	1.00E00
cyclic-nucleotide-mediated signaling (GO:0019935)	17	0	.23	-	 < 0.01	1.00E00
positive regulation of axonogenesis (GO:0050772)	5	0	.07	-	 < 0.01	1.00E00
mitochondrial RNA processing (GO:0000963)	5	0	.07	-	 < 0.01	1.00E00
regulation of TORC1 signaling (GO:1903432)	17	0	.23	-	 < 0.01	1.00E00
cGMP-mediated signaling (GO:0019934)	2	0	.03	-	 < 0.01	1.00E00
cAMP-mediated signaling (GO:0019933)	15	0	.20	-	 < 0.01	1.00E00
binding of sperm to zona pellucida (GO:0007339)	1	0	.01	-	 < 0.01	1.00E00
bone mineralization (GO:0030282)	1	0	.01	-	 < 0.01	1.00E00
single fertilization (GO:0007338)	5	0	.07	-	 < 0.01	1.00E00
phosphorylation (GO:0016310)	199	0	2.68	-	 < 0.01	1.18E-01
endocytic recycling (GO:0032456)	26	0	.35	-	 < 0.01	1.00E00
regulation of neuronal synaptic plasticity (GO:0048168)	8	0	.11	-	 < 0.01	1.00E00
regulation of synaptic plasticity (GO:0048167)	23	0	.31	-	 < 0.01	1.00E00
cellular response to unfolded protein (GO:0034620)	18	0	.24	-	 < 0.01	1.00E00
mitochondrial protein processing (GO:0034982)	4	0	.05	-	 < 0.01	1.00E00
positive regulation of neurogenesis (GO:0050769)	15	0	.20	-	 < 0.01	1.00E00
mitochondrial RNA metabolic process (GO:0000959)	11	0	.15	-	 < 0.01	1.00E00
intermembrane lipid transfer (GO:0120009)	1	0	.01	-	 < 0.01	1.00E00
nuclear-transcribed mRNA catabolic process (GO:0000956)	38	0	.51	-	 < 0.01	1.00E00
negative regulation of cAMP-mediated signaling (GO:0043951)	2	0	.03	-	 < 0.01	1.00E00
polyamine biosynthetic process (GO:0006596)	6	0	.08	-	 < 0.01	1.00E00
response to endoplasmic reticulum stress (GO:0034976)	53	0	.71	-	 < 0.01	1.00E00
polyamine metabolic process (GO:0006595)	7	0	.09	-	 < 0.01	1.00E00
response to tumor necrosis factor (GO:0034612)	7	0	.09	-	 < 0.01	1.00E00
lipid storage (GO:0019915)	3	0	.04	-	 < 0.01	1.00E00
chromosome condensation (GO:0030261)	6	0	.08	-	 < 0.01	1.00E00
melanosome organization (GO:0032438)	2	0	.03	-	 < 0.01	1.00E00
positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436)	13	0	.18	-	 < 0.01	1.00E00
negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435)	4	0	.05	-	 < 0.01	1.00E00
regulation of cAMP-mediated signaling (GO:0043949)	2	0	.03	-	 < 0.01	1.00E00
regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434)	20	0	.27	-	 < 0.01	1.00E00
positive regulation of defense response (GO:0031349)	17	0	.23	-	 < 0.01	1.00E00
cellular response to heat (GO:0034605)	5	0	.07	-	 < 0.01	1.00E00
catecholamine metabolic process (GO:0006584)	5	0	.07	-	 < 0.01	1.00E00
pyrimidine nucleotide metabolic process (GO:0006220)	11	0	.15	-	 < 0.01	1.00E00
neurogenesis (GO:0022008)	279	0	3.76	-	 < 0.01	3.48E-02
regulation of cell killing (GO:0031341)	1	0	.01	-	 < 0.01	1.00E00
lipid modification (GO:0030258)	56	0	.75	-	 < 0.01	1.00E00
monocarboxylic acid metabolic process (GO:0032787)	101	0	1.36	-	 < 0.01	6.48E-01
positive regulation of DNA-templated transcription, elongation (GO:0032786)	7	0	.09	-	 < 0.01	1.00E00
intracellular protein transmembrane transport (GO:0065002)	17	0	.23	-	 < 0.01	1.00E00
regulation of DNA-templated transcription elongation (GO:0032784)	10	0	.13	-	 < 0.01	1.00E00
biogenic amine metabolic process (GO:0006576)	17	0	.23	-	 < 0.01	1.00E00
negative regulation of protein-containing complex assembly (GO:0031333)	22	0	.30	-	 < 0.01	1.00E00
regulation of non-canonical NF-kappaB signal transduction (GO:1901222)	1	0	.01	-	 < 0.01	1.00E00
positive regulation of cellular catabolic process (GO:0031331)	43	0	.58	-	 < 0.01	1.00E00
tyrosine metabolic process (GO:0006570)	6	0	.08	-	 < 0.01	1.00E00
negative regulation of cellular catabolic process (GO:0031330)	26	0	.35	-	 < 0.01	1.00E00
positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731)	8	0	.11	-	 < 0.01	1.00E00
regulation of peptidyl-tyrosine phosphorylation (GO:0050730)	12	0	.16	-	 < 0.01	1.00E00
non-canonical NF-kappaB signal transduction (GO:0038061)	2	0	.03	-	 < 0.01	1.00E00
carbohydrate homeostasis (GO:0033500)	7	0	.09	-	 < 0.01	1.00E00
lysosome localization (GO:0032418)	4	0	.05	-	 < 0.01	1.00E00
synaptic vesicle transport (GO:0048489)	9	0	.12	-	 < 0.01	1.00E00
RNA biosynthetic process (GO:0032774)	74	0	1.00	-	 < 0.01	6.28E-01
regulation of monoatomic ion transmembrane transporter activity (GO:0032412)	38	0	.51	-	 < 0.01	1.00E00
positive regulation of transporter activity (GO:0032411)	11	0	.15	-	 < 0.01	1.00E00
pyrimidine nucleobase catabolic process (GO:0006208)	5	0	.07	-	 < 0.01	1.00E00
pyrimidine nucleobase metabolic process (GO:0006206)	8	0	.11	-	 < 0.01	1.00E00
regulation of cellular catabolic process (GO:0031329)	89	0	1.20	-	 < 0.01	6.35E-01
actomyosin contractile ring assembly (GO:0000915)	2	0	.03	-	 < 0.01	1.00E00
leukocyte chemotaxis (GO:0030595)	3	0	.04	-	 < 0.01	1.00E00
neutrophil chemotaxis (GO:0030593)	3	0	.04	-	 < 0.01	1.00E00
regulation of transporter activity (GO:0032409)	40	0	.54	-	 < 0.01	1.00E00
oogenesis (GO:0048477)	5	0	.07	-	 < 0.01	1.00E00
secondary alcohol biosynthetic process (GO:1902653)	6	0	.08	-	 < 0.01	1.00E00
secondary alcohol metabolic process (GO:1902652)	11	0	.15	-	 < 0.01	1.00E00
execution phase of apoptosis (GO:0097194)	7	0	.09	-	 < 0.01	1.00E00
intrinsic apoptotic signaling pathway (GO:0097193)	16	0	.22	-	 < 0.01	1.00E00
extrinsic apoptotic signaling pathway (GO:0097191)	10	0	.13	-	 < 0.01	1.00E00
apoptotic signaling pathway (GO:0097190)	27	0	.36	-	 < 0.01	1.00E00
cell morphogenesis (GO:0000902)	163	0	2.20	-	 < 0.01	1.77E-01
poly(A)+ mRNA export from nucleus (GO:0016973)	9	0	.12	-	 < 0.01	1.00E00
feeding behavior (GO:0007631)	4	0	.05	-	 < 0.01	1.00E00
cellular response to nutrient levels (GO:0031669)	21	0	.28	-	 < 0.01	1.00E00
cellular response to extracellular stimulus (GO:0031668)	21	0	.28	-	 < 0.01	1.00E00
response to nutrient levels (GO:0031667)	31	0	.42	-	 < 0.01	1.00E00
amelogenesis (GO:0097186)	2	0	.03	-	 < 0.01	1.00E00
lipopolysaccharide-mediated signaling pathway (GO:0031663)	1	0	.01	-	 < 0.01	1.00E00
regulation of protein secretion (GO:0050708)	5	0	.07	-	 < 0.01	1.00E00
erythrocyte differentiation (GO:0030218)	5	0	.07	-	 < 0.01	1.00E00
T cell differentiation (GO:0030217)	4	0	.05	-	 < 0.01	1.00E00
Rac protein signal transduction (GO:0016601)	2	0	.03	-	 < 0.01	1.00E00
circadian rhythm (GO:0007623)	19	0	.26	-	 < 0.01	1.00E00
establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197)	14	0	.19	-	 < 0.01	1.00E00
receptor-mediated endocytosis (GO:0006898)	26	0	.35	-	 < 0.01	1.00E00
glutamate metabolic process (GO:0006536)	2	0	.03	-	 < 0.01	1.00E00
Golgi to vacuole transport (GO:0006896)	4	0	.05	-	 < 0.01	1.00E00
Golgi to endosome transport (GO:0006895)	1	0	.01	-	 < 0.01	1.00E00
Golgi to plasma membrane transport (GO:0006893)	20	0	.27	-	 < 0.01	1.00E00
aspartate metabolic process (GO:0006531)	1	0	.01	-	 < 0.01	1.00E00
post-Golgi vesicle-mediated transport (GO:0006892)	30	0	.40	-	 < 0.01	1.00E00
intra-Golgi vesicle-mediated transport (GO:0006891)	16	0	.22	-	 < 0.01	1.00E00
retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)	14	0	.19	-	 < 0.01	1.00E00
glycosaminoglycan metabolic process (GO:0030203)	20	0	.27	-	 < 0.01	1.00E00
cytoplasmic translational initiation (GO:0002183)	8	0	.11	-	 < 0.01	1.00E00
cytoplasmic translation (GO:0002181)	27	0	.36	-	 < 0.01	1.00E00
cellular response to lipid (GO:0071396)	21	0	.28	-	 < 0.01	1.00E00
behavior (GO:0007610)	7	0	.09	-	 < 0.01	1.00E00
arginine metabolic process (GO:0006525)	11	0	.15	-	 < 0.01	1.00E00
regulation of protein stability (GO:0031647)	14	0	.19	-	 < 0.01	1.00E00
amino acid metabolic process (GO:0006520)	95	0	1.28	-	 < 0.01	6.41E-01
positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060)	13	0	.18	-	 < 0.01	1.00E00
regulation of hemopoiesis (GO:1903706)	7	0	.09	-	 < 0.01	1.00E00
negative regulation of molecular function (GO:0044092)	80	0	1.08	-	 < 0.01	6.30E-01
sensory perception of chemical stimulus (GO:0007606)	3	0	.04	-	 < 0.01	1.00E00
sensory perception of sound (GO:0007605)	9	0	.12	-	 < 0.01	1.00E00
cellular response to steroid hormone stimulus (GO:0071383)	6	0	.08	-	 < 0.01	1.00E00
visual perception (GO:0007601)	20	0	.27	-	 < 0.01	1.00E00
mitotic DNA replication initiation (GO:1902975)	6	0	.08	-	 < 0.01	1.00E00
sensory perception (GO:0007600)	37	0	.50	-	 < 0.01	1.00E00
intracellular iron ion homeostasis (GO:0006879)	5	0	.07	-	 < 0.01	1.00E00
organic hydroxy compound transport (GO:0015850)	22	0	.30	-	 < 0.01	1.00E00
protein quality control for misfolded or incompletely synthesized proteins (GO:0006515)	5	0	.07	-	 < 0.01	1.00E00
regulation of cell junction assembly (GO:1901888)	15	0	.20	-	 < 0.01	1.00E00
protein monoubiquitination (GO:0006513)	5	0	.07	-	 < 0.01	1.00E00
regulation of ubiquitin-dependent protein catabolic process (GO:2000058)	21	0	.28	-	 < 0.01	1.00E00
intracellular calcium ion homeostasis (GO:0006874)	47	0	.63	-	 < 0.01	1.00E00
regulation of membrane depolarization (GO:0003254)	3	0	.04	-	 < 0.01	1.00E00
negative regulation of protein depolymerization (GO:1901880)	21	0	.28	-	 < 0.01	1.00E00
mitotic DNA replication (GO:1902969)	9	0	.12	-	 < 0.01	1.00E00
cellular response to peptide hormone stimulus (GO:0071375)	22	0	.30	-	 < 0.01	1.00E00
organic acid transport (GO:0015849)	94	0	1.27	-	 < 0.01	6.40E-01
proton transmembrane transport (GO:1902600)	12	0	.16	-	 < 0.01	1.00E00
membrane protein ectodomain proteolysis (GO:0006509)	8	0	.11	-	 < 0.01	1.00E00
cell fate commitment (GO:0045165)	55	0	.74	-	 < 0.01	1.00E00
lipid transport (GO:0006869)	73	0	.98	-	 < 0.01	6.28E-01
GPI anchor biosynthetic process (GO:0006506)	14	0	.19	-	 < 0.01	1.00E00
axonemal dynein complex assembly (GO:0070286)	7	0	.09	-	 < 0.01	1.00E00
regulation of protein depolymerization (GO:1901879)	23	0	.31	-	 < 0.01	1.00E00
GPI anchor metabolic process (GO:0006505)	15	0	.20	-	 < 0.01	1.00E00
amino acid transport (GO:0006865)	56	0	.75	-	 < 0.01	1.00E00
regulation of G1/S transition of mitotic cell cycle (GO:2000045)	18	0	.24	-	 < 0.01	1.00E00
receptor internalization (GO:0031623)	12	0	.16	-	 < 0.01	1.00E00
negative regulation of double-strand break repair via homologous recombination (GO:2000042)	5	0	.07	-	 < 0.01	1.00E00
protein sumoylation (GO:0016925)	10	0	.13	-	 < 0.01	1.00E00
cellular response to growth factor stimulus (GO:0071363)	73	0	.98	-	 < 0.01	6.28E-01
organophosphate biosynthetic process (GO:0090407)	128	0	1.73	-	 < 0.01	4.23E-01
peptide transport (GO:0015833)	5	0	.07	-	 < 0.01	1.00E00
oligopeptide transport (GO:0006857)	2	0	.03	-	 < 0.01	1.00E00
tissue remodeling (GO:0048771)	1	0	.01	-	 < 0.01	1.00E00
cell-cell signaling by wnt (GO:0198738)	51	0	.69	-	 < 0.01	1.00E00
establishment or maintenance of apical/basal cell polarity (GO:0035088)	14	0	.19	-	 < 0.01	1.00E00
regulation of B cell proliferation (GO:0030888)	3	0	.04	-	 < 0.01	1.00E00
regulation of centriole replication (GO:0046599)	3	0	.04	-	 < 0.01	1.00E00
intracellular receptor signaling pathway (GO:0030522)	13	0	.18	-	 < 0.01	1.00E00
axoneme assembly (GO:0035082)	11	0	.15	-	 < 0.01	1.00E00
response to organic substance (GO:0010033)	207	0	2.79	-	 < 0.01	1.20E-01
cellular response to tumor necrosis factor (GO:0071356)	7	0	.09	-	 < 0.01	1.00E00
homologous chromosome segregation (GO:0045143)	6	0	.08	-	 < 0.01	1.00E00
mesenchymal cell differentiation (GO:0048762)	26	0	.35	-	 < 0.01	1.00E00
leucine transport (GO:0015820)	1	0	.01	-	 < 0.01	1.00E00
tricarboxylic acid transport (GO:0006842)	2	0	.03	-	 < 0.01	1.00E00
regulation of system process (GO:0044057)	33	0	.44	-	 < 0.01	1.00E00
neuron projection guidance (GO:0097485)	92	0	1.24	-	 < 0.01	6.38E-01
intracellular steroid hormone receptor signaling pathway (GO:0030518)	2	0	.03	-	 < 0.01	1.00E00
negative regulation of BMP signaling pathway (GO:0030514)	21	0	.28	-	 < 0.01	1.00E00
regulation of G2/M transition of mitotic cell cycle (GO:0010389)	17	0	.23	-	 < 0.01	1.00E00
regulation of BMP signaling pathway (GO:0030510)	27	0	.36	-	 < 0.01	1.00E00
cellular response to cytokine stimulus (GO:0071345)	36	0	.49	-	 < 0.01	1.00E00
regulation of lipase activity (GO:0060191)	1	0	.01	-	 < 0.01	1.00E00
glycine transport (GO:0015816)	3	0	.04	-	 < 0.01	1.00E00
mitochondrial transport (GO:0006839)	40	0	.54	-	 < 0.01	1.00E00
aspartate transmembrane transport (GO:0015810)	9	0	.12	-	 < 0.01	1.00E00
meiotic chromosome segregation (GO:0045132)	9	0	.12	-	 < 0.01	1.00E00
inner dynein arm assembly (GO:0036159)	4	0	.05	-	 < 0.01	1.00E00
outer dynein arm assembly (GO:0036158)	2	0	.03	-	 < 0.01	1.00E00
dicarboxylic acid transport (GO:0006835)	15	0	.20	-	 < 0.01	1.00E00
water transport (GO:0006833)	4	0	.05	-	 < 0.01	1.00E00
BMP signaling pathway (GO:0030509)	13	0	.18	-	 < 0.01	1.00E00
glucan metabolic process (GO:0044042)	5	0	.07	-	 < 0.01	1.00E00
cortical actin cytoskeleton organization (GO:0030866)	11	0	.15	-	 < 0.01	1.00E00
cortical cytoskeleton organization (GO:0030865)	16	0	.22	-	 < 0.01	1.00E00
L-amino acid transport (GO:0015807)	16	0	.22	-	 < 0.01	1.00E00
protein localization to extracellular region (GO:0071692)	15	0	.20	-	 < 0.01	1.00E00
neutral amino acid transport (GO:0015804)	20	0	.27	-	 < 0.01	1.00E00
branched-chain amino acid transport (GO:0015803)	1	0	.01	-	 < 0.01	1.00E00
regulation of bone resorption (GO:0045124)	3	0	.04	-	 < 0.01	1.00E00
basic amino acid transport (GO:0015802)	2	0	.03	-	 < 0.01	1.00E00
acidic amino acid transport (GO:0015800)	6	0	.08	-	 < 0.01	1.00E00
iron ion transport (GO:0006826)	11	0	.15	-	 < 0.01	1.00E00
chloride transport (GO:0006821)	36	0	.49	-	 < 0.01	1.00E00
monoatomic anion transport (GO:0006820)	42	0	.57	-	 < 0.01	1.00E00
regulation of epithelial cell differentiation (GO:0030856)	7	0	.09	-	 < 0.01	1.00E00
epithelial cell differentiation (GO:0030855)	16	0	.22	-	 < 0.01	1.00E00
glial cell differentiation (GO:0010001)	9	0	.12	-	 < 0.01	1.00E00
protein neddylation (GO:0045116)	7	0	.09	-	 < 0.01	1.00E00
defense response to other organism (GO:0098542)	29	0	.39	-	 < 0.01	1.00E00
phosphate ion transport (GO:0006817)	7	0	.09	-	 < 0.01	1.00E00
calcium ion transport (GO:0006816)	67	0	.90	-	 < 0.01	1.00E00
sodium ion transport (GO:0006814)	45	0	.61	-	 < 0.01	1.00E00
protein localization to cytoskeleton (GO:0044380)	7	0	.09	-	 < 0.01	1.00E00
